# EDGAR Filing Document

**Accession Number:** 0000916201
**File Stem:** 0001628280-26-023853
**Filing Date:** 2026-4
**Character Count:** 281399
**Document Hash:** 35b719327f854be7844988bc70c1aace
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-023853.hdr.sgml**: 20260406

**ACCESSION NUMBER**: 0001628280-26-023853

**CONFORMED SUBMISSION TYPE**: N-VPFS

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260406

**DATE AS OF CHANGE**: 20260406

**EFFECTIVENESS DATE**: 20260406

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** RELIASTAR LIFE INSURANCE Co NORTHSTAR VARIABLE ACCOUNT
- **CENTRAL INDEX KEY:** 0000916201

**ORGANIZATION NAME:**
- **EIN:** 410451140
- **STATE OF INCORPORATION:** MN
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-VPFS
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-08224
- **FILM NUMBER:** 26840621

**BUSINESS ADDRESS:**
- **STREET 1:** 20 WASHINGTON AVENUE SOUTH
- **CITY:** MINNEAPOLIS
- **STATE:** MN
- **ZIP:** 55401
- **BUSINESS PHONE:** 6123725432

**MAIL ADDRESS:**
- **STREET 1:** 20 WASHINGTON AVENUE SOUTH
- **CITY:** MINNEAPOLIS
- **STATE:** MN
- **ZIP:** 55401

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NORTHSTAR VARIABLE ACCOUNT
- **DATE OF NAME CHANGE:** 20010907

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NORTHSTAR NWNL VARIABLE ACCOUNT
- **DATE OF NAME CHANGE:** 19931215

## Series and Classes Contracts Data

### NORTHSTAR VARIABLE ACCOUNT (Series ID: S000001499)

| Class ID   | Class Name                 | Ticker Symbol   |
|:---|:---|:---|
| C000004020 | Northstar Variable Annuity |  |

Report of Independent Registered Public Accounting Firm

To the Board of Directors of ReliaStar Life Insurance Company and Contract Owners of ReliaStar Life Insurance Company Northstar Variable Account

**Opinion on the Financial Statements**

We have audited the accompanying statement of assets and liabilities of each of the subaccounts listed in the Appendix that comprise ReliaStar Life Insurance Company Northstar Variable Account (the Separate Account), as of December 31, 2025, the related statement of operations and the statements of changes in net assets for each of the periods indicated in the Appendix, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of each subaccount as of December 31, 2025, the results of its operations and changes in its net assets for each of the periods indicated in the Appendix, in conformity with U.S. generally accepted accounting principles.

**Basis for Opinion**

These financial statements are the responsibility of the Separate Account's management. Our responsibility is to express an opinion on each of the subaccounts' financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Separate Account in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our procedures included confirmation of securities owned as of December 31, 2025, by correspondence with the fund companies or their transfer agents, as applicable. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

/S/ ERNST & YOUNG LLP

We have served as the Separate Accounts Auditor since 2001.

Atlanta, GA

April 6, 2026

------

**Appendix**

Subaccounts comprising ReliaStar Life Insurance Company Northstar Variable Account

---

| | | |
|:---|:---|:---|
| **Subaccounts** | **Statement of Operations** | **Statements of Changes in Net Assets** |
| Voya High Yield Portfolio - Institutional Class | For the year ended December 31, 2025 | For each of the two years in the period ended December 31, 2025 |
| Voya Growth and Income Portfolio - Class I | For the year ended December 31, 2025 | For each of the two years in the period ended December 31, 2025 |
| Voya SmallCap Opportunities Portfolio - Class I | For the year ended December 31, 2025 | For each of the two years in the period ended December 31, 2025 |
|  | For the year ended December 31, 2025 | For each of the two years in the period ended December 31, 2025 |
| Voya Index Plus SmallCap Portfolio - Class I | For the period from January 21, 2025 (commencement of operations) through December 31, 2025 | For the period from January 21, 2025 (commencement of operations) through December 31, 2025 |
|  | For the period from January 21, 2025 (commencement of operations) through December 31, 2025 | For the period from January 21, 2025 (commencement of operations) through December 31, 2025 |
|  | For the period from January 21, 2025 (commencement of operations) through December 31, 2025 | For the period from January 21, 2025 (commencement of operations) through December 31, 2025 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**NORTHSTAR VARIABLE ACCOUNT**

**Statement of Assets and Liabilities**

**December 31, 2025**

*(In thousands, except number of shares)*

---

| | | | |
|:---|:---|:---|:---|
| | **Voya High Yield Portfolio - Institutional Class** | **Voya Growth and Income Portfolio - Class I** | **Voya Index Plus SmallCap Portfolio - Class I** |
| **Assets** | | | |
| Investments in mutual funds |  |  |  |
| &nbsp;&nbsp;&nbsp;at fair value | $23 | $4 | $201 |
| Total assets | 23 | 4 | 201 |
| Net assets | $23 | $4 | $201 |
| Total number of mutual fund shares | 2607 | 177 | 8715 |
| Cost of mutual fund shares | $24 | $4 | $203 |

---

Note: The Statement of Assets and Liabilities was zero as of December 31, 2025 for the closed subaccount listed in the *Organization* Note. <br>

*The accompanying notes are an integral part of these financial statements.*

------

**RELIASTAR LIFE INSURANCE COMPANY**

**NORTHSTAR VARIABLE ACCOUNT**

**Statement of Operations**

**For the Period or Year Ended December 31, 2025**

*(In thousands)*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Voya High Yield Portfolio - Institutional Class** | **Voya Growth and Income Portfolio - Class I** | **Voya Index Plus SmallCap Portfolio - Class I** | **Voya SmallCap Opportunities Portfolio - Class I** |
| **Net investment income (loss)** | | | | |
| Investment income: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Dividends | $1 | $— | $1 | $— |
| Expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Mortality and expense risk charges |  |  | 2 |  |
| Net investment income (loss) | 1 |  | (1) |  |
| **Realized and unrealized gain (loss)** |  |  |  |  |
| &nbsp;&nbsp;**on investments** |  |  |  |  |
| Net realized gain (loss) on investments |  |  |  | 16 |
| Capital gains distributions |  |  | 10 |  |
| Total realized gain (loss) on investments |  |  |  |  |
| &nbsp;&nbsp;&nbsp;and capital gains distributions |  |  | 10 | 16 |
| Net unrealized appreciation |  |  |  |  |
| &nbsp;&nbsp;&nbsp;(depreciation) of investments | 1 |  | (1) | (7) |
| Net realized and unrealized gain (loss) |  |  |  |  |
| &nbsp;&nbsp;&nbsp;on investments | 1 |  | 9 | 9 |
| Net increase (decrease) in net assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;resulting from operations | $2 | $— | $8 | $9 |

---

*The accompanying notes are an integral part of these financial statements.*

------

**RELIASTAR LIFE INSURANCE COMPANY**

**NORTHSTAR VARIABLE ACCOUNT**

**Statements of Changes in Net Assets**

**For the Periods or Years Ended December 31, 2025 and 2024**

*(In thousands)*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Voya High Yield Portfolio - Institutional Class** | **Voya Growth and Income Portfolio - Class I** | **Voya Index Plus SmallCap Portfolio - Class I** | **Voya SmallCap Opportunities Portfolio - Class I** |
| **Net assets at January 1, 2024** | $28 | $12 | $— | $190 |
| **Increase (decrease) in net assets** |  |  |  |  |
| Operations: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net investment income (loss) | 2 |  |  | (2) |
| &nbsp;&nbsp;&nbsp;Total realized gain (loss) on investments |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;and capital gains distributions | (1) |  |  |  |
| &nbsp;&nbsp;&nbsp;Net unrealized appreciation |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(depreciation) of investments | 1 | 2 |  | 33 |
| Net increase (decrease) in net assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;resulting from operations | 2 | 2 |  | 31 |
| Changes from principal transactions: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Surrenders & withdrawals | (8) | (10) |  | (36) |
| &nbsp;&nbsp;&nbsp;Transfers between subaccounts (including |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;fixed account), net |  | (1) |  | 1 |
| Increase (decrease) in net assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;derived from principal transactions | (8) | (11) |  | (35) |
| Total increase (decrease) in net assets | (6) | (9) |  | (4) |
| **Net assets at December 31, 2024** | 22 | 3 |  | 186 |
| **Increase (decrease) in net assets** |  |  |  |  |
| Operations: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net investment income (loss) | 1 |  | (1) |  |
| &nbsp;&nbsp;&nbsp;Total realized gain (loss) on investments |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;and capital gains distributions |  |  | 10 | 16 |
| &nbsp;&nbsp;&nbsp;Net unrealized appreciation |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;(depreciation) of investments | 1 |  | (1) | (7) |
| Net increase (decrease) in net assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;resulting from operations | 2 |  | 8 | 9 |
| Changes from principal transactions: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Surrenders & withdrawals |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Transfers between subaccounts (including |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;fixed account), net | (1) | 1 | 193 | (195) |
| Increase (decrease) in net assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;derived from principal transactions | (1) | 1 | 193 | (195) |
| Total increase (decrease) in net assets | 1 | 1 | 201 | (186) |
| **Net assets at December 31, 2025** | $23 | $4 | $201 | $— |

---

*The accompanying notes are an integral part of these financial statements.*

------

**RELIASTAR LIFE INSURANCE COMPANY**

**NORTHSTAR VARIABLE ACCOUNT**

**Notes to Financial Statements**

**1.&nbsp;&nbsp;&nbsp;&nbsp;ORGANIZATION**

ReliaStar Life Insurance Company Northstar Variable Account (the "Account") was established by ReliaStar Life Insurance Company ("ReliaStar Life" or the "Company") to support the operations of variable annuity contracts ("Contracts"). The Account is closed to new deposits and new policyholders. The Company is an indirect, wholly owned subsidiary of Voya Financial, Inc., a holding company domiciled in the State of Delaware.

The Account is registered as a unit investment trust with the Securities and Exchange Commission under the Investment Company Act of 1940, as amended. ReliaStar Life provides for variable accumulation and benefits under the Contracts by crediting annuity considerations to one or more subaccounts within the Account or an investment option in the Company's fixed account, as directed by the contract owners. The portion of the Account's assets applicable to Contracts will not be charged with liabilities arising out of any other business ReliaStar Life may conduct, but obligations of the Account, including the promise to make benefit payments, are obligations of ReliaStar Life. Under applicable insurance law, the assets and liabilities of the Account are clearly identified and distinguished from the other assets and liabilities of ReliaStar Life.

The Account has one reporting segment. The President of the Company is the chief operating decision maker ("CODM"). The CODM reviews the Net increase (decrease) in net assets resulting from operations as presented in the Statement of Operations and assesses year-over-year changes in evaluating operating performance and allocating resources. The measure of segment assets is reported on the Statement of Assets and Liabilities as Net assets. Significant expenses regularly provided to the CODM are consistent with those presented in the Statement of Operations.

As of December 31, 2025, the Account had three subaccounts, all of which invest in mutual funds managed by an affiliate, Voya Investments, LLC. The assets in each subaccount are invested in shares of a designated fund of various investment trusts (the "Trusts"). The subaccounts with asset balances at December 31, 2025 are as follows:

---

| |
|:---|
| **Voya Investors Trust:** |
| &nbsp;&nbsp;&nbsp;Voya High Yield Portfolio - Institutional Class |
| **Voya Variable Funds:** |
| &nbsp;&nbsp;&nbsp;Voya Growth and Income Portfolio - Class I |
| **Voya Variable Portfolios, Inc.:** |
| &nbsp;&nbsp;&nbsp;Voya Index Plus SmallCap Portfolio - Class I |

---

The following subaccount was closed to contract owners during 2025. This subaccount is not included in the Statement of Assets and Liabilities or *Financial Highlights* Note.

---

| |
|:---|
| **Voya Variable Products Trust:** |
| &nbsp;&nbsp;&nbsp;Voya SmallCap Opportunities Portfolio - Class I |

---

The following subaccount was added as a new investment product in 2025. Refer to the *Financial Highlights* Note for the Fund Inception Date.

---

| |
|:---|
| **Voya Variable Portfolios, Inc.:** |
| &nbsp;&nbsp;&nbsp;Voya Index Plus SmallCap Portfolio - Class I |

---

**2.&nbsp;&nbsp;&nbsp;&nbsp;SIGNIFICANT ACCOUNTING POLICIES**

The following is a summary of the significant accounting policies of the Account:

***Use of Estimates***

The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**NORTHSTAR VARIABLE ACCOUNT**

**Notes to Financial Statements**

***Investments***

Investments are made in shares of a subaccount and are recorded at fair value, determined by the net asset value per share of the respective subaccount. Investment transactions in each subaccount are recorded on the trade date. Distributions of net investment income and capital gains from each subaccount are recognized on the ex-distribution date. Realized gains and losses on redemptions of the shares of the subaccount are generally determined using the specific identification method. The difference between cost and current fair value of investments owned on the day of measurement is recorded as unrealized appreciation or depreciation of investments.

***Federal Income Taxes***

Operations of the Account form a part of, and are taxed with, the total operations of ReliaStar Life, which is taxed as a life insurance company under the Internal Revenue Code ("IRC"). Under the current provisions of the IRC, the Company does not expect to incur federal income taxes on the earnings of the Account to the extent the earnings are credited to contract owners. Accordingly, earnings and realized capital gains of the Account attributable to the contract owners are excluded in the determination of the federal income tax liability of ReliaStar Life, and no charge is being made to the Account for federal income taxes for these amounts. The Company will review this tax accounting in the event of changes in the tax law. Such changes in the law may result in a charge for federal income taxes. Uncertain tax positions are assessed at the parent level on a consolidated basis, including taxes of the operations of the Account.

***Contract Owner Reserves***

The annuity reserves of the Account are represented by net assets on the Statement of Assets and Liabilities and are equal to the aggregate account values of the contract owners invested in the subaccounts. To the extent that benefits to be paid to the contract owners exceed their account values, ReliaStar Life will contribute additional funds to the benefit proceeds. Conversely, if amounts allocated exceed amounts required, transfers may be made to ReliaStar Life. All Contracts in the Account are currently in the accumulation period. Prior to the annuitization date, the Contracts are redeemable for the net cash surrender value of the Contracts.

***Changes from Principal Transactions***

Included in Changes from principal transactions on the Statements of Changes in Net Assets are items which relate to contract owner activity, including deposits, surrenders and withdrawals, death benefits, and contract charges. Also included are transfers between the fixed account and the subaccounts, transfers between subaccounts, and transfers to (from) ReliaStar Life related to gains and losses resulting from actual mortality experience (the full responsibility for which is assumed by ReliaStar Life).

***Subsequent Events***

The Company has evaluated all events through the date the financial statements were issued to determine whether any event required either recognition or disclosure in the financial statements. The Company is not aware of any subsequent events that would have a material effect on the financial statements of the Account.

**3.&nbsp;&nbsp;&nbsp;&nbsp;FINANCIAL INSTRUMENTS**

The Account invests assets in shares of open-end mutual funds, which process orders to purchase and redeem shares on a daily basis at the fund's next computed net asset values ("NAV"). The fair value of the Account's assets is based on the NAVs of mutual funds, which are obtained from the transfer agents or fund companies and reflect the fair values of the mutual fund investments. The NAV is calculated daily upon close of the New York Stock Exchange and is based on the fair values of the underlying securities.

The Account's assets are recorded at fair value on the Statement of Assets and Liabilities and are categorized as Level 1 as of December 31, 2025 based on the priority of the inputs to the valuation technique below. There were no transfers among the levels for the year ended December 31, 2025. The Account had no liabilities as of December 31, 2025.

The Account categorizes its financial instruments into a three-level hierarchy based on the priority of inputs to the valuation technique. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure fair value fall within different levels of the hierarchy, the category level is based on the lowest priority level input that is significant to the fair value measurement of the instrument.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**NORTHSTAR VARIABLE ACCOUNT**

**Notes to Financial Statements**

&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 - Unadjusted quoted prices for identical assets or liabilities in an active market. The Account defines an active market as a market in which transactions take place with sufficient frequency and volume to provide pricing information on an ongoing basis.

&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 - Quoted prices in markets that are not active or valuation techniques that require inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Quoted prices for similar assets or liabilities in active markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Quoted prices for identical or similar assets or liabilities in non-active markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Inputs other than quoted market prices that are observable; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Inputs that are derived principally from or corroborated by observable market data through correlation or other means.

&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 - Prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These valuations, whether derived internally or obtained from a third party, use critical assumptions that are not widely available to estimate market participant expectations in valuing the asset or liability.

**4.&nbsp;&nbsp;&nbsp;&nbsp;CHARGES AND FEES**

Under the terms of the Contracts, certain charges and fees are incurred by the Contracts to cover ReliaStar Life's expenses in connection with the issuance and administration of the Contracts. Following is a summary of these charges and fees:

***Mortality and Expense Risk Charges***

ReliaStar Life assumes mortality and expense risks related to the operations of the Account and, in accordance with the terms of the Contracts, deducts a daily charge equal to an annual rate of 1.25% of the average daily net asset value of each subaccount from the assets of the Account to cover these risks, as specified in the Contracts. These charges are assessed through a reduction in unit values.

***Asset-Based Administrative Charges***

A daily charge to cover administrative expenses of the Account is deducted at an annual rate of 0.15% of the assets attributable to the Contracts. These charges are assessed through a reduction in unit values.

***Contract Maintenance Charges***

An annual Contract maintenance fee of $35 may be deducted from the accumulation value of Contracts to cover ongoing administrative expenses, as specified in the Contracts. These charges are assessed through the redemption of units.

***Contingent Deferred Sales Charges***

For certain Contracts, a contingent deferred sales charge ("Surrender Charge") is imposed as a percentage that ranges up to 7.00% of each premium payment if the Contract is surrendered or an excess partial withdrawal is taken, as specified in the Contract. These charges are assessed through the redemption of units.

***Fees Waived by ReliaStar Life***

Certain charges and fees for various types of Contracts may be waived by ReliaStar Life. ReliaStar Life reserves the right to discontinue these waivers at its discretion or to conform with changes in the law.

**5.&nbsp;&nbsp;&nbsp;&nbsp;RELATED PARTY TRANSACTIONS**

Management fees were paid to Voya Investments, LLC, an affiliate of the Company, in its capacity as investment adviser to Voya Investors Trust, Voya Variable Funds, Voya Variable Portfolios, Inc., and Voya Variable Products Trust. The investment advisory agreements of the Trusts provide for fees at annual rates ranging from 0.47% to 0.85% of the average net assets of each respective fund.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**NORTHSTAR VARIABLE ACCOUNT**

**Notes to Financial Statements**

**6.&nbsp;&nbsp;&nbsp;&nbsp;PURCHASES AND SALES OF INVESTMENT SECURITIES**

The aggregate cost of purchases and proceeds from sales of investments for the year ended December 31, 2025 follow:

---

| | | |
|:---|:---|:---|
| | **Purchases** | **Sales** |
|  | *(In thousands)* | *(In thousands)* |
| **Voya Investors Trust:** |  |  |
| &nbsp;&nbsp;&nbsp;Voya High Yield Portfolio - Institutional Class | $1 | $— |
| **Voya Variable Funds:** |  |  |
| &nbsp;&nbsp;&nbsp;Voya Growth and Income Portfolio - Class I |  |  |
| **Voya Variable Portfolios, Inc.:** |  |  |
| &nbsp;&nbsp;&nbsp;Voya Index Plus SmallCap Portfolio - Class I | 205 | 2 |
| **Voya Variable Products Trust:** |  |  |
| &nbsp;&nbsp;&nbsp;Voya SmallCap Opportunities Portfolio - Class I |  | 195 |

---

**7.&nbsp;&nbsp;&nbsp;&nbsp;CHANGES IN UNITS**

The net changes in units outstanding follow:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** | **Year Ended December 31,** |
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| | **Units Issued** | **Units Redeemed** | **Net Increase (Decrease)** | **Units Issued** | **Units Redeemed** | **Net Increase (Decrease)** |
| **Voya Investors Trust:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Voya High Yield Portfolio - Institutional Class |  | 1 | (1) |  | 743 | (743) |
| **Voya Variable Funds:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Voya Growth and Income Portfolio - Class I |  |  |  |  | 266 | (266) |
| **Voya Variable Portfolios, Inc.:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Voya Index Plus SmallCap Portfolio - Class I | 19572 | 6 | 19566 |  |  |  |
| **Voya Variable Products Trust:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Voya SmallCap Opportunities Portfolio - Class I |  | 1853 | (1853) |  | 368 | (368) |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**NORTHSTAR VARIABLE ACCOUNT**

**Notes to Financial Statements**

**8.&nbsp;&nbsp;&nbsp;&nbsp;FINANCIAL HIGHLIGHTS**

A summary of units outstanding, unit values, net assets, investment income ratios, expense ratios and total returns for each of the five years in the period ended December 31, 2025 follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Fund** | | **Unit** | **Net** | **Investment** | | |
| | **Inception** | **Units** | **Fair** | **Assets** | **Income** | **Expense** | **Total** |
| | **Date**<sup>A</sup> | **(000s)** | **Value** | **(000s)** | **Ratio**<sup>B</sup> | **Ratio**<sup>C</sup> | **Return**<sup>D</sup> |
| Voya High Yield Portfolio - Institutional Class | Voya High Yield Portfolio - Institutional Class | Voya High Yield Portfolio - Institutional Class | Voya High Yield Portfolio - Institutional Class | Voya High Yield Portfolio - Institutional Class | Voya High Yield Portfolio - Institutional Class | Voya High Yield Portfolio - Institutional Class | Voya High Yield Portfolio - Institutional Class |
| 2025 |  | 2 | $12.38 | $23 | 4.44% | 1.40% | 7.02% |
| 2024 |  | 2 | $11.54 | $22 | 8.00% | 1.40% | 5.97% |
| 2023 |  | 3 | $10.89 | $28 | 7.27% | 1.40% | 10.78% |
| 2022 |  | 3 | $9.83 | $27 | 7.14% | 1.40% | -13.54% |
| 2021 |  | 3 | $11.37 | $29 | 6.78% | 1.40% | 3.84% |
| Voya Growth and Income Portfolio - Class I | Voya Growth and Income Portfolio - Class I | Voya Growth and Income Portfolio - Class I | Voya Growth and Income Portfolio - Class I | Voya Growth and Income Portfolio - Class I | Voya Growth and Income Portfolio - Class I | Voya Growth and Income Portfolio - Class I | Voya Growth and Income Portfolio - Class I |
| 2025 |  |  | $46.33 | $4 | 0.00% | 1.40% | 16.76% |
| 2024 |  |  | $39.74 | $3 | 0.00% | 1.40% | 22.13% |
| 2023 |  |  | $32.54 | $12 | 0.00% | 1.40% | 25.64% |
| 2022 |  |  | $25.90 | $9 | 0.00% | 1.40% | -15.88% |
| 2021 |  |  | $30.79 | $12 | 0.00% | 1.40% | 27.23% |
| Voya Index Plus SmallCap Portfolio - Class I | Voya Index Plus SmallCap Portfolio - Class I | Voya Index Plus SmallCap Portfolio - Class I | Voya Index Plus SmallCap Portfolio - Class I | Voya Index Plus SmallCap Portfolio - Class I | Voya Index Plus SmallCap Portfolio - Class I | Voya Index Plus SmallCap Portfolio - Class I | Voya Index Plus SmallCap Portfolio - Class I |
| 2025 | 01/21/2025 | 20 | $10.29 | $201 | (e) | 1.40% | (e) |
| 2024 |  | (e) | (e) | (e) | (e) | (e) | (e) |
| 2023 |  | (e) | (e) | (e) | (e) | (e) | (e) |
| 2022 |  | (e) | (e) | (e) | (e) | (e) | (e) |
| 2021 |  | (e) | (e) | (e) | (e) | (e) | (e) |

---

---

| | |
|:---|:---|
| **A** | The Fund Inception Date represents the first date the fund received money. |
| **B** | The Investment Income Ratio represents dividends received by the subaccount, excluding capital gains distributions, divided by the average net assets. The recognition of investment income is determined by the timing of the declaration of dividends by the underlying fund in which the subaccount invests. |
| **C** | The Expense Ratio considers only the annualized contract expenses borne directly by the Account, excluding expenses charged through the redemption of units, and is equal to the mortality and expense, administrative, and other charges, as defined in the Charges and Fees Note. |
| **D** | Total Return is calculated as the change in unit value for each Contract presented in the Statement of Assets and Liabilities. |
| **(e)** | As subaccount had no investments until 2025, this data is not meaningful and therefore not presented. |

---

------

**Report of Independent Auditors**

The Board of Directors and Stockholder

ReliaStar Life Insurance Company

Opinion

We have audited the statutory-basis financial statements of ReliaStar Life Insurance Company (the Company), which comprise the balance sheets as of December 31, 2025 and 2024, and the related statements of operations, changes in capital and surplus and cash flows for each of the three years in the period ended December 31, 2025, and the related notes to the financial statements (collectively referred to as the "financial statements").

*Unmodified Opinion on Statutory Basis of Accounting*

In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2025, on the basis of accounting described in Note 1.

*Adverse Opinion on U.S. Generally Accepted Accounting Principles*

In our opinion, because of the significance of the matter described in the Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles section of our report, the financial statements do not present fairly, in accordance with accounting principles generally accepted in the United States of America, the financial position of the Company at December 31, 2025 and 2024, or the results of its operations or its cash flows for each of the three years in the period ended December 31, 2025.

**Basis for Opinion**

We conducted our audits in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditor's Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinions.

*Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles*

As described in Note 1 to the financial statements, the Company prepared these financial statements using accounting practices prescribed or permitted by the Minnesota Department of Commerce, Division of Insurance, which is a basis of accounting other than accounting principles generally accepted in the United States of America. The effects on the financial statements of the variances between these statutory accounting practices described in Note 1 and accounting principles generally accepted in the United States of America, although not reasonably determinable, are presumed to be material and pervasive.

------

**Responsibilities of Management for the Financial Statements**

Management is responsible for the preparation and fair presentation of the financial statements in accordance with the accounting practices prescribed or permitted by the Minnesota Department of Commerce, Division of Insurance. Management is also responsible for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for one year after the date that the financial statements are issued.

**Auditor's Responsibilities for the Audit of the Financial Statements**

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

In performing an audit in accordance with GAAS, we:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Exercise professional judgment and maintain professional skepticism throughout the audit.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control. Accordingly, no such opinion is expressed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluate the overall presentation of the financial statements.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

/s/ Ernst & Young LLP

April 1, 2026

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Balance Sheets – Statutory Basis**

---

| | | |
|:---|:---|:---|
| | **December 31** | **December 31** |
| | **2025** | **2024** |
|  | *(In Thousands)* | *(In Thousands)* |
| **Admitted Assets** |  |  |
| Cash and invested assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Bonds | $6041362 | $6334398 |
| &nbsp;&nbsp;&nbsp;&nbsp;Bonds - securities loaned and pledged | 148002 | 219422 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage loans | 915530 | 963460 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contract loans | 147746 | 161973 |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and short term investments | 167304 | 144672 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other invested assets | 699912 | 687947 |
| &nbsp;&nbsp;&nbsp;&nbsp;Subsidiaries | 417063 | 481460 |
| &nbsp;&nbsp;&nbsp;&nbsp;Securities lending collateral | 103868 | 116786 |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivatives | 41757 | 53336 |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred stocks | 109039 | 69232 |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stocks | 39607 | 37635 |
| &nbsp;&nbsp;&nbsp;&nbsp;Real estate - occupied and held for sale | 32423 | 41613 |
| Total cash and invested assets | 8863613 | 9311934 |
| Deferred and uncollected premiums | (486533) | (527387) |
| Accrued investment income | 63790 | 67660 |
| Reinsurance balances recoverable | 787908 | 867470 |
| Federal income tax recoverable | 6150 | 24155 |
| Indebtedness from related parties | 302 | 27358 |
| Net deferred tax asset | 175349 | 143256 |
| Other assets | 66238 | 57421 |
| Separate account assets | 2792595 | 2645800 |
| Total admitted assets | $12269414 | $12617667 |

---

*The accompanying notes are an integral part of these financial statements.*

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Balance Sheets – Statutory Basis**

---

| | | |
|:---|:---|:---|
| | **December 31** | **December 31** |
| | **2025** | **2024** |
|  | *(In Thousands, except share amounts)* | *(In Thousands, except share amounts)* |
| **Liabilities and Capital and Surplus** |  |  |
| Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Policy and contract liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Life and annuity reserves | $5213514 | $5551641 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accident and health reserves | 113553 | 115201 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deposit type contracts | 843794 | 1003114 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Policyholders' funds | 164 | 190 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends payable | (3462) | (3991) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Policy and contract claims | 717578 | 833271 |
| &nbsp;&nbsp;&nbsp;&nbsp;Total policy and contract liabilities | 6885141 | 7499426 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest maintenance reserve | 23697 | 15187 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued expenses | 100799 | 103158 |
| &nbsp;&nbsp;&nbsp;&nbsp;Reinsurance balances | 486595 | 506842 |
| &nbsp;&nbsp;&nbsp;&nbsp;Indebtedness to related parties | 33427 | 35227 |
| &nbsp;&nbsp;&nbsp;&nbsp;Asset valuation reserve | 134902 | 161907 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net transfers to separate accounts due or accrued | 1434 | 1535 |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivatives | 44257 | 46996 |
| &nbsp;&nbsp;&nbsp;&nbsp;Borrowed money |  | 83056 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payable for securities lending | 103868 | 116786 |
| &nbsp;&nbsp;&nbsp;&nbsp;Payable for securities | 34325 | 3772 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | 284031 | 299681 |
| &nbsp;&nbsp;&nbsp;&nbsp;Separate account liabilities | 2792595 | 2645800 |
| Total liabilities | 10925072 | 11519373 |
| Capital and surplus: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock: authorized 25,000,000 shares of $1.25 par value; 2,000,000 shares issued and outstanding | 2500 | 2500 |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred capital stock | 100 | 100 |
| &nbsp;&nbsp;&nbsp;&nbsp;Paid-in and contributed surplus | 7620 | 7620 |
| &nbsp;&nbsp;&nbsp;&nbsp;Unassigned surplus | 1334222 | 1088174 |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred capital stock, held in treasury | (100) | (100) |
| Total capital and surplus | 1344342 | 1098294 |
| Total liabilities and capital and surplus | $12269414 | $12617667 |

---

*The accompanying notes are an integral part of these financial statements.*

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Statements of Operations – Statutory Basis**

---

| | | | |
|:---|:---|:---|:---|
| | **Year ended December 31** | **Year ended December 31** | **Year ended December 31** |
| | **2025** | **2024** | **2023** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Premiums and other revenues: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Life, annuity, and accident and health premiums | $1405888 | $1331412 | $1206152 |
| &nbsp;&nbsp;&nbsp;&nbsp;Considerations for supplementary contracts with life contingencies | 4789 | 4353 | 6529 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net investment income | 481921 | 503076 | 501852 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of interest maintenance reserve | (10828) | (9232) | 3186 |
| &nbsp;&nbsp;&nbsp;&nbsp;Commissions, expense allowances and reserve adjustments on reinsurance ceded | (4015) | 272260 | 206011 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other revenue | 78081 | 67589 | 64430 |
| Total premiums and other revenues | 1955836 | 2169458 | 1988160 |
| Benefits paid or provided: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Death benefits | 96238 | 108026 | 103271 |
| &nbsp;&nbsp;&nbsp;&nbsp;Annuity benefits | 58828 | 58023 | 63129 |
| &nbsp;&nbsp;&nbsp;&nbsp;Surrender benefits and withdrawals | 670257 | 836810 | 795956 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest and adjustments on contract or deposit-type contract funds | 25817 | 34014 | 34030 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accident and health benefits | 487269 | 850907 | 414769 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other benefits | 5809 | 6670 | 5784 |
| &nbsp;&nbsp;&nbsp;&nbsp;Decrease in life, annuity and accident and health reserves | (339775) | (554567) | (534752) |
| Net transfers from separate accounts | (197393) | (189848) | (132079) |
| Total benefits paid or provided | 807050 | 1150035 | 750108 |
| Insurance expenses and other deductions: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Commissions | 348284 | 365937 | 340935 |
| &nbsp;&nbsp;&nbsp;&nbsp;General expenses | 448438 | 400987 | 361053 |
| &nbsp;&nbsp;&nbsp;&nbsp;Insurance taxes, licenses and fees | 97886 | 97863 | 84371 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other deductions | 5350 | 7251 | 29360 |
| Total insurance expenses and other deductions | 899958 | 872038 | 815719 |
| Gains from operations before policyholder dividends, federal income taxes and net realized capital loss | 248828 | 147385 | 422333 |
| Dividends to policyholders | 580 | 889 | 1277 |
| Gains from operations before federal income taxes and net realized capital loss | 248248 | 146496 | 421056 |
| Federal income tax (benefit) expense | (19321) | (30316) | 18503 |
| Gains from operations before net realized capital loss | 267569 | 176812 | 402553 |
| Net realized capital loss | (23099) | (14304) | (1960) |
| Net income | $244470 | $162508 | $400593 |

---

*The accompanying notes are an integral part of these financial statements.*

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Statements of Changes in Capital and Surplus – Statutory Basis**

---

| | | | |
|:---|:---|:---|:---|
| | **Year ended December 31** | **Year ended December 31** | **Year ended December 31** |
| | **2025** | **2024** | **2023** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Common stock: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning and end of year | $2500 | $2500 | $2500 |
| Preferred stock: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning and end of year | 100 | 100 | 100 |
| Paid-in and contributed surplus: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of year | 7620 | 7620 | 7620 |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of year | 7620 | 7620 | 7620 |
| Unassigned surplus: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at beginning of year | 1088174 | 1436406 | 1774199 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income | 244470 | 162508 | 400593 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in net unrealized capital (loss) gain | (40957) | (39953) | 16104 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in nonadmitted assets | 84144 | (20872) | (31886) |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in liability for reinsurance in unauthorized companies | 12921 | (4828) | 4629 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in reserve due to change in valuation basis |  |  | 44985 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in asset valuation reserve | 27005 | 6613 | 26891 |
| &nbsp;&nbsp;&nbsp;&nbsp;Tax on change in valuation basis |  |  | (8706) |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in net deferred income tax | (57803) | (26538) | (18496) |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of gain on reinsurance | (22587) | (23243) | (23488) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends to stockholder |  | (402000) | (746500) |
| &nbsp;&nbsp;&nbsp;&nbsp;Amortization of pension and other post-employment benefits | (1146) | 81 | (1919) |
| &nbsp;&nbsp;&nbsp;&nbsp;Balance at end of year | 1334222 | 1088174 | 1436406 |
| Preferred capital stock held in treasury balance at beginning and end of year | (100) | (100) | (100) |
| Total capital and surplus | $1344342 | $1098294 | $1446526 |

---

*The accompanying notes are an integral part of these financial statements.*

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Statements of Cash Flows – Statutory Basis**

---

| | | | |
|:---|:---|:---|:---|
| | **Year ended December 31** | **Year ended December 31** | **Year ended December 31** |
| | **2025** | **2024** | **2023** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **Operations** |  |  |  |
| Premiums, policy proceeds, and other considerations received, net of reinsurance paid | $1358016 | $1426178 | $1247540 |
| Net investment income received | 503874 | 527047 | 513022 |
| Commissions and expenses paid | (869465) | (853126) | (805758) |
| Benefits paid | (1682443) | (1835726) | (1652493) |
| Net transfers from separate accounts | 197292 | 190434 | 131330 |
| Dividends paid to policyholders | (51) | (1045) | (1076) |
| Federal income taxes recovered (paid) | 32493 | 14942 | (25007) |
| Miscellaneous income | 379799 | 294073 | 435276 |
| Net cash used in operations | (80484) | (237223) | (157166) |
| **Investment Activities** |  |  |  |
| Proceeds from investments sold, matured, or repaid: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Bonds | 1529525 | 1452173 | 1902136 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stocks | 66466 | 1452 | 91217 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage loans | 186710 | 150536 | 135153 |
| &nbsp;&nbsp;&nbsp;&nbsp;Real estate |  | 285 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other invested assets | 59582 | 45120 | 83314 |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (loss) gain on cash and short term investments | (207) | (63) | 18 |
| &nbsp;&nbsp;&nbsp;&nbsp;Miscellaneous proceeds | 56180 | 41748 | 32132 |
| Total investment proceeds | 1898256 | 1691251 | 2243970 |
| Cost of investments acquired: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Bonds | 1250950 | 1112432 | 1015658 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stocks | 14926 | 19132 | 4062 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage loans | 143996 | 58155 | 95787 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other invested assets | 87761 | 92096 | 41042 |
| &nbsp;&nbsp;&nbsp;&nbsp;Miscellaneous applications |  | 9875 | 7001 |
| Total cost of investments acquired | 1497632 | 1291690 | 1163550 |
| Net decrease in contract loans | 14223 | 10768 | 10400 |
| Net cash provided by investment activities | 414847 | 410329 | 1090820 |
| **Financing and Miscellaneous Activities** |  |  |  |
| Other cash (applied) provided: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Borrowed money | (83056) | 83056 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net withdrawals on deposit type contracts | (159320) | (13719) | (116988) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends paid to stockholder |  | (402000) | (746500) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other cash applied | (69355) | (3761) | (134498) |
| Net cash used in financing and miscellaneous activities | (311731) | (336424) | (997986) |
| Net increase (decrease) in cash and short term investments | 22632 | (163318) | (64332) |
| Cash and short term investments: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Beginning of year | 144672 | 307990 | 372322 |
| &nbsp;&nbsp;&nbsp;&nbsp;End of year | $167304 | $144672 | $307990 |

---

---

| | | |
|:---|:---|:---|
| Note: Supplemental disclosures of cash flow information for non-cash transactions: | Note: Supplemental disclosures of cash flow information for non-cash transactions: | Note: Supplemental disclosures of cash flow information for non-cash transactions: |
| Principles-Based Bond Definition | $66560 | $– $|

---

*The accompanying notes are an integral part of these financial statements.*

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**1. Organization and Significant Accounting Policies**

ReliaStar Life Insurance Company (the "Company") is domiciled in Minnesota and is a wholly owned subsidiary of Voya Holdings Inc. ("Voya Holdings"), a Connecticut holding and management company. Voya Holdings is a wholly owned subsidiary of Voya Financial, Inc., a publicly traded corporation with its common stock listed on the New York Stock Exchange, under the symbol "VOYA."

***Description of Business***

The Company is principally engaged in the business of providing employee benefit products and services, retirement plans, and life and health reinsurance. The Company is presently licensed in all states (approved for reinsurance only in New York), the District of Columbia, Guam, and Puerto Rico.

***Use of Estimates***

The preparation of the financial statements of the Company requires management to make estimates and assumptions that affect amounts reported in the financial statements and accompanying notes. Such estimates and assumptions could change in the future as more information becomes known, which could impact the amounts reported and disclosed herein.

***Recently Adopted Accounting Principles***

Effective January 1. 2025, the NAIC adopted revisions to NAIC Accounting Practices and Procedures Manual, ("NAIC SAP") Statutory Accounting Principle No. 26, *Bonds* ("SSAP No. 26"), and SSAP No. 43, *Assets-Backed Securities* ("SSAP No. 43") to reflect accounting and reporting guidance under Principles Based Bond Definition ("PBBD") for qualified investments. As a result of these adoptions, investments qualified as issuer credit obligation ("ICO") are reported under SSAP No. 26; investments qualified as asset-backed security ("ABS") are reported under SSAP No. 43.

Effective January 1, 2025, the NAIC adopted revisions to SSAP No.21, *Other Admitted Assets* ("SSAP No. 21") to reflect accounting and reporting guidance for investments that do not meet the requirements of PBBD, and for residual tranches or interests/loss positions.

The aggregate book adjusted carrying value for all securities reclassified off Schedule D-1 is ICO's of $56.4 and ABS' of $10.1. The measurement basis for the transferred securities did not change. There is no change to the Company's net income or capital and surplus.

On August 13, 2023, with an effective date of September 30, 2023, the NAIC adopted *Interpretation of the Statutory Accounting Principles (E) Working Group Net Negative (Disallowed) Interest Maintenance Reserve* ("INT 23-01") to provide temporary relief

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

resulting from the nonadmit of the net realized losses deferred to the interest maintenance reserve ("IMR").

On August 11, 2025, this interpretation was extended one year until December 31, 2026, with modifications to provide clarity and establish an additional current-period admittance limit. Admittance is optional and subject to strict limits, including capital and surplus thresholds, risk-based capital requirements, and exclusions for certain derivative losses. Reporting entities that admit net negative IMR must reflect the amounts in reserving or asset adequacy testing, complete specified disclosures, and reconcile admitted IMR to amounts used in PBR and cash flow testing. The interpretation is a limited-time exception and is scheduled to be automatically nullified on January 1, 2027.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

***Basis of Presentation***

The accompanying financial statements of the Company have been prepared in conformity with accounting practices prescribed or permitted by the Minnesota Department of Commerce-Insurance Division, which practices differ from United States Generally Accepted Accounting Principles ("U.S. GAAP"). The more significant variances from U.S. GAAP are:

*Investments:* Investments in bonds and mandatorily redeemable preferred stocks are reported at amortized cost or fair value based on a designation assigned by the NAIC.

The Company periodically reviews the value of its investments in bonds, non-bond debt securities and mandatorily redeemable preferred stocks. If the fair value of any investment falls below its cost basis, the decline is analyzed to determine whether it is an other-than-temporary decline. To make this determination for each security, the following are some of the factors considered:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The length of time and the extent to which the fair value has been below cost.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The financial condition and near-term prospects of the issuer of the security, including any specific events that may affect its operations or earnings potential.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company's intent to sell the security prior to its maturity at an amount below its carrying value.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The Company's intent and ability to hold the security long enough for it to recover its fair value.

Based on the analysis, the Company makes a judgment as to whether the decline in fair value is other-than-temporary. When an Other Than Temporary Impairment ("OTTI") is recorded because there is intent to sell or the Company does not have the intent and ability to hold the security for a period of time sufficient to recover the amortized cost basis, the security is written down to fair value. The interest related OTTI is deferred through the IMR and the non-interest related OTTI is included in the asset valuation reserve ("AVR") in the period that the OTTI is considered to have occurred as prescribed by the NAIC. Losses resulting from OTTI charges, net of transfers to IMR, are recorded within net realized capital gains (losses) in the statements of operations.

The Company invests in asset-backed securities ("ABS"), non-bond securities backed by other loans, including residential mortgage backed securities ("RMBS"), collateralized mortgage obligations, collateralized debt obligations, and commercial mortgage backed securities ("CMBS"). Asset-backed securities are reported at amortized cost or fair value based on a designation assigned by the NAIC. They are amortized using the interest method over the period which repayment of principal is expected to occur. For asset-backed securities in unrealized loss positions, the Company determines whether it has the intent to sell or the intent and ability to hold the security for a period of time sufficient to recover the amortized cost. If the Company has the intent and ability to hold the security to recovery, the

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

Company must compare the present value of the expected future cash flows for this security to its carrying value. If the present value of the expected future cash flows for the security is lower than its carrying value, the security is written down to its present value of the expected future cash flows.

Net realized gains and losses on disposed investments are reported in the statements of operations, net of federal income tax and transfers to the IMR.

Under U.S. GAAP, the Company's fixed maturities are designated at purchase as trading or available-for-sale, except for those accounted for using the fair value option ("FVO"). Fixed maturity investments are reported at fair value. For FVO securities or those designated as trading, changes in fair value are reported in the statements of operations. Available-for-sale securities are reported at fair value with changes in fair value reported as a separate component of other comprehensive income (loss) in shareholder's equity. For available-for-sale securities for which the Company has determined that a credit loss exists, the present value of cash flows expected to be collected from the security are compared to the amortized cost basis of the security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss allowance is recorded for the credit loss, limited by the amount that the fair value is less than the amortized cost basis. Changes in the allowance for credit losses are recorded in the statements of operations. Included within fixed maturities are loan-backed securities, RMBS, CMBS and ABS. Amortization of the premium or discount from the purchase of these securities considers the estimated timing and amount of prepayments of the underlying loans. Interest income on fixed maturities is recorded when earned using an effective yield method, giving effect to amortization of premiums and accretion of discounts. Dividends on equity securities are recorded when declared. Such dividends and interest income are recorded in Net investment income.

*Asset Valuation Reserve*: The AVR is intended to establish a reserve to offset potential credit related investment losses on most invested asset categories. AVR is determined by an NAIC prescribed formula and is reported as a liability rather than as a valuation allowance or an appropriation of surplus. The change in AVR is recorded directly to unassigned surplus.

*Interest Maintenance Reserve:* Under a formula prescribed by the NAIC, the Company defers the portion of realized gains and losses on sales of fixed income investments, principally bonds, derivatives, and mortgage loans, attributable to changes in the general level of interest rates and amortizes those deferrals over the remaining period to maturity based on groupings of individual securities sold in five year bands. The Company reports the net deferral of IMR as a liability on the accompanying balance sheets. When the net deferral of IMR is negative, the amount is reported as part of other assets and would be admitted to the extent that the amount is less than 10% of the Company's adjusted general account capital and surplus and the asset sales were not the result of liquidity pressures. See "*Recently Adopted Accounting Principles*" for additional information.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

*Cash and Short-term Investments*: Cash and short-term investments represent cash balances, demand deposits, and short-term fixed maturity investments with initial maturities of one year or less at the date of acquisition. Short-term investments are reported at amortized cost which approximates fair value.

Under U.S. GAAP, the corresponding caption of cash and cash equivalents includes cash on hand, amounts due from banks and other highly liquid investments, such as money market instruments and debt instruments with maturities of three months or less at the time of purchase. Short-term investments include investments with remaining maturities of one year or less, but greater than three months, at the time of purchase. Cash, cash equivalents and short term investments are stated at fair value.

*Derivatives:* The Company follows the hedge accounting guidance in SSAP No. 86, *Derivatives* ("SSAP No. 86") for derivative transactions. Under SSAP No. 86, derivatives that are deemed effective hedges are accounted for entirely in a manner which is consistent with the underlying hedged item. Derivatives used in hedging transactions that do not meet the requirements of SSAP No. 86 as an effective hedge are carried at fair value with the change in value recorded in surplus as unrealized gains or losses. Embedded derivatives are not accounted for separately from the host contract.

Under U.S. GAAP, the effective and ineffective portions of a cash flow hedge are accounted for separately. The effective portion of the gain or loss on the derivative instrument is reported as a component of accumulated other comprehensive income and reclassified into earnings in the same periods during which the hedged transaction impacts earnings in the same line item associated with the forecasted transaction. The ineffective portion of the derivative's change in value, if any, along with any of the derivative's change in value that is excluded from the assessment of hedge effectiveness, are recorded in other net realized capital gains (losses). For derivative instruments that are designated and qualify as a fair value hedge, the gain or loss on the derivative instrument, as well as the hedged item, to the extent of the risk being hedged, are recognized in other net realized capital gains (losses). An embedded derivative within a contract that is not clearly and closely related to the economic characteristics and risk of the host contract is reported with the host contract on the balance sheets at fair value, and the change in fair value is recorded in income.

*Mortgage Loans*: Mortgage loans are reported at amortized cost, less write downs for impairments. If the value of any mortgage loan is determined to be impaired (i.e., when it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the loan agreement), the carrying value of the mortgage loan is reduced to the lesser of either the present value of expected cash flows from the loan, discounted at the loan's original purchase yield or fair value of the collateral. For those mortgages that are determined to require foreclosure, the carrying value is reduced to the fair value of the underlying collateral, net of estimated costs to obtain and sell at the point of foreclosure. The

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

carrying value of the impaired loans is reduced by establishing a permanent write-down recorded in net realized capital gains (losses).

Under U.S. GAAP, the Company reports mortgage loans at amortized cost, net of allowance for credit losses. Management estimates the credit loss allowance balance using a factor-based method of probability of default and loss given default which incorporates relevant available information, from internal and external sources, relating to past events, current conditions, and reasonable and supportable forecasts. The change in the allowance for credit losses is recorded in net realized capital gains (losses) in the statements of operations. Loans are written off against the allowance when management believes the uncollectability of a loan balance is confirmed.

*Deferred Income Taxes*: Deferred tax assets and liabilities represent the future tax recoveries or obligations associated with the accumulation of temporary differences between the tax and financial statement bases of the Company's assets and liabilities. Deferred tax assets are provided for and admitted to an amount determined under a standard formula in accordance with SSAP No. 101, *Income Taxes* ("SSAP No. 101"). A valuation allowance is required if based on the available evidence, it is more likely than not (a likelihood of more than 50 percent) that some portion or all of the gross deferred tax assets will not be realized. This assessment is determined on a separate reporting entity basis.

After reduction for any valuation allowance, the Company follows the admissibility formula prescribed under SSAP No. 101. These provisions limit the amount of gross deferred tax assets that can be admitted to surplus to those for which ultimate recoverability can be demonstrated. This limitation is based on availability of taxes paid in prior years that could be recovered through carrybacks, the expected timing of reversals for accumulated temporary differences over the next three years to offset future taxes, surplus limits, and the amount of gross deferred tax liabilities available for offset. Any deferred tax assets not covered under the formula are nonadmitted.

SSAP No. 101 requires all changes in deferred tax balances to be included as surplus adjustments; under U.S. GAAP, however, most changes in deferred tax balances are recorded in the income statement (with the exception of certain items that are recorded through Other Comprehensive Income or directly to the equity section of the balance sheet) as a component of the total income tax provision.

U.S. GAAP also requires that deferred taxes be included for all jurisdictions that determine taxes based on income. Thus deferred state income taxes must be recorded under U.S. GAAP. SSAP No. 101, however, specifically prohibits establishing deferred state income tax assets and liabilities.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

*Investments in Real Estate:* Investments in real estate are reported net of related obligations rather than on a gross basis. Real estate owned and occupied by the Company is included in investments, and investment income and operating expenses include rent for the Company's occupancy of those properties. Changes between depreciated cost and admitted asset investment amounts are credited or charged directly to unassigned surplus. Properties held for sale are reported at the lower of depreciated cost or fair value, less encumbrances and estimated costs to sell the property. Any real estate not meeting the appraisal requirements established in SSAP No. 40, *Real Estate Investments* ("SSAP No. 40"), shall be nonadmitted until the required appraisals are obtained.

Under U.S. GAAP, property is carried at cost, less accumulated depreciation, and is reported gross of related obligations in other assets on the balance sheets.

*Policy Acquisition Costs*: The costs of acquiring and renewing business are expensed when incurred.

Under U.S. GAAP, incremental, direct costs of contract acquisition and certain costs related directly to successful acquisition activities are capitalized. Indirect or unsuccessful acquisition costs, maintenance, product development and overhead expenses are charged to expense as incurred. In addition, the outstanding value of in force business acquired is capitalized. Deferred acquisition costs and value of business acquired is amortized on a constant level basis over the expected term of the related contracts.

*Premiums*: Life premiums are recognized as revenue when due. Premiums for annuity policies with mortality and morbidity risk, except for guaranteed interest and group annuity contracts, are recognized as revenue when received. Premiums received for annuity policies without mortality or morbidity risk and for guaranteed interest and group annuity contracts are recorded using deposit accounting.

Under U.S. GAAP, premiums related to traditional life insurance contracts and payout contracts with life contingencies are recognized as revenue when due. Amounts received for investment-type, universal life-type, fixed annuities, payout contracts without life contingencies and fixed-indexed annuity contracts are reported as deposits to contract owner account balances. Revenues from these contracts consist primarily of fees assessed against the contract owner account balance for mortality and policy administration charges.

*Benefits Paid or Provided*: Benefits incurred for universal life and annuity policies represent the total of death benefits paid and the change in policy reserves.

Under U.S. GAAP, benefits and expenses for investment-type, universal life-type, fixed annuities, payout contracts without life contingencies and fixed-indexed annuity contracts include claims in excess of related account balances, expenses of contract administration and interest credited to contract owner account balances.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

*Benefit and Contract Reserves*: Life policy and contract reserves under statutory accounting practices are calculated based upon both the net level premium method and Commissioners' Reserve Valuation Method ("CRVM") using statutory rates for mortality and interest. Annuity policy and contract reserves under statutory accounting practices are calculated based upon the Commissioners' Annuity Reserve Valuation Method ("CARVM") using statutory rates for mortality and interest.

Under U.S. GAAP, actuarially determined reserves are calculated to meet future obligations. This includes estimates of unpaid claims and claims that have been incurred but have not been reported as of the balance sheet date. Reserves for long-duration traditional life insurance contracts and accident and health insurance represent the present value of future benefits to be paid to or on behalf of contract owners and related expenses, less the present value of future net premiums. Reserves for payout contracts with life contingencies are equal to the present value of future payments. For interest sensitive products, the U.S. GAAP policy reserve is equal to the policy fund balance plus an unearned revenue reserve which reflects the unamortized balance of early year policy loads over renewal year policy loads.

*Separate Accounts*: The assets and liabilities of the separate accounts are carried at fair value. Seed money contributed by the Company is reported as a component of Surplus in the separate account. Reserves are calculated based upon the CARVM.

Under U.S. GAAP, the Market Value Adjustment ("MVA") separate accounts do not qualify as separate accounts and are reported as assets and liabilities of the Company's general account. Seed money is reported as an equity investment. Reserves for individual and group deferred annuity investment contracts and individual immediate annuities without life contingent payouts are equal to cumulative deposits, less charges and withdrawals, plus credited interest thereon, net of adjustments for investment experience that the Company is entitled to reflect in future credited interest. Reserves for individual immediate annuities with life contingent payout benefits are computed on the basis of assumed interest discount rates, mortality, and expenses, including a margin for adverse deviations.

*Reinsurance*: Policy and contract liabilities ceded to reinsurers have been reported as reductions of the related reserves. Commissions allowed by reinsurers on business ceded are reported as income when received. Losses generated in certain reinsurance transactions are recognized immediately in income, with gains reported as a separate component of surplus and amortized over the remaining life of the business. For business ceded to unauthorized reinsurers, statutory accounting practices require that reinsurance credits permitted by the treaty be recorded as an offsetting liability and charged against unassigned surplus.

Under U.S. GAAP, ceded future policy benefits and contract owner liabilities are reported gross on the balance sheets. Only those reinsurance recoverable balances deemed probable of recovery are reflected as assets on the balance sheets and are stated net of allowances for credit losses, which are charged to earnings. Gains and losses on reinsurance, including

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

commission and expense allowances, are deferred and amortized over the remaining life of the business.

*Nonadmitted Assets*: Certain assets designated as "nonadmitted," principally disallowed interest maintenance reserves, non-operating system software, past due agents' balances, furniture and equipment, intangible assets, and other assets not specifically identified as an admitted asset within the NAIC SAP are excluded from the accompanying balance sheets and are charged directly to unassigned surplus. In addition, non-admitted assets include deferred tax assets that are not admissible under SSAP No. 101. See *Deferred Income Taxes* above.

*Subsidiaries*: The accounts and operations of the Company's subsidiaries are not consolidated.

Under U.S. GAAP, the accounts and operations of the Company's wholly owned subsidiaries are consolidated. Intercompany transactions and balances are eliminated.

*Policyholder Dividends*: Policyholder dividends are recognized when declared.

*Reconciliation to U.S. GAAP*: The effects of the preceding variances from U.S. GAAP on the accompanying statutory basis financial statements have not been determined, but are presumed to be material.

Other significant accounting practices are as follows:

Certain reclassifications may be made to prior year amounts to maintain comparability of the years presented.

*Investments:* Investments are stated at values prescribed by the NAIC, as follows:

Bonds not backed by other loans are stated at either amortized cost using the yield to worst method or the lower of cost or fair market value. The Company does not have any SVO-Identified investments as defined in SSAP No. 26.

Asset-backed securities and non-bond securities backed by other loans are stated at either amortized cost or the lower of amortized cost or fair market value. Amortized cost is determined using the interest method and includes anticipated prepayments. The prospective adjustment method is used to determine the amortized cost for the majority of asset-backed securities. For certain securities, the retrospective adjustments methodology is utilized, including agency and non-agency pools.

Redeemable preferred stocks rated as medium quality or better are valued at amortized cost. All other redeemable preferred stocks are reported at the lower of amortized cost or fair value

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

and Perpetual preferred stocks are reported at its fair value with a ceiling of its effective call price.

Common stocks are reported at fair value and the related unrealized capital gains/losses are reported in unassigned surplus along with adjustment for federal income taxes. Federal Home Loan Bank ("FHLB") common stock is priced at par value.

The Company engages in securities lending whereby certain securities from its portfolio are loaned to other institutions, through a lending agent, for short periods of time. The Company has the right to approve any institution with whom the lending agent transacts on its behalf. Initial cash and/or non-cash collateral is required at a rate of 102% of the market value of the loaned securities. The market value of the loaned securities is monitored on a daily basis with additional collateral obtained or refunded as the market value of the loaned securities fluctuates. The lending agent indemnifies the Company against losses resulting from the failure of a counterparty's ability to return securities pledged where collateral is insufficient to cover the loss. Under the securities lending program, the Company also accepts non-cash collateral in the form of securities. The securities retained as collateral may not be sold or re-pledged, except in the event of default, and are not reflected in the Company's Balance Sheets. This collateral generally consists of U.S. Treasury, U.S. Government agency securities and Mortgage-Backed Securities pools.

Short-term investments are reported at amortized cost which approximates fair value.

Partnership interests, which are included in other invested assets, are reported at the underlying audited U.S. GAAP equity of the investee. Changes in surplus from distributions are reported in investment income.

Residual collateralized mortgage obligations, which are included in other invested assets on the balance sheet, are reported at the lower of amortized cost or fair value using the effective interest method or the practical expedient method.

Surplus notes acquired, which are included in other invested assets on the balance sheets, are reported at amortized cost using the effective interest method.

Realized capital gains and losses are generally determined using the specific identification method.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The Company's use of derivatives is primarily for economic hedging purposes to reduce the Company's exposure to cash flow variability of assets and liabilities, interest rate risk, credit risk, and market risk. For those derivatives in effective hedging relationships, the Company values all derivative instruments on a consistent basis with the hedged item. Upon termination, gains and losses on instruments are included in the carrying values of the underlying hedged items and are amortized over the remaining lives of the hedged items as adjustments to investment income or benefits from the hedged items. Any unamortized gains or losses are recognized when the underlying hedged items are sold. The unrealized gains and losses from derivatives not designated as accounting hedges are reported at fair value through surplus. Upon termination, interest related gains and losses on asset hedges are included in IMR and are amortized over the remaining lives of the derivatives; other gains and losses are included in the AVR.

Gains and losses for effective hedges are reported in the same section where cash flows of the hedged item are reported (required by SSAP No. 86, paragraph 15). Economic hedges (those not receiving effective hedge accounting) are based on the nature of the instrument.

The Company enters into the following derivatives:

*Credit Contracts:*

Credit default swaps: Credit default swaps are used to reduce credit loss exposure with respect to certain assets that the Company owns, or to assume credit exposure on certain assets that the Company does not own. Payments are made to or received from the counterparty at specified intervals. In the event of a default on the underlying credit exposure, the Company will either receive a payment (purchased credit protection) or will be required to make a payment (sold credit protection) equal to the par minus recovery value of the swap contract. The Company utilizes these contracts in replication and non qualifying hedging relationships.

*Equity Contracts:*

Options: The Company may use equity options to hedge against an increase in various equity indices, and interest rate options to hedge against an increase in the interest rate benchmarking crediting strategies within Fixed Indexed Annuities ("FIA") contracts. Such increases may result in increased payments to the holders of the FIA contracts. The Company pays an upfront premium to purchase these options. The Company utilizes these options in non-qualifying hedging relationships.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

*Foreign Exchange Contracts:*

Currency forwards: The Company uses currency forward contracts to hedge currency exposure related to its invested assets. The Company utilizes these contracts in non-qualifying hedging relationships.

Foreign exchange swaps: The Company uses foreign exchange or currency swaps to reduce the risk of change in the value, yield or cash flows associated with certain foreign denominated invested assets. Foreign exchange swaps represent contracts that require the exchange of foreign currency cash flows against U.S. dollar cash flows at regular periods, typically quarterly or semi-annually. The Company utilizes these contracts in qualifying hedging relationships.

*Interest Rate Contracts:*

Futures: The Company uses interest rate futures contracts to hedge interest rate risks associated with the CMO-B portfolio. Changes in the general level of interest rates can result in the potential for adverse changes in the portfolio. The Company enters into exchange traded futures with regulated futures commissions that are members of the exchange. The Company also posts initial and variation margin with the exchange on a daily basis. The Company utilizes exchange-traded futures in non-qualifying hedging relationships.

Interest rate swaps: Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and/or liabilities. Interest rate swaps are also used to hedge the interest rate risk associated with the value of assets it owns or in an anticipation of acquiring them. Using interest rate swaps, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest payments, calculated by reference to an agreed upon notional principal amount. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made to/from the counterparty at each due date. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships.

Forwards: The Company uses forward contracts to hedge certain invested assets against movement in interest rates, particularly mortgage rates. The Company uses To Be Announced mortgage-backed securities as an economic hedge against rate movements. The Company utilizes forward contracts in non- qualifying hedging relationships.

*Investments in Subsidiary:* SSAP No. 97, *Investments in Subsidiary, Controlled and Affiliated Entities* ("SSAP No. 97"), applies to the Company's subsidiaries, and controlled and affiliated entities ("SCA"). The Company's insurance subsidiary is reported at the underlying statutory basis net assets, and the Company's non-insurance subsidiary is reported at the underlying audited U.S. GAAP equity amount as promulgated by the NAIC SAP.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

Dividends from subsidiaries are included in net investment income. The remaining net change in the subsidiaries' equity is included in the change in net unrealized capital gains or losses. SCA entities for which audited statements are not available or expected to be available are nonadmitted. Management regularly reviews its SCAs to determine if an OTTI has occurred. During this review, management makes a judgment as to whether it is probable that the reporting entity will be unable to recover the carrying amount of the investment or there is evidence indicating inability of the investee to sustain earnings.

*Contract Loans:* Contract loans are reported at unpaid principal balances but not in excess of the cash surrender value of the related insurance/annuity policy.

*Aggregate Reserve for Life Policies and Contracts*: Life, annuity, and accident and health reserves are developed by actuarial methods and are determined based on published tables using statutorily specified interest rates and valuation methods that will provide, in the aggregate, reserves that are greater than or equal to the minimum or guaranteed policy cash value or the amounts required by law. Interest rates range from 1.00% to 13.25% for 2025.

The Company waives the deduction of deferred fractional premiums upon the death of the insured. It is the Company's practice to return a pro rata portion of any premium paid beyond the policy month of death, although it is not contractually required to do so for certain issues. A reserve has been established of $91.5 and $97.6 for any surrender value promised in excess of the legally computed reserves at December 31, 2025 and 2024, respectively.

The methods used in valuation of substandard policies are as follows:

For life, endowment and term policies issued substandard, the standard reserve during the premium paying period is increased by 50% of the gross annual extra premium. Standard reserves are held on Paid-Up Limited Pay contracts.

For reinsurance with flat extra premiums, the standard reserve is increased by 50% of the flat extra.

The amount of insurance in force for which the gross premiums are less than the net premiums, according to the standard of valuation required by the Minnesota Department of Commerce-Insurance Division, is $2.6 billion and $3.0 billion at December 31, 2025 and 2024, respectively. The amount of premium deficiency reserves for policies on which gross premiums are less than the net premiums is $255.5 and $296.6 at December 31, 2025 and 2024, respectively.

The tabular interest has been determined from the basic data for the calculation of policy reserves for all direct ordinary life insurance and for the portion of group life insurance classified as group under Internal Revenue Code ("IRC") Section 79. The method of determination of tabular interest of funds not involving life contingencies is as follows: one

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

hundredth of the product of such valuation rate of interest times the mean of the amount of funds subject to such valuation rate of interest held at the beginning and end of the year of valuation.

*Reinsurance*: Reinsurance premiums, commissions, expense reimbursements, and reserves related to reinsured business are accounted for on a basis consistent with those used in accounting for the original policies issued and the terms of the reinsurance contracts. Reserves are based on the terms of the reinsurance contracts and are consistent with the risks assumed. Premiums and benefits ceded to other companies have been reported as a reduction of premium revenue and benefits expense. Amounts applicable to reinsurance ceded for reserves and unpaid claim liabilities have been reported as reductions of these items, and expense allowances received in connection with reinsurance ceded have been reflected in operations. The Company establishes a receivable for amounts due from reinsurers for claims paid and other amounts recoverable under the terms of the reinsurance contracts.

*Electronic Data Processing Equipment*: Electronic data processing equipment is carried at cost less accumulated depreciation. Depreciation for major classes of such assets is calculated on a straight line basis over the estimated useful life of the asset, not to exceed three years.

*Participating Insurance*: Participating business approximates less than 1% of the Company's life insurance in force and less than 1% of premium income. The amount of dividends to be paid to participating policyholders is determined annually by the Board of Directors. Amounts allocable to participating policyholders are based on published dividend projections or expected dividend scales.

*Benefit Plans*: The Company provides noncontributory retirement plans for substantially all employees and certain agents. Pension costs from the qualified pension plan are allocated to the Company and charged to operations as contributions are made to the plan. Costs from plans sponsored by the Company are directly charged as incurred. Refer to Note 7 for details of the Company's employee benefit plans. The Company also provides a contributory retirement plan for substantially all employees.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

*Nonadmitted Assets*: Nonadmitted assets are summarized as follows:

---

| | | |
|:---|:---|:---|
| | **December 31** | **December 31** |
| | **2025** | **2024** |
|  | *(In Thousands)* | *(In Thousands)* |
| Deferred and uncollected premium | $8455 | $8682 |
| Agents' debit balances | 644 | 1293 |
| Net deferred tax asset | 187942 | 269341 |
| Other | 5413 | 7281 |
| Total nonadmitted assets | $202453 | $286597 |

---

Changes in nonadmitted assets are reported directly in unassigned surplus as an increase or decrease in nonadmitted assets.

*Claims and Claims Adjustment Expenses*: Claims and claims adjustment expenses represent the estimated ultimate net cost of all reported and unreported claims incurred through December 31, 2025. The Company does not discount claims and claims adjustment expense reserves. Such estimates are based on actuarial projections applied to historical claim payment data. Such liabilities are considered to be reasonable and adequate to discharge the Company's obligations for claims incurred but unpaid as of December 31, 2025.

*Guaranteed Benefits*: For variable annuity guarantees, Valuation Manual 21 ("VM21") is followed. This guideline interprets how to apply the NAIC Commissioners' Annuity Reserve Valuation Method to Variable Annuities. Minimum reserves are equal to a stochastic reserve plus an additional standard projection amount. Both reinsurance and hedging are also reflected. Taxes are not incorporated. All assumptions for the Standard Projected Amount are prescribed. All other assumptions are set by the actuary using prudent best-estimates except for prescribed asset defaults and spreads.

*Separate Accounts*: Most separate account assets and liabilities held by the Company represent funds held for the benefit of the Company's variable life and annuity policy and contract holders who bear all of the investment risk associated with the policies. Such policies are of a non-guaranteed nature. All net investment experience, positive or negative, is attributed to the policy and contract holders' account values. The assets and liabilities of these accounts are carried at fair value and are legally segregated and are not subject to claims that arise out of any other business of the Company.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**2.**&nbsp;&nbsp;&nbsp;&nbsp;**Permitted Statutory Basis Accounting Practices** 

The financial statements of the Company are presented on the basis of accounting practices prescribed or permitted by the Minnesota Department of Commerce-Insurance Division. The Minnesota Department of Commerce-Insurance Division recognizes only statutory accounting practices prescribed or permitted by the State of Minnesota for determining and reporting the financial condition and results of operations of an insurance company and for determining its solvency under the Minnesota Insurance Laws. The NAIC SAP has been adopted as a component of prescribed practices by the State of Minnesota. The Minnesota Commissioner of Commerce has the right to permit other specific practices that deviate from prescribed practices.

The Company is required to identify those significant accounting practices that are permitted, and obtain written approval of the practices from the Minnesota Department of Commerce-Insurance Division.

The Company, with the permission of the Minnesota Department of Commerce - Insurance Division, utilizes a straight-line amortization method over the estimated life of the reinsured business of 25 years to calculate the quarterly amortization on the deferred gain resulting from the January 4, 2021 reinsurance treaty with Security Life of Denver Company ("SLD"), to determine the amount to be recognized as income, instead of on a net tax basis as earnings emerge as required by SSAP No. 61*, Life, Deposit-Type and Accident and Health Reinsurance* ("SSAP No. 61"). There is no impact to the Company's total capital and surplus as a result of this permitted practice. The Company's net income was decreased by an approximately $100.1 and $21.9, and increased by approximately $8.5 for the years ended December 31, 2025, 2024 and 2023, respectively, as a result of the permitted practice. The Company's risk-based capital would not have triggered a regulatory event had the Company not used this permitted practice.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**3.**&nbsp;&nbsp;&nbsp;&nbsp;**Investments**

***Bonds and Debt Securities***

The cost or amortized cost and fair value of bonds are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Book Adjusted Carrying Value** | **Gross Unrealized Gains** | **Gross Unrealized Losses** | **Fair Value** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **At December 31, 2025** |  |  |  |  |
| **ICOs:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;U.S. Government Obligations (Exempt from RBC) | $109226 | $38 | $10784 | $98480 |
| &nbsp;&nbsp;&nbsp;Other U.S. Government Obligations (Not Exempt from RBC) | 764 | 16 |  | 780 |
| &nbsp;&nbsp;&nbsp;Non-U.S. Sovereign Jurisdiction Securities | 99744 | 1730 | 7003 | 94471 |
| &nbsp;&nbsp;&nbsp;Municipal Bonds – General Obligations (Direct & Guaranteed) | 14141 |  | 2197 | 11943 |
| &nbsp;&nbsp;&nbsp;Municipal Bonds – Special Revenue | 156343 | 126 | 25699 | 130770 |
| &nbsp;&nbsp;&nbsp;Project Finance Bonds Issued by Operating Entities | 310520 | 7611 | 10548 | 307583 |
| &nbsp;&nbsp;&nbsp;Corporate Bonds | 2581324 | 43334 | 216920 | 2407738 |
| &nbsp;&nbsp;Single Entity Backed Obligation | 55738 | 2883 | 1009 | 57613 |
| &nbsp;&nbsp;&nbsp;Bonds Issued by Funds Representing Operating Entities | 19392 | 216 | 1405 | 18203 |
| &nbsp;&nbsp;&nbsp;Bank Loans – Issued | 50453 | 1267 | 59 | 51662 |
| &nbsp;&nbsp;&nbsp;Bank Loans – Acquired | 102749 | 781 | 813 | 102717 |
| &nbsp;&nbsp;&nbsp;Other Issuer Credit Obligations | 27280 | 259 | 633 | 26906 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total ICOs** | $3527674 | $58261 | $277069 | $3308866 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Book Adjusted Carrying Value** | **Gross Unrealized Gains** | **Gross Unrealized Losses** | **Fair Value** |
| **ABS:** | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **Financial Asset-Backed Securities – Self-Liquidating** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Agency Residential Mortgage-Backed Securities – Guaranteed (Exempt from RBC) | $155365 | $4899 | $1296 | $158968 |
| &nbsp;&nbsp;&nbsp;Agency Commercial Mortgage-Backed Securities – Guaranteed (Exempt from RBC) | 348444 | 15 | 103365 | 245094 |
| &nbsp;&nbsp;&nbsp;Agency Residential Mortgage-Backed Securities – Not/Partially Guaranteed (Not Exempt from RBC) | 427607 | 15580 | 10750 | 432437 |
| &nbsp;&nbsp;&nbsp;Agency Commercial Mortgage-Backed Securities – Not/Partially Guaranteed (Not Exempt from RBC) | 12092 |  | 1079 | 11013 |
| &nbsp;&nbsp;&nbsp;Non-Agency Residential Mortgage-Backed Securities | 503214 | 8087 | 89134 | 422167 |
| &nbsp;&nbsp;&nbsp;Non-Agency Commercial Mortgage-Backed Securities | 446982 | 600 | 37645 | 409937 |
| &nbsp;&nbsp;&nbsp;Non-Agency – CLOs/CBOs/CDOs | 418022 | 4214 | 424 | 421812 |
| &nbsp;&nbsp;&nbsp;Other Financial Asset-Backed Securities – Self-Liquidating | 180046 | 2224 | 3033 | 179237 |
| **Financial Asset-Backed Securities – Not Self-Liquidating** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Other Financial Asset-Backed Securities – Not Self-Liquidating | 7340 |  | 61 | 7279 |
| **Non-Financial Asset-Backed Securities – Practical Expedient** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Lease-Backed Securities – Practical Expedient | 440 | 10 |  | 450 |
| &nbsp;&nbsp;&nbsp;Other Non-Financial Asset-Backed Securities – Practical Expedient | 115884 | 3574 | 2589 | 116869 |
| **Non-Financial Asset-Backed Securities – Full Analysis** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Lease-Backed Securities – Full Analysis | 500 | 2 |  | 502 |
| &nbsp;&nbsp;&nbsp;Other Non-Financial Asset-Backed Securities – Full Analysis | 45755 | 803 | 932 | 45625 |
| &nbsp;&nbsp;&nbsp;&nbsp;**Total ABSs** | 2661690 | 40008 | 250308 | 2451390 |
| **Total - long-term bonds (ICOs and ABSs)** | $6189364 | $98269 | $527377 | $5760256 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Book Adjusted Carrying Value** | **Gross Unrealized Gains** | **Gross Unrealized Losses** | **Fair Value** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **At December 31, 2024** |  |  |  |  |
| U.S. Treasury securities and obligations of U.S. government, corporations, and agencies | $67222 | $— | $10815 | $56408 |
| States, municipalities, and political subdivisions | 208418 | 12 | 36335 | 172095 |
| Foreign other (par value - $891,102) | 890274 | 13881 | 61701 | 842454 |
| Foreign government (par value - $68,227) | 65857 | 190 | 7267 | 58780 |
| Public utilities securities |  |  |  |  |
| Corporate securities | 2621867 | 25855 | 260833 | 2386889 |
| Residential mortgage backed securities | 979586 | 21212 | 128616 | 872182 |
| Commercial mortgage backed securities | 1036567 | 1347 | 171539 | 866375 |
| Other asset backed securities | 684028 | 11004 | 7398 | 687634 |
| Total bonds | 6553820 | 73500 | 684504 | 5942817 |
| Preferred stocks | 68424 | 1637 | 2591 | 67470 |
| Common stocks | 39789 | 741 | 2895 | 37635 |
| Total equity securities | 108213 | 2379 | 5486 | 105105 |
| Total | $6662033 | $75879 | $689990 | $6047922 |

---

Reconciliation of bonds from amortized cost to carrying values is as follows:

---

| | |
|:---|:---|
| | **December 31**<br>**2025** |
|  | *(In Thousands)* |
| Cost or amortized cost - ICO | $3527674 |
| Cost or amortized cost - ABS | 2661690 |
| Adjustment for below investment grade bonds - ICO |  |
| Adjustment for below investment grade bonds - ABS |  |
| Carrying value | $6189364 |

---

---

| | |
|:---|:---|
| | **December 31**<br>**2024** |
|  | *(In Thousands)* |
| Bonds | $6553820 |
| Adjustment for below investment grade bonds  |  |
| Carrying value | $6553820 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The aggregate fair value of bonds with unrealized losses and the time period that amortized cost exceeded fair value are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Less than 6 Months Below Cost** | **More than 6 Months and Less than 12 Months Below Cost** | **More than 12 Months Below Cost** | **Total** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **At December 31, 2025** |  |  |  |  |
| Fair value - ICO | $1504372 | $4461 | $1800033 | $3308866 |
| Fair value - ABS | 1270458 | 27185 | 1153747 | 2451390 |
| Unrealized loss - ICO | 10418 | 524 | 266127 | 277069 |
| Unrealized loss - ABS | 1105 | 534 | 248668 | 250308 |
| **At December 31, 2024** |  |  |  |  |
| Fair value | $915740 | $40798 | $4986278 | $5942816 |
| Unrealized loss | 15676 | 1045 | 667782 | 684503 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The amortized cost and fair value of investments in bonds and non-bond debt securities at December 31, 2025, by contractual maturity, are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.

---

| | | |
|:---|:---|:---|
| | **Amortized Cost** | **Fair Value** |
|  | *(In Thousands)* | *(In Thousands)* |
| Maturity: ICO - SSAP No. 26 & 2 |  |  |
| Due in 1 year or less | $160493 | $161341 |
| Due after 1 year through 5 years | 643136 | 643644 |
| Due after 5 years through 10 years | 648917 | 653791 |
| Due after 10 years through 20 years | 1411907 | 1267572 |
| Over 20 years | 769426 | 688723 |
| **Total ICO** | $3633879 | $3415071 |
| Maturity: ABS - SSAP No. 43 |  |  |
| Due in 1 year or less | $5043 | $4356 |
| Due after 1 year through 5 years | 58130 | 58385 |
| Due after 5 years through 10 years | 279401 | 280662 |
| Due after 10 years through 20 years | 693770 | 688389 |
| Over 20 years | 1625345 | 1419598 |
| **Total ABS** | $2661690 | $2451390 |
| Maturity: Non-Bond Debt Securities - SSAP No. 21 |  |  |
| Due in 1 year or less | $— | $— |
| Due after 1 year through 5 years | 4113 | 4000 |
| Due after 5 years through 10 years | 78120 | 82030 |
| Due after 10 years through 20 years | 69915 | 65110 |
| Over 20 years | 35055 | 34838 |
| **Total Non-Bond Debt Securities** | $187203 | $185978 |

---

In managing our risk exposure to subprime and Alt-A mortgages, we take into account collateral performance and structural characteristics associated with our various positions.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

While the Company actively invests in and continues to manage a portfolio of such exposures in the form of securitized investments, the Company does not originate or purchase subprime or Alt-A whole-loan mortgages. Subprime lending is the origination of loans to customers with weaker credit profiles. The Company defines Alt-A mortgages to include the following: residential mortgage loans originated before 2009 to customers with better credit profiles (vis-à-vis subprime borrowers) but lack some element(s), such as documentation to substantiate income; residential mortgage loans originated before 2009 to borrowers that would otherwise be classified as prime but for which loan structure provides repayment options to the borrower that increase the risk of default; and any securities originated before 2009 backed by residential mortgage collateral not clearly identifiable as prime or subprime.

The following table summarizes the Company's exposure to subprime mortgage backed securities and Alt-A mortgage backed securities through other investments:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Actual Cost** | **Book/Adjusted Carrying Value (excluding interest)** | **Fair Value** | **Other Than Temporary Impairment Losses Recognized** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **December 31, 2025** |  |  |  |  |
| Asset-backed securities | $53043 | $51450 | $51815 | $— |
| Equity investment in subsidiary, controlled or affiliated companies | 10505 | 10662 | 10482 |  |
| Total | $63548 | $62112 | $62297 | $— |
| **December 31, 2024** |  |  |  |  |
| Residential mortgage-backed securities | $35424 | $33792 | $33876 | $5 |
| Equity investment in subsidiary, controlled or affiliated companies | 324 | 317 | 310 | 2 |
| Structured securities | 4489 | 4492 | 4803 |  |
| Total | $40237 | $38601 | $38989 | $7 |
| **December 31, 2023** |  |  |  |  |
| Residential mortgage-backed securities | $39499 | $39028 | $36572 | $29 |
| Equity investment in subsidiary, controlled or affiliated companies | 356 | 353 | 348 |  |
| Structured securities | 5832 | 5842 | 6119 |  |
| Total | $45687 | $45223 | $43039 | $29 |

---

The Company did not have underwriting exposure to subprime mortgage risk through investments in subprime mortgage loans, mortgage guaranty or financial guaranty insurance coverage as of December 31, 2025, 2024 or 2023.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The following table shows prepayment penalty and acceleration fees at December 31, 2025, 2024, and 2023:

---

| | |
|:---|:---|
| | **General Account** |
|  | *(In Thousands)* |
| **2025** |  |
| Number of CUSIPs | 17 |
| Aggregate Amount of Investment Income | $523 |
| **2024** |  |
| Number of CUSIPs | 16 |
| Aggregate Amount of Investment Income | $1087 |
| **2023** |  |
| Number of CUSIPs | 23 |
| Aggregate Amount of Investment Income | $1328 |

---

The following table shows NAIC designation 5GI securities at December 31, 2025 and 2024:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | | | **Aggregate Book Adjusted Carrying Value** | **Aggregate Book Adjusted Carrying Value** | **Aggregate Fair Value** | **Aggregate Fair Value** |
|  | **Number of 5GI Securities** | **Number of 5GI Securities** | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **Investment** | **2025** | **2024** | **2025** | **2024** | **2025** | **2024** |
| ICO - AC | 3 | 5 | $439 | $1846 | $1280 | $2174 |
| ABS - AC | 7 | 8 | 934 | 787 | 2010 | 1707 |
| Preferred Stock-AC |  |  |  |  |  |  |
| Preferred Stock- FV |  |  |  |  |  |  |
| Total | 10 | 13 | $1373 | $2633 | $3290 | $3881 |
| AC- Amortized Cost FV- Fair Value | AC- Amortized Cost FV- Fair Value | AC- Amortized Cost FV- Fair Value | AC- Amortized Cost FV- Fair Value | AC- Amortized Cost FV- Fair Value | AC- Amortized Cost FV- Fair Value | AC- Amortized Cost FV- Fair Value |

---

***Mortgage Loans and Real Estate***

All mortgage loans are evaluated by seasoned underwriters, including an appraisal of loan-specific credit quality, property characteristics, and market trends, and assigned a quality rating using the Company's internally developed quality rating system. The Company's mortgage loans on real estate are all commercial mortgage loans, held for investment.

The maximum and minimum lending rates for long-term mortgage loans acquired or made during 2025 were 9.35% and 5.55%.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

There were no taxes, assessments or any amounts advanced and not included in the mortgage loan total as of December 31, 2025 and 2024.

Property insurance is required on all collateral securing commercial real estate mortgage loans. Generally the coverage is "all risk" at a level equal to the replacement cost of the improvements. Additional coverage may be required to cover flood, windstorm and other risks associated with collateral type, use and location.

During 2025, the maximum percentage of any loan to the value of collateral at the time of the loan, exclusive of insured or guaranteed or purchase money mortgages was 79.7% on commercial properties.

The following table shows an age analysis of mortgage loans by type and mortgage loans in which the insurer is a participant or co-lender in a mortgage loan agreement as of December 31, 2025 and 2024:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **Residential** | **Residential** | **Commercial** | **Commercial** | | |
| |<br>**Farm** | **Insured** | **All Other** | **Insured** | **All Other** |<br>**Mezzanine** |<br>**Total** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **December 31, 2025** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Recorded investment (all) |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current | $— | $— | $— | $— | $915530 | $— | $915530 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30-59 Days Past Due |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;60-89 Days Past Due |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;90-179 Days Past Due |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;180+ Days Past Due |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Participant or Co-lender in a Mortgage Loan Agreement |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Recorded Investment | $— | $— | $— | $— | $905968 | $— | $905968 |
| **December 31, 2024** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Recorded investment (all) |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Current | $— | $— | $— | $— | $962404 | $— | $962404 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30-59 Days Past Due |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;60-89 Days Past Due |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;90-179 Days Past Due |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;180+ Days Past Due |  |  |  |  | 1056 |  | 1056 |
| &nbsp;&nbsp;&nbsp;Participant or Co-lender in a Mortgage Loan Agreement |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Recorded Investment | $— | $— | $— | $— | $950356 | $— | $950356 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The Company had no investments in impaired mortgage loans with or without an allowance for credit losses or in any impaired loans subject to a participant or co-lender mortgage loan agreement for which the Company is restricted from unilaterally foreclosing on the mortgage loan as of December 31, 2025 and December 31, 2024.

The following table shows investments in impaired mortgage loans held by the Company and the related average recorded investment, the interest income recognized and the investments on nonaccrual status pursuant to SSAP No. 34, *Investment Income Due and Accrued* as of December 31, 2025, 2024 and 2023:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **Residential** | **Residential** | **Commercial** | **Commercial** | | |
| |<br>**Farm** | **Insured** | **All Other** | **Insured** | **All Other** |<br>**Mezzanine** |<br>**Total** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **December 31, 2025** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Average recorded investment | $— | $— | $— | $— | $4826 | $— | $4826 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income recognized |  |  |  |  | 143 |  | 143 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amount of interest income recognized using a cash-basis method of accounting |  |  |  |  | 162 |  | 162 |
| **December 31, 2024** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Average recorded investment | $— | $— | $— | $— | $7846 | $— | $7846 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income recognized |  |  |  |  | 310 |  | 310 |
| &nbsp;&nbsp;&nbsp;&nbsp;Recorded Investments on nonaccrual status |  |  |  |  | 1056 |  | 1056 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amount of interest income recognized using a cash-basis method of accounting |  |  |  |  | 311 |  | 311 |
| **December 31, 2023** |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Average recorded investment | $— | $— | $— | $— | $7871 | $— | $7871 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest income recognized |  |  |  |  | 336 |  | 336 |
| &nbsp;&nbsp;&nbsp;&nbsp;Recorded Investments on nonaccrual status |  |  |  |  | 4877 |  | 4877 |
| &nbsp;&nbsp;&nbsp;&nbsp;Amount of interest income recognized using a cash-basis method of accounting |  |  |  |  | 346 |  | 346 |

---

The Company recognizes interest income on its impaired loans upon receipt.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The Company has no allowances for credit losses as of December 31, 2025 and 2024.

The following table shows mortgage loans derecognized as a result of foreclosure as of December 31, 2025 and 2024.

---

| | | |
|:---|:---|:---|
| | **2025** | **2024** |
|  | *(In Thousands)* | *(In Thousands)* |
| Aggregate amount of mortgage loans derecognized | $3882 | $4877 |

---

During the first quarter of 2026, the Company sold the Atlanta building. The sale resulted in an impairment loss of $7.3, which reflects the excess of the building's carrying value over the final sale proceeds, net of closing costs. Because the conditions leading to the sale and the related loss existed as of December 31, 2025, the the loss was recognized in the current reporting year.

As a result of the sale of the Atlanta building during first quarter of 2026, the Company placed the asset in held for sale status.

During the third quarter of 2024, the Company sold 1.244 acres of residential land. As a result of this sale, the company recognized a gain of $0.1.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

***Net Realized Capital Gains and Losses***

Realized capital (losses) gains are reported net of federal income taxes and amounts transferred to the IMR are as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **December 31** | **December 31** | **December 31** |
| | **2025** | **2024** | **2023** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Realized capital loss | $(26593) | $(10798) | $(34450) |
| Amount transferred to IMR (net of related taxes of |  |  |  |
| ($2213) in 2025, ($397) in 2024 and ($7360) in 2023) | 8326 | 1494 | 27686 |
| Federal income tax (expense) benefit | (4832) | (5000) | 4804 |
| Net realized capital loss | $(23099) | $(14304) | $(1960) |

---

Realized capital losses include losses of $12.4, $10.5 and $42.3 related to securities that have experienced an other than temporary decline in value during 2025, 2024 and 2023, respectively.

Proceeds and gross gains and losses from sales and maturities of bonds captured in SSAP No. 2, SSAP No. 26 and SSAP No. 43, and non-bond debt securities captured in SSAP No. 21 as of December 31, 2025:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **Sales** | **Sales** | **Sales** | **Maturities** | **Maturities** | **Maturities** |
|<br>**Investments** | | **Proceeds** | **Realized Gains** | **Realized Losses** | **Proceeds** | **Realized Gains** | **Realized Losses** |
|  |  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Bonds | SSAP No. 2 | $1504678 | $— | $483 | $113344 | $125 | $— |
|  | SSAP No. 26 | 543716 | 6769 | 18122 | 274942 | 718 | 1939 |
|  | SSAP No. 43 | 233883 | 5374 | 1478 | 585434 | 167 | 4 |
| Non-Bond Debt Securities | SSAP No. 21 | 5306 |  | 70 | 9035 |  | 4 |
|  | **Total** | $2287583 | $12143 | $20153 | $982755 | $1010 | $1947 |

---

Proceeds from sales of investments in bonds and other fixed maturity interest securities were $0.8 billion and $1.4 billion in 2024 and 2023, respectively. Gross gains of $6.5 and $18.2 and gross losses of $33.4 and $48.6 during 2024 and 2023, respectively, were realized on those sales. A portion of the gains and losses realized in 2025, 2024 and 2023 has been deferred to future periods in the IMR.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The following table discloses in aggregate, the OTTI recognized by the Company in accordance with asset-backed securities subject to SSAP No. 43 and non-bond debt securities subject to SSAP No. 21 due to intent to sell or inability or lack of intent to hold to recovery in 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Amortized Cost Basis Before Other-than-Temporary Impairment** | **Other-than-Temporary Impairment Recognized** | **Other-than-Temporary Impairment Recognized** | |
| | **Amortized Cost Basis Before Other-than-Temporary Impairment** | **Interest** | **Non-interest** |<br>**Fair Value** |
|  |  | *(In Thousands)* | *(In Thousands)* |  |
| First quarter: |  |  |  |  |
| Aggregate intent to sell | $489 | $67 | $— | $422 |
| Aggregate inability or lack of intent to hold to recovery |  |  |  |  |
| Total first quarter | $489 | $67 | $— | $422 |
| Second quarter: |  |  |  |  |
| Aggregate intent to sell | $156 | $19 | $— | $136 |
| Aggregate inability or lack of intent to hold to recovery |  |  |  |  |
| Total second quarter | $156 | $19 | $— | $136 |
| Third quarter: |  |  |  |  |
| Aggregate intent to sell | $24 | $1 | $— | $23 |
| Aggregate inability or lack of intent to hold to recovery |  |  |  |  |
| Total third quarter | $24 | $1 | $— | $23 |
| Fourth quarter: |  |  |  |  |
| Aggregate intent to sell | $4244 | $2615 | $— | $1629 |
| Aggregate inability or lack of intent to hold to recovery |  |  |  |  |
| Total fourth quarter | $4244 | $2615 | $— | $1629 |
| Total | N/A | $2702 | $— | N/A |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The following table discloses in aggregate the OTTI recognized by the Company in accordance with asset-backed securities subject to SSAP No. 43 due to intent to sell or inability or lack of intent to hold to recovery in 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Amortized Cost Basis Before Other-than-Temporary Impairment** | **Other-than-Temporary Impairment Recognized** | **Other-than-Temporary Impairment Recognized** | |
| | **Amortized Cost Basis Before Other-than-Temporary Impairment** | **Interest** | **Non-interest** |<br>**Fair Value** |
|  |  | *(In Thousands)* | *(In Thousands)* |  |
| First quarter: |  |  |  |  |
| Aggregate intent to sell | $2016 | $77 | $— | $1939 |
| Aggregate inability or lack of intent to hold to recovery |  |  |  |  |
| Total first quarter | $2016 | $77 | $— | $1939 |
| Second quarter: |  |  |  |  |
| Aggregate intent to sell | $3273 | $1316 | $— | $1957 |
| Aggregate inability or lack of intent to hold to recovery |  |  |  |  |
| Total second quarter | $3273 | $1316 | $— | $1957 |
| Third quarter: |  |  |  |  |
| Aggregate intent to sell | $692 | $138 | $— | $554 |
| Aggregate inability or lack of intent to hold to recovery |  |  |  |  |
| Total third quarter | $692 | $138 | $— | $554 |
| Fourth quarter: |  |  |  |  |
| Aggregate intent to sell | $10716 | $2036 | $— | $8680 |
| Aggregate inability or lack of intent to hold to recovery |  |  |  |  |
| Total fourth quarter | $10716 | $2036 | $— | $8680 |
| Total | N/A | $3567 | $— | N/A |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The following table discloses in aggregate the OTTI recognized by the Company in accordance with asset-backed securities subject to SSAP No. 43 due to intent to sell or inability or lack of intent to hold to recovery in 2023.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Amortized Cost Basis Before OTTI** | **Other-than-Temporary Impairments** | **Other-than-Temporary Impairments** | |
| | **Amortized Cost Basis Before OTTI** | **Interest** | **Non-interest** |<br>**Fair Value** |
|  |  | *(In Thousands)* | *(In Thousands)* |  |
| First quarter: |  |  |  |  |
| Aggregate intent to sell | $395 | $99 | $— | $296 |
| Aggregate inability or lack of intent to hold to recovery |  |  |  |  |
| Total first quarter | $395 | $99 | $— | $296 |
| Second quarter: |  |  |  |  |
| Aggregate intent to sell | $20241 | $5782 | $— | $14458 |
| Aggregate inability or lack of intent to hold to recovery |  |  |  |  |
| Total second quarter | $20241 | $5782 | $— | $14458 |
| Third quarter: |  |  |  |  |
| Aggregate intent to sell | $95547 | $35834 | $— | $59713 |
| Aggregate inability or lack of intent to hold to recovery |  |  |  |  |
| Total third quarter | $95547 | $35834 | $— | $59713 |
| Fourth quarter: |  |  |  |  |
| Aggregate intent to sell | $2099 | $384 | $— | $1715 |
| Aggregate inability or lack of intent to hold to recovery |  |  |  |  |
| Total fourth quarter | $2099 | $384 | $— | $1715 |
| Total | N/A | $42099 | $— | N/A |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The following table discloses, in detail the OTTI's arising from the present value of expected cash flows being less than the amortized cost of asset-backed securities subject to SSAP No. 43 and all non-bond debt securities subject to SSAP No. 21 in 2025:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **CUSIP** | **Book/Adjusted Carrying Value Amortized Cost Before Current Period OTTI** | **Present Value of Projected Cash Flows** | **Recognized Other-Than-Temporary Impairment** | **Amortized Cost After Other-Than-Temporary Impairment** | **Fair Value at Time of OTTI** | **Date of Financial Statement Where Reported** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |  |
| **Asset-Backed Securities:** |  |  |  |  |  |  |
| 92913BAJ7 | $53 | $8 | $45 | $8 | $8 | 12/31/2025 |
| 92914QAJ3 | 21 | 16 | 5 | 16 | 16 | 12/31/2025 |
| 92917EAC2 | 40 | 15 | 25 | 15 | 15 | 12/31/2025 |
| &nbsp;&nbsp;**Total** |  |  | $75 |  |  |  |

---

The total amount of OTTI's recognized by the Company arising from the present value of expected cash flows being less than the amortized cost of asset-backed securities subject to SSAP No. 43 was $0.4 and $0.2 in 2024 and 2023, respectively.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The following table discloses, in the aggregate, all impaired debt securities subject to SSAP No. 21 and bonds subject to SSAP No. 26 and SSAP No. 43 for which an OTTI has not been recognized in earnings as a realized loss. This includes securities with a recognized OTTI for non-interest related declines when a non-recognized interest related impairment remains:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| | **SSAP No. 26 - ICO** | **SSAP No. 43 - ABS** | **SSAP No. 21 - Non-Bond Debt Securities** | **SSAP No. 21 - Residuals under Allowable Earned Yield Method** | **Total - Impaired Debt Securities** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| a. Aggregate amount of unrealized losses: |  |  |  |  |  |
| 1. Less than 12 Months | $10942 | $1640 | $— | $8 | $12589 |
| 2. 12 Months or Longer | 266127 | 248668 | 5877 |  | 520673 |
| **Total** | $**277069** | $**250308** | $**5877** | $**8** | $**533262** |
| b. The aggregate related fair value of securities with unrealized losses: |  |  |  |  |  |
| 1. Less than 12 Months | $219444 | $118018 | $— | $117 | $337579 |
| 2. 12 Months or Longer | 1800033 | 1153747 | 67270 |  | 3021049 |
| **Total** | $**2019477** | $**1271765** | $**67270** | $**117** | $**3358628** |

---

During 2025, the Company had impairments on holdings where the market value was less than 90% of book value, and it was determined that these values were not recoverable. The fair value of these investments is based upon the Company's overall proportional ownership interest in the underlying partnership. The investment and the amount of the impairment in 2025 are as follows:

---

| | |
|:---|:---|
| **Description** | **Amount of Impairment** |
|  | *(In Thousands)* |
| POMONA CAPITAL V LP | $118 |
| POMONA VOYA HOLDINGS CO-INV II LP | 880 |
| Total | $998 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

***Investment Income***

Major categories of net investment income are summarized as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Year ended December 31** | **Year ended December 31** | **Year ended December 31** |
| | **2025** | **2024** | **2023** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Income: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Bonds | $324908 | $345575 | $360744 |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity securities | 9606 | 6303 | 10130 |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock - affiliated | 55457 | 46996 | 37698 |
| &nbsp;&nbsp;&nbsp;&nbsp;Mortgage loans | 43889 | 47065 | 49287 |
| &nbsp;&nbsp;&nbsp;&nbsp;Real estate | 4214 | 3448 | 4283 |
| &nbsp;&nbsp;&nbsp;&nbsp;Contract loans | 6998 | 7388 | 8103 |
| &nbsp;&nbsp;&nbsp;&nbsp;Derivatives | 2149 | 4495 | 34 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other invested assets | 54887 | 59961 | 51707 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 12293 | 13880 | 13982 |
| Total investment income | 514400 | 535110 | 535968 |
| Investment expenses | (32479) | (32034) | (34116) |
| Net investment income | $481921 | $503076 | $501852 |

---

The table above reflects income the Company received from its subsidiaries Reliastar Life Insurance Company of New York ("RNY") and Voya Special Investments, Inc. ("VSI"). RNY paid dividends to the Company of $42.0, $45.0 and $24.0 in 2025, 2024 and 2023, respectively. VSI paid dividends to the Company of $13.5, $2.0 and $13.7 in 2025, 2024 and 2023, respectively.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The gross, nonadmitted, and admitted amounts for interest income due and accrued as of year-end are as follows:

---

| | | |
|:---|:---|:---|
| **Accrued Interest Income** | **2025** | **2024** |
|  | *(In Thousands)* | *(In Thousands)* |
| Gross | $58196 | $68212 |
| Nonadmitted |  | 552 |
| Admitted | $58196 | $67660 |

---

All investment income due and accrued with amounts that are over 90 days past due was excluded from surplus with the exception of mortgage loans in process of foreclosure in accordance with SSAP No. 37, *Mortgage Loans*.

The company's aggregate deferred interest was $0.5 and $0 as of December 31, 2025 and December 31, 2024, respectively.

The cumulative amount of paid-in-kind interest included in the current principal balance is $39.7 and $37.0, respectively for the years ended December 31, 2025 and December 31, 2024.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

***Securities Lending***

The Company engages in securities lending whereby certain securities from its portfolio are loaned to other institutions, through a lending agent, for short periods of time. The securities received in the program cannot be sod or repledged. As of December 31, 2025 and 2024, the fair value of securities retained as collateral by the lending agent on the Company's behalf was $8.8 and $54.7, respectively.

The Company had loaned securities, which are reflected as invested assets on the balance sheets, with a fair value of approximately $108.4 and $164.7 at December 31, 2025 and 2024, respectively.

The aggregate fair value amount of collateral received, by specific time period, for securities lending agreements at December 31, 2025 and 2024 are shown below:

---

| | | |
|:---|:---|:---|
| | **2025** | **2024** |
|  | *(In Thousands)* | *(In Thousands)* |
| Open | $— | $— |
| 30 days or less | 64637 | 45473 |
| 31 to 60 days | 5030 | 27091 |
| 61 to 90 days | 4400 | 4050 |
| Greater than 90 days | 29802 | 40172 |
| Total collateral received | $103869 | $116786 |

---

The Company uses cash collateral received for income generation and general liquidity purposes. At the end of the loan term, the Company will take back its securities, and the counterparty will receive the amount loaned, together with the agreed upon interest.

The Company has not pledged any of its assets as collateral that are not reclassified and separately reported on the balance sheet.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The aggregate amount of collateral reinvested, by specific time period, for securities lending agreements at December 31, 2025 and 2024 are shown below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2024** | **2024** |
| | **Amortized Cost** | **Fair Value** | **Amortized Cost** | **Fair Value** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Open | $— | $— | $— | $— |
| 30 days or less | 64637 | 64638 | 45473 | 45476 |
| 31 to 60 days | 5030 | 5031 | 27091 | 27093 |
| 61 to 90 days | 4400 | 4402 | 4050 | 4052 |
| 91 to 120 days | 17513 | 17513 | 20105 | 20110 |
| 121 to 180 days | 4804 | 4809 | 7066 | 7074 |
| 181 to 365 days | 5330 | 5334 | 9000 | 9017 |
| 1 to 2 years | 2155 | 2155 | 785 | 786 |
| 2 to 3 years |  |  | 3216 | 3218 |
| Total collateral reinvested | $103869 | $103882 | $116786 | $116826 |

---

The maturity dates of the liabilities appropriately match the invested assets in the securities lending program.

The amounts held as collateral for transactions that extend beyond one year at December 31, 2025 and 2024 are shown below:

---

| | | |
|:---|:---|:---|
| **Description of Collateral** | **2025** | **2024** |
|  | *(In Thousands)* | *(In Thousands)* |
| FORDO_25-C - USD | $505 | $— |
| HALST_25-C - USD | 1400 |  |
| VALET_25-2 - USD | 250 |  |
| GMALT_24-1 - USD |  | 367 |
| HALST_24-B - USD |  | 418 |
| PILOT_24-1 - USD |  | 396 |
| FORDL_24-B - USD |  | 917 |
| GMCAR_24-2 - USD |  | 392 |
| HART_24-B - USD |  | 745 |
| GMCAR_24-3 - USD |  | 766 |
| Total Collateral Extending beyond one year | $2155 | $4001 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

***Federal Home Loan Bank Agreements***

The Company is a member of the FHLB of Des Moines. Through its membership, the Company has conducted business activity (issued funding agreements) with the FHLB. It is part of the Company's strategy to utilize these funds for spread lending purposes. The Company has determined the estimated maximum borrowing capacity as $3.8 billion. The Company has the ability to obtain funding from the FHLB based on a percentage of the value of its assets and subject to the availability of eligible collateral. The limit across all programs is 30% of the general and separate accounts total assets of the Company, one quarter in arrears.

The amount of FHLB capital stock held by the Company is as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2025** | **2024** | **2024** | **2024** |
| | **General Account** | **Separate Account** | **Total** | **General Account** | **Separate Account** | **Total** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Membership stock - Class A | $— | $— | $— | $— | $— | $— |
| Membership stock - Class B | 7743 |  | 7743 | 8034 |  | 8034 |
| Activity stock | 23625 |  | 23625 | 23625 |  | 23625 |
| Excess stock |  |  |  |  |  |  |
| &nbsp;&nbsp;Aggregate total | $31368 | $— | $31368 | $31659 | $— | $31659 |
| Actual or estimated borrowing capacity as determined by the insurer |  |  | $709870 |  |  | $669238 |

---

All FHLB membership stock is not eligible for redemption.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The amount of collateral pledged to FHLB at the end of the reporting period, and the maximum amount that was pledged to FHLB during the reporting period is as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Amount Pledged at End of Reporting Period** | **Amount Pledged at End of Reporting Period** | **Amount Pledged at End of Reporting Period** | **Maximum Amount Pledged During Reporting Period** | **Maximum Amount Pledged During Reporting Period** | **Maximum Amount Pledged During Reporting Period** |
| | **Fair Value** | **Carrying Value** | **Aggregate Total Borrowing** | **Fair Value** | **Carrying Value** | **Aggregate Total Borrowing** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **As of December 31, 2025** |  |  |  |  |  |  |
| General account | $803763 | $994604 | $525000 | $803763 | $994604 | $525000 |
| Total | $803763 | $994604 | $525000 | $803763 | $994604 | $525000 |
| **As of December 31, 2024** |  |  |  |  |  |  |
| General account | $769748 | $989738 | $525000 | $884448 | $1057501 | $525000 |
| Total | $769748 | $989738 | $525000 | $884448 | $1057501 | $525000 |

---

The amount borrowed from FHLB resulted in the following at the end of December 31, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Total** | **General Account** | **Funding Agreements Reserves Established** | **Maximum Amount During Reporting Period** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **As of December 31, 2025** |  |  |  |  |
| Funding Agreements | $525000 | $525000 | $527440 | $525000 |
| Aggregate Total  | $525000 | $525000 | $527440 | $525000 |
| **As of December 31, 2024** |  |  |  |  |
| Funding Agreements | $525000 | $525000 | $528345 | $525000 |
| Aggregate Total | $525000 | $525000 | $528345 | $545000 |

---

The Company has no prepayment obligations for debt, funding agreements, or other as of December 31, 2025.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

***Restricted Assets***

The following table shows assets pledged as collateral or restricted at December 31, 2025:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Gross (Admitted & Nonadmitted) Restricted** | **Gross (Admitted & Nonadmitted) Restricted** | **Gross (Admitted & Nonadmitted) Restricted** | **Gross (Admitted & Nonadmitted) Restricted** | **Gross (Admitted & Nonadmitted) Restricted** | **Gross (Admitted & Nonadmitted) Restricted** | **Gross (Admitted & Nonadmitted) Restricted** | **Gross (Admitted & Nonadmitted) Restricted** |
| | **General Account** | **Separate Account** | **Total Assets** | **Total From Prior Year** | **Increase/(Decrease)** | **Total Admitted Restricted** | **Gross (Admitted & Nonadmitted) Restricted to Total Assets** | **Admitted Restricted to Total Admitted Assets** |
|<br>**Restricted Asset Category** | **Total Assets** | **Total Assets** | **Total Assets** | **Total From Prior Year** | **Increase/(Decrease)** | **Total Admitted Restricted** | **Gross (Admitted & Nonadmitted) Restricted to Total Assets** | **Admitted Restricted to Total Admitted Assets** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |  |  |
| Collateral held under security lending agreements | $112342 | $— | $112342 | $192261 | $(79920) | $112342 | 0.90% | 0.92% |
| Subject to reverse repurchase agreements |  |  |  | 18178 | (18178) |  |  |  |
| FHLB capital stock | 31368 |  | 31368 | 31659 | (291) | 31368 | 0.25 | 0.26 |
| On deposit with states | 25602 |  | 25602 | 26331 | (729) | 25602 | 0.21 | 0.21 |
| Pledged as collateral to FHLB (including assets backing funding agreements) | 994604 |  | 994604 | 989738 | 4866 | 994604 | 8.01 | 8.11 |
| Derivative pledged as collateral  | 35660 |  | 35660 | 27161 | 8499 | 35660 | 0.29 | 0.29 |
| Assets held under modco reinsurance agreements | 244487 | 1818410 | 2062896 |  | 2062896 | 2062896 | 16.61 | 16.81 |
| Assets held under funds withheld reinsurance agreements | 352602 |  | 352602 |  | 352602 | 352602 | 2.84 | 2.87 |
| Total restricted assets | $1796664 | $1818410 | $3615073 | $1285328 | $2329745 | $3615073 | 29.11% | 29.47% |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The following table shows assets pledged as collateral or restricted at December 31, 2024:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Gross (Admitted & Nonadmitted) Restricted** | **Gross (Admitted & Nonadmitted) Restricted** | **Gross (Admitted & Nonadmitted) Restricted** | **Gross (Admitted & Nonadmitted) Restricted** | **Gross (Admitted & Nonadmitted) Restricted** | **Gross (Admitted & Nonadmitted) Restricted** | **Gross (Admitted & Nonadmitted) Restricted** |
| | **General Account** | **Total Assets** | **Total From Prior Year** | **Increase/(Decrease)** | **Total Admitted Restricted** | **Gross (Admitted & Nonadmitted) Restricted to Total Assets** | **Admitted Restricted to Total Admitted Assets** |
|<br>**Restricted Asset Category** | **Total Assets** | **Total Assets** | **Total From Prior Year** | **Increase/(Decrease)** | **Total Admitted Restricted** | **Gross (Admitted & Nonadmitted) Restricted to Total Assets** | **Admitted Restricted to Total Admitted Assets** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |  |  |
| Collateral held under security lending agreements | $192261 | $192261 | $159636 | $32625 | $192261 | 1.49% | 1.52% |
| Subject to reverse repurchase agreements | 18178 | 18178 |  | 18178 | 18178 | 0.14 | 0.14 |
| FHLB capital stock | 31659 | 31659 | 31061 | 598 | 31659 | 0.25 | 0.25 |
| On deposit with states | 26331 | 26331 | 26319 | 12 | 26331 | 0.20 | 0.21 |
| Pledged collateral to FHLB (including assets backing funding agreements) | 989738 | 989738 | 944852 | 44886 | 989738 | 7.67 | 7.84 |
| Derivative Pledged Collateral | 27161 | 27161 | 51301 | (24140) | 27161 | 0.21 | 0.22 |
| Total restricted assets | $1285328 | $1285328 | $1213169 | $72159 | $1285328 | 10.0% | 10.2% |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The following table shows collateral received and assets held under modco/funds withheld ("FWH") reinsurance agreements reflected as assets at December 31, 2025.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Assets** | **Book/Adjusted Carrying Value (BACV)<br> Collateral \*\*\*** | **Book/Adjusted <br>Carrying Value (BACV) Modco \*\*\*\*** | **Book/Adjusted Carrying Value (BACV) <br>FWH \*\*\*\*\*** | **Fair Value <br>Collateral** | **Fair Value <br>Modco** | **Fair Value<br>FWH** | **% of BACV to Total Assets (Admitted and Nonadmitted)\*** | **% of BACV to Total Admitted Assets\*\*** |
| **General Account** | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |  |  |
| Cash, Cash Equivalents and Short-Term Investments | $39921 | $10061 | $32666 | $39921 | $10061 | $32666 | 0.85% | 0.87% |
| Schedule D, Part 1 Section 1 |  | 155543 | 274497 |  | 145888 | 244056 | 4.44 | 4.54 |
| Schedule D, Part 1 Section 2 |  | 52509 | 45439 |  | 52348 | 44688 | 1.01 | 1.03 |
| Schedule D, Part 2, Section 1 |  | 3000 |  |  | 2928 |  | 0.03 | 0.03 |
| Schedule B |  | 14339 |  |  |  |  | 0.15 | 0.15 |
| Schedule BA, Part 1 |  | 9035 |  |  | 8592 |  | 0.09 | 0.10 |
| Schedule DL, Part 1 | 103868 |  |  | 103882 |  |  | 1.07 | 1.10 |
| Total Assets | $143789 | $244486 | $352602 | $143803 | $219818 | $321410 | 7.65% | 7.82% |
| **Separate Account:** |  |  |  |  |  |  |  |  |
| Cash, Cash Equivalents and Short-Term Investments | $— | $8909 | $— | $— | $8909 | $— | 0.32% | 0.32% |
| Schedule D, Part 1 Section 1 |  | 511 |  |  | 511 |  | 0.02 | 0.02 |
| Schedule D, Part 1, Section 2 |  | 225 |  |  | 225 |  |  |  |
| Schedule D, Part 2, Section 2 |  | 1808765 |  |  | 1808765 |  | 64.77 | 64.77 |
| Total Assets | $— | $1818410 | $— | $— | $1818410 | $— | 65.12% | 65.12% |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The following table shows related party code for assets held under modco/FWH reinsurance agreements reflected as assets at December 31, 2025.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **Related Party Code** | **Related Party Code** | **Related Party Code** | **Related Party Code** | **Related Party Code** | **Related Party Code** |
|<br>**Assets** | **Book/Adjusted Carrying Value (BACV)**<br>**FWH Including Modco** | **1** | **2** | **3** | **4** | **5** | **6** |
| **General Account** | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Cash, Cash Equivalents and Short-Term Investments | $42728 | $— | $— | $— | $— | $— | $42728 |
| Schedule D, Part 1 Section 1 | 430040 |  |  |  |  |  | 430040 |
| Schedule D, Part 1 Section 2 | 97948 |  |  |  |  |  | 97948 |
| Schedule D, Part 2, Section 1 | 3000 |  |  |  |  |  | 3000 |
| Schedule B | 14339 |  |  |  |  |  | 14339 |
| Schedule A |  |  |  |  |  |  |  |
| Schedule BA, Part 1 | 9035 |  |  |  |  |  | 9035 |
| Schedule DL, Part 1 |  |  |  |  |  |  |  |
| Total Assets | $597090 | $— | $— | $— | $— | $— | $597090 |
|  | **Book/Adjusted Carrying Value (BACV)** | **Related Party Code** | **Related Party Code** | **Related Party Code** | **Related Party Code** | **Related Party Code** | **Related Party Code** |
| **Assets** | **FWH Including Modco** | **1** | **2** | **3** | **4** | **5** | **6** |
| **Separate Account:** | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Cash, Cash Equivalents and Short-Term Investments | $8909 | $— | $— | $— | $— | $— | $8909 |
| Schedule D, Part 1 Section 1 | 511 |  |  |  |  |  | 511 |
| Schedule D, Part 1 Section 2 | 225 |  |  |  |  |  | 225 |
| Schedule D, Part 2, Section 2 | 1808765 |  |  | 1325104 |  |  | 483661 |
| Total Assets | $1818410 | $— | $— | $1325104 | $— | $— | $493305 |

---

---

| | | |
|:---|:---|:---|
| | **Amount** | **% of Liability to Total Liabilities\*** |
| Recognized Obligation to Return Collateral Asset (General Account) | $143789 | 1.77% |
| Recognized Obligation to Return Collateral Asset (Separate Account) | $— | —% |
| Recognized Obligation for Modco assets (General Account) | $240940 | 2.96% |
| Recognized Obligation for Modco assets (Separate Account) | $2090541 | 74.86% |
| Recognized Obligation for FWH (excluding Modco) assets (General Account) | $351477 | 4.32% |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The following table shows collateral received and reflected as assets at December 31, 2024:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Collateral Assets** | **Book/Adjusted Carrying Value (BACV)** | **Fair Value** | **Fair Value** | **% of BACV to Total Assets (Admitted and Nonadmitted)\*** | **% of BACV to Total Admitted Assets\*\*** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |  |  |
| Cash, Cash Equivalents and Short-Term Investments | $56543 | $| 56543 | 0.55% | 0.57% |
| Reinvested collateral assets owned | 116786 | 116825 | 116825 | 1.14 | 1.17 |
| Total collateral assets | $173329 | $| 173368 | 1.69% | 1.74% |
| \*BACV divided by total assets excluding Separate Accounts | \*BACV divided by total assets excluding Separate Accounts | \*BACV divided by total assets excluding Separate Accounts | \*BACV divided by total assets excluding Separate Accounts |  |  |
| \*\*BACV divided by total admitted assets excluding Separate Accounts | \*\*BACV divided by total admitted assets excluding Separate Accounts | \*\*BACV divided by total admitted assets excluding Separate Accounts | \*\*BACV divided by total admitted assets excluding Separate Accounts | \*\*BACV divided by total admitted assets excluding Separate Accounts |  |
|  | **Amount** | **% of Liability to Total Liabilities\*** | **% of Liability to Total Liabilities\*** |  |  |
|  | *(In Thousands)* |  |  |  |  |
| Recognized Obligation to return Collateral Asset (General Account)\* | $173329 | 1.95 | 1.95% |  |  |
| Recognized Obligation to Return Collateral Asset (Separate Account)\*\* | $— |  | —% |  |  |
| \*BACV divided by total liabilities excluding Separate Accounts | \*BACV divided by total liabilities excluding Separate Accounts | \*BACV divided by total liabilities excluding Separate Accounts | \*BACV divided by total liabilities excluding Separate Accounts |  |  |
| \*\*BACV divided by total liabilities on Separate Accounts | \*\*BACV divided by total liabilities on Separate Accounts | \*\*BACV divided by total liabilities on Separate Accounts | \*\*BACV divided by total liabilities on Separate Accounts |  |  |

---

***Troubled Debt Restructuring***

The Company has a high quality, well performing, portfolio of commercial mortgage loans and private placement debts. Under certain circumstances, modifications to these contracts are granted. Each modification is evaluated as to whether troubled debt restructuring has occurred. A modification is a troubled debt restructure when the borrower is in financial difficulty and the creditor makes concessions. Generally, the types of concessions may include: reduction of the face amount or maturity amount of the debt as originally stated, reduction of the contractual interest rate, extension of the maturity date at an interest rate lower than current market interest rates and/or reduction of accrued interest. The Company considers the amount, timing and extent of the concession granted in determining any impairment or changes in the specific valuation allowance recorded in connection with the troubled debt restructuring. A valuation allowance may have been recorded prior to the quarter when the loan is modified in a troubled debt restructuring. Accordingly, the carrying value (net of the specific valuation allowance) before and after modification through a troubled debt restructuring may not change significantly, or may increase if the expected recovery is higher than the pre-modification recovery assessment.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

As of December 31, 2025, the Company's investments which experienced troubled debt restructuring consisted of one commercial mortgage loan with a total carrying value of $1.5. As of December 31, 2024, the Company held three commercial mortgage loans with a carrying value of $7.3. The Company had no realized losses related to these investments during 2025, 2024, and 2023, respectively.

The Company has no contractual commitments to extend credit to debtors owing receivables whose terms have been modified in troubled debt restructurings.

The Company accrues interest income on impaired loans to the extent it is deemed collectible, that is delinquent less than 90 days, and the loan continues to perform under its original or restructured contractual terms. Interest income on non-performing loans is generally recognized on a cash basis.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

***Reverse Repurchase Agreements***

The Company may periodically enter into a reverse repurchase secured borrowing agreement as a temporary bridge liquidity facility to better match operational cash flow needs. In such cases, the Company will pledge investment grade corporate bonds to an approved dealer counterparty. As part of the agreement, the dealer will apply haircuts depending on specific collateral characteristics, and only advance funds against the lendable value (i.e., over-collateralized loan) of the collateral. The effective reverse repurchase borrowing rate will be market dependent, but in line with similar short-term collateralized lending rates.

The company entered into repo agreements with bilateral trades with the following original and residual maturity amounts in 2025 and 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| Original (Flow) & Residual Maturity |  |  |  |  |
| **12/31/2025** | FIRST<br>QUARTER | SECOND<br>QUARTER | THIRD<br>QUARTER | FOURTH<br>QUARTER |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Maximum Amount |  |  |  |  |
| > 1 Week to 1 Month | $200021 | $164964 | $15466 | $14330 |
| > 1 Month to 3 Months | $— | $— | $75601 | $— |
| Ending Balance |  |  |  |  |
| > 1 Week to 1 Month | $150246 | $— | $7339 | $— |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **12/31/2024** | FIRST<br>QUARTER | SECOND<br>QUARTER | THIRD<br>QUARTER | FOURTH<br>QUARTER |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Maximum Amount |  |  |  |  |
| 2 Days to 1 Week | $— | $— | $30004 | $— |
| > 1 Week to 1 Month | $— | $3000 | $170001 | $73903 |
| Ending Balance |  |  |  |  |
| > 1 Week to 1 Month | $— | $3000 | $25000 | $15001 |

---

No securities sold and/or acquired resulted in default.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The fair value of the securities acquired by the Company, under repo secured borrowings during the years 2025 and 2024 are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **12/31/2025** | FIRST<br>QUARTER | SECOND<br>QUARTER | THIRD<br>QUARTER | FOURTH<br>QUARTER |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Maximum Amount | $200021 | $164964 | $91067 | $14330 |
| Ending Balance | $149942 | $— | $7339 | $— |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **12/31/2024** | FIRST<br>QUARTER | SECOND<br>QUARTER | THIRD<br>QUARTER | FOURTH<br>QUARTER |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Maximum Amount | $— | $3000 | $200005 | $73903 |
| Ending Balance | $— | $3000 | $25000 | $15001 |

---

Securities Acquired Under Repo – The Company did not hold secured borrowings as of December 31, 2025. As of December 31, 2024 the Company held bonds with an NAIC 1 Designation and a fair value of $15.0 in secured borrowings.

Collateral provided for secured borrowings during the years 2025 and 2024 are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **12/31/2025** | FIRST<br>QUARTER | SECOND<br>QUARTER | THIRD<br>QUARTER | FOURTH<br>QUARTER |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Maximum Amount | Maximum Amount | Maximum Amount |  |  |
| Securities (FV) | $210548 | $173624 | $94053 | $14774 |
| Ending Balance |  |  |  |  |
| Securities (FV) | $155338 | $— | $7696 | $— |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **12/31/2024** | FIRST<br>QUARTER | SECOND<br>QUARTER | THIRD<br>QUARTER | FOURTH<br>QUARTER |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Maximum Amount |  |  |  |  |
| Cash | $— | $— | $— | $252 |
| Securities (FV) | $— | $3448 | $210531 | $77794 |
| Ending Balance |  |  |  |  |
| Cash | $— | $— | $— | $252 |
| Securities (FV) | $— | $3448 | $26316 | $15254 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The Company did not have collateral pledged as of December 31, 2025.

Allocation of aggregate collateral pledged by remaining contractual maturity as of December 31, 2024 were as follows:

---

| | | |
|:---|:---|:---|
| | AMORTIZED<br>COST | FAIR<br>VALUE |
|  | *(In Thousands)* | *(In Thousands)* |
| Overnight and Continuous | $252 | $252 |
| > 90 Days | $18178 | $15254 |

---

The Company had no recognized receivable for return of collateral on secured borrowings as of December 31, 2025 or 2024.

The Company recognized liabilities to return collateral on secured borrowings during the year are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **12/31/2025** | FIRST<br>QUARTER | SECOND<br>QUARTER | THIRD<br>QUARTER | FOURTH<br>QUARTER |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Maximum Amount |  |  |  |  |
| Repo Securities Sold/Acquired with<br>Cash Collateral | $200021 | $164964 | $91067 | $14330 |
| Ending Balance |  |  |  |  |
| Repo Securities Sold/Acquired with<br>Securities Collateral (FV) | $150246 | $— | $7339 | $— |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| **12/31/2024** | FIRST<br>QUARTER | SECOND<br>QUARTER | THIRD<br>QUARTER | FOURTH<br>QUARTER |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Maximum Amount |  |  |  |  |
| Repo Securities Sold/Acquired with Cash Collateral | $— | $3000 | $200005 | $73903 |
| Ending Balance |  |  |  |  |
| Repo Securities Sold/Acquired with<br>Cash Collateral | $— | $3000 | $25000 | $15001 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**4.**&nbsp;&nbsp;&nbsp;&nbsp;**Derivative Financial Instruments Held for Purposes Other than Trading**

The Company's use of derivatives is primarily for economic hedging purposes to reduce the Company's exposure to cash flow variability of assets and liabilities, interest rate risk, credit risk, and market risk. The Company enters into the following type of derivatives: *Credit Contracts*, *Equity Contracts*, *Foreign Exchange Contracts* and *Interest Rate Contracts*. The Company's use and hedging strategy of derivatives is detailed in Note 1.

Upfront fees paid or received on derivative contracts are included on the balance sheets as an asset or liability and are being amortized to investment income over the remaining terms of the contracts.

Periodic payments from such contracts are included in investment income on the statements of operations. Accrued amounts payable to or receivable from counterparties are included in other liabilities or accrued investment income on the balance sheet. Gains or losses realized as a result of early terminations are recognized in income in the statement of operations or deferred into IMR and amortized into investment income.

The Company is exposed to credit loss in the event of nonperformance by counterparties on certain derivative contracts; however, the Company does not anticipate nonperformance by any of these counterparties. The amount of such exposure is generally the unrealized gains in such contracts. The Company manages the potential credit exposure from interest rate contracts through careful evaluation of the counterparties' credit standing, collateral agreements, and master netting agreements.

Under the terms of the Company's Over-The-Counter ("OTC") Derivative International Swaps and Derivatives Association, Inc. ("ISDA") agreements, the Company may receive from, or deliver to, counterparties, collateral to assure that all terms of the ISDA agreements will be met with regard to the Credit Support Annex ("CSA"). The terms of the CSA call for the Company to pay interest on any cash received equal to the Federal Funds rate. Collateral held is used in accordance with the CSA to satisfy any obligations. Investment grade bonds owned by the Company are the source of noncash collateral posted, which is reported on the balance sheet.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The table below summarizes the Company's types and amounts of collateral held, pledged and delivered related to OTC derivative contracts and cleared derivative contracts:

---

| | | |
|:---|:---|:---|
| | **As of December 31, 2025** | **As of December 31, 2024** |
| **Collateral Type:** | *(In Thousands)* | *(In Thousands)* |
| Cash |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Held - OTC contracts | $— | $5744 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pledged - OTC contracts | $643 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Pledged - Cleared Contracts | $17640 | $3092 |
| Securities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Held | $— | $409 |
| &nbsp;&nbsp;&nbsp;&nbsp;Delivered | $35660 | $27161 |

---

The Company sells credit default swap protection, in conjunction with other investments, to replicate the income characteristics of otherwise permitted investments. The standard contract is five or seven years. In the event of default of the reference entity, the Company would be required to pay the notional amount of the contract. At December 31, 2025 and 2024, the total amount would be $14.2 and $15.2, respectively.

The table below summarizes the Company's derivative contracts at December 31, 2025 and 2024:

---

| | | | |
|:---|:---|:---|:---|
| | **Notional Amount** | **Net Carrying Value** | **Fair Value** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **December 31, 2025** |  |  |  |
| Derivative contracts: |  |  |  |
| &nbsp;&nbsp;&nbsp;Credit contracts | $14198 | $— | $(24) |
| &nbsp;&nbsp;&nbsp;Equity contracts | 32909 | 718 | 718 |
| &nbsp;&nbsp;&nbsp;Foreign exchange contracts | 105865 | (4208) | (1990) |
| &nbsp;&nbsp;&nbsp;Interest rate contracts | 2785882 | 990 | (17077) |
| Total derivatives | $2938854 | $(2500) | $(18373) |
| **December 31, 2024** |  |  |  |
| Derivative contracts: |  |  |  |
| &nbsp;&nbsp;&nbsp;Credit contracts | $15162 | $(58) | $(113) |
| &nbsp;&nbsp;&nbsp;Equity contracts | 35337 | 713 | 713 |
| &nbsp;&nbsp;&nbsp;Foreign exchange contracts | 115659 | 6009 | 7608 |
| &nbsp;&nbsp;&nbsp;Interest rate contracts | 3650241 | (324) | (5117) |
| Total derivatives | $3816399 | $6340 | $3091 |

---

The Company does not have any derivative contracts with financing premiums.

The Company does not have any derivative with excluded components.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**5.**&nbsp;&nbsp;&nbsp;&nbsp;**Concentrations of Credit Risk**

The Company held below investment grade corporate bonds with an aggregate book value of $288.0 and $302.0 and an aggregate fair value of $272.9 and $271.7 at December 31, 2025 and 2024, respectively. Those holdings amounted to 4.4% and 4.6% of the Company's investments in bonds at December 31, 2025 and 2024, respectively. The holdings of below investment grade bonds are widely diversified and of satisfactory quality based on the Company's investment policies and credit standards.

The Company held unrated bonds with a carrying value of $72.0 and $49.9 with an aggregate fair value of $73.3 and $48.2 at December 31, 2025 and 2024, respectively. The carrying value of these holdings amounted to 1.3% and 0.8% of the Company's investment in bonds at December 31, 2025 and 2024, respectively.

The Company's commercial mortgage loan portfolio is diversified by geographic region and property type to manage concentration risk. The Company manages risk when originating commercial mortgage loans by generally lending only up to 75% of the estimated fair value of the underlying real estate. Subsequently, the Company continuously evaluates all mortgage loans based on relevant current information including a review of loan-specific credit, property characteristics and market trends. Loan performance is continuously monitored on a loan-specific basis throughout the year. This review includes submitted appraisals, operating statements, rent revenues and annual inspection reports, among other items. This review evaluates whether the properties are performing at a consistent and acceptable level to secure the debt. The components to evaluate debt service coverage are received and reviewed at least annually to determine the level of risk.

The Company rates all commercial mortgages to quantify the level of risk. The Company places those loans with higher risk on a watch list and closely monitors these loans for collateral deficiency or other credit events that may lead to a potential loss of principal and/or interest.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

Loan-to-value ("LTV") and debt service coverage ("DSC") ratios are measures commonly used to assess the risk and quality of commercial mortgage loans. The LTV ratio is expressed as a percentage of the amount of the loan relative to the value of the underlying property. An LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the value of the underlying collateral. The DSC ratio, based upon the most recently received financial statements, is expressed as a percentage of the amount of a property's net income (loss) to its debt service payments. A DSC ratio of less than 1.0 indicates that property's operations do not generate sufficient income to cover debt payments. These ratios are utilized as part of the review process described above. LTV and DSC ratios as of the dates indicated are presented below:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **2025** | **2025** | **2024** | **2024** |
| | **Carrying Value** | **%** | **Carrying Value** | **%** |
|  | *(In Thousands)* |  | *(In Thousands)* |  |
| **Loan-to-Value** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;0% - 50% | $650672 | 71.1% | $757669 | 78.6% |
| &nbsp;&nbsp;&nbsp;50% - 60% | 245234 | 26.8 | 185749 | 19.3 |
| &nbsp;&nbsp;&nbsp;60% - 70% | 17623 | 1.9 | 18986 | 2.0 |
| &nbsp;&nbsp;&nbsp;70% - 80% | 2000 | 0.2 |  |  |
| &nbsp;&nbsp;&nbsp;80% - 90% |  |  | 1056 | 0.1 |
| &nbsp;&nbsp;&nbsp;Total | $915530 | 100.0% | $963460 | 100.0% |
| **Debt Service Coverage Ratio** |  |  |  |  |
| &nbsp;&nbsp;Greater than 1.5x | $662411 | 72.4% | $666231 | 69.1% |
| &nbsp;&nbsp;1.25x to 1.5x | 121853 | 13.3 | 139234 | 14.5 |
| &nbsp;&nbsp;1.0x to 1.25x | 100940 | 11.0 | 92450 | 9.6 |
| &nbsp;&nbsp;Less than 1.0x | 30326 | 3.3 | 54045 | 5.6 |
| &nbsp;&nbsp;Not Applicable\* |  |  | 11500 | 1.2 |
| &nbsp;&nbsp;&nbsp;Total | $915530 | 100.0% | $963460 | 100.0% |
| \*Commercial mortgage loans secured by land or construction loans | \*Commercial mortgage loans secured by land or construction loans | \*Commercial mortgage loans secured by land or construction loans | \*Commercial mortgage loans secured by land or construction loans | \*Commercial mortgage loans secured by land or construction loans |

---

If the value of any mortgage loan is determined to be impaired (i.e., when it is probable that the Company will be unable to collect on all amounts due according to the contractual terms of the loan agreement), the carrying value of the mortgage loan is reduced to either the present value of expected cash flows from the loan, discounted at the loan's effective interest rate, or fair value of the collateral.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The following table shows the Company's mortgage loan portfolio diversification by property type:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **As of December 31, 2025** | **As of December 31, 2025** | **As of December 31, 2024** | **As of December 31, 2024** |
|<br>**Property Type** | **Carrying Value** | **%** | **Carrying Value** | **%** |
|  | *(In Thousands)* |  | *(In Thousands)* |  |
| Apartments | $224427 | 24.4% | $243753 | 25.2% |
| Hotel/Motel | 18824 | 2.1 | 23215 | 2.4 |
| Industrial | 269645 | 29.5 | 259114 | 26.9 |
| Mixed Use | 10833 | 1.2 | 12151 | 1.3 |
| Office | 139697 | 15.3 | 161595 | 16.8 |
| Other | 30284 | 3.3 | 42451 | 4.4 |
| Retail | 221821 | 24.2 | 221181 | 23.0 |
| Total | $915530 | 100.0% | $963460 | 100.0% |

---

The following table shows the Company's mortgage loan portfolio diversification by region:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **As of December 31, 2025** | **As of December 31, 2025** | **As of December 31, 2024** | **As of December 31, 2024** |
|<br>**Region** | **Carrying Value** | **%** | **Carrying Value** | **%** |
|  | *(In Thousands)* |  | *(In Thousands)* |  |
| Pacific | $282629 | 30.9% | $290175 | 30.2% |
| South Atlantic | 182722 | 20.0 | 221559 | 23.1 |
| West South Central | 107584 | 11.8 | 96650 | 10.0 |
| East North Central | 63482 | 6.9 | 67201 | 7.0 |
| Middle Atlantic | 148878 | 16.3 | 140730 | 14.6 |
| Mountain | 79831 | 8.7 | 80200 | 8.3 |
| West North Central | 15113 | 1.7 | 33975 | 3.5 |
| New England | 15443 | 1.7 | 18360 | 1.9 |
| East South Central | 19848 | 2.2 | 14610 | 1.5 |
| Total | $915530 | 100.0% | $963460 | 100.0% |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The following table shows the carrying value of the Company's mortgage loan portfolio breakdown by year of origination:

---

| | | |
|:---|:---|:---|
| **Year of Origination** | **2025** | **2024** |
|  | *(In Thousands)* | *(In Thousands)* |
| 2025 | $139889 | $— |
| 2024 | 57885 | 55011 |
| 2023 | 67604 | 85332 |
| 2022 | 65990 | 80257 |
| 2021 | 75895 | 89333 |
| 2020 | 33406 | 37459 |
| 2019 and prior | 474860 | 616068 |
| Total | $915530 | $963460 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**6.**&nbsp;&nbsp;&nbsp;&nbsp;**Reserves**

At December 31, 2025 and 2024, the Company's annuity reserves, including those held in separate accounts and deposit fund liabilities that are subject to discretionary withdrawal (with adjustment), subject to discretionary withdrawal (without adjustment), and not subject to discretionary withdrawal provisions are summarized as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **General Account** | **Separate Account with Guarantees** | **Separate Account Non-Guaranteed** | **Total** | **Percent of Total** |
| **December 31, 2025** | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |  |
| **Individual Annuities:** |  |  |  |  |  |
| Subject to discretionary withdrawal: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;With market value adjustment | $5299 | $9459 | $— | $14758 | 0.3% |
| &nbsp;&nbsp;&nbsp;At book value less current surrender charge of 5% or more | 11506 |  |  | 11506 | 0.3 |
| &nbsp;&nbsp;&nbsp;At fair value |  |  | 1025024 | 1025024 | 24.1 |
| &nbsp;&nbsp;&nbsp;Total with market value adjustment or at fair value | 16805 | 9459 | 1025024 | 1051288 | 24.7% |
| Subject to discretionary withdrawal (without adjustment): |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;At book value without adjustment (minimal or no charge or adjustment) | 3044231 |  |  | 3044231 | 71.7 |
| Not subject to discretionary withdrawal | 152185 |  | 5 | 152191 | 3.6 |
| Total gross individual annuities reserves | 3213221 | 9459 | 1025029 | 4247710 | 100.0% |
| Less reinsurance ceded | 273171 |  |  | 273171 |  |
| Total net individual annuities reserves | $2940050 | $9459 | $1025029 | $3974539 |  |
| Amount at book value with surrender charge in the current year that will move to at book value without adjustment for the first time within the year after the statement date | $2069 | $— | $— | $2069 |  |
| **Group Annuities:** |  |  |  |  |  |
| Subject to discretionary withdrawal: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;With market value adjustment | $— | $— | $— | $— | —% |
| &nbsp;&nbsp;&nbsp;At book value less current surrender charge of 5% or more | 171 |  |  | 171 |  |
| &nbsp;&nbsp;&nbsp;At fair value |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Total with market value adjustment or at fair value | 171 |  |  | 171 | —% |
| Subject to discretionary withdrawal (without adjustment): |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;At book value without adjustment (minimal or no charge or adjustment) | 1536131 |  |  | 1536131 | 94.4 |
| Not subject to discretionary withdrawal | 91325 |  |  | 91325 | 5.6 |
| Total gross group annuities reserves | 1627627 |  |  | 1627627 | 100.0% |
| Less reinsurance ceded | 18578 |  |  | 18578 |  |
| Total net group annuities reserves | $1609049 | $— | $— | $1609049 |  |
| Amount at book value with surrender charge in the current year that will move to at book value without adjustment for the first time within the year after the statement date | $77 | $— | $— | $77 |  |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **General Account** | **Separate Account with Guarantees** | **Separate Account Non-guaranteed** | **Total** | **Percent of Total** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |  |
| **Deposit Type Contracts (no life contingencies):** |  |  |  |  |  |
| Subject to discretionary withdrawal: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;With market value adjustment | $— | $— | $— | $— | —% |
| &nbsp;&nbsp;&nbsp;At book value less current surrender charge of 5% or more |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;At fair value |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Total with market value adjustment or at fair value |  |  |  |  | —% |
| Subject to discretionary withdrawal (without adjustment): |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;At book value without adjustment (minimal or no charge or adjustment) | 307583 |  |  | 307583 | 33.6 |
| Not subject to discretionary withdrawal | 607554 |  |  | 607554 | 66.4 |
| Total gross deposit type contracts reserves | 915138 |  |  | 915138 | 100.0% |
| Less reinsurance ceded | 71344 |  |  | 71344 |  |
| Total net deposit type contracts reserves | $843794 | $— | $— | $843794 |  |
| Amount at book value with surrender charge in the current year that will move to at book value without adjustment for the first time within the year after the statement date | $— | $— | $— | $— |  |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **General Account** | **Separate Account with Guarantees** | **Separate Account Non-Guaranteed** | **Total** | **Percent of Total** |
| **December 31, 2024** | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |  |
| **Individual Annuities:** |  |  |  |  |  |
| Subject to discretionary withdrawal: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;With market value adjustment | $6217 | $10872 | $— | $17089 | 0.4% |
| &nbsp;&nbsp;&nbsp;At book value less current surrender charge of 5% or more | 29857 |  |  | 29857 | 0.7 |
| &nbsp;&nbsp;&nbsp;At fair value |  |  | 1010383 | 1010383 | 22.0 |
| Total with market value adjustment or at fair value | 36074 | 10872 | 1010383 | 1057329 | 23.0% |
| &nbsp;&nbsp;&nbsp;At book value without adjustment (minimal or no charge or adjustment) | 3370075 |  |  | 3370075 | 73.5 |
| Not subject to discretionary withdrawal | 159675 |  | 6 | 159681 | 3.5 |
| Total gross individual annuities reserves | 3565824 | 10872 | 1010389 | 4587085 | 100.0% |
| Less reinsurance ceded | 322385 |  |  | 322385 |  |
| Total net individual annuities reserves | $3243439 | $10872 | $1010389 | $4264700 |  |
| Amount at book value with surrender charge in the current year that will move to at book value without adjustment in the year after the statement date | $6299 | $— | $— | $6299 |  |
| **Group Annuities:** |  |  |  |  |  |
| Subject to discretionary withdrawal: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;With market value adjustment | $— | $— | $— | $— | —% |
| &nbsp;&nbsp;&nbsp;At book value less current surrender charge of 5% or more | 421 |  |  | 421 |  |
| &nbsp;&nbsp;&nbsp;At fair value |  |  |  |  |  |
| Total with market value adjustment or at fair value | 421 |  |  | 421 | —% |
| &nbsp;&nbsp;&nbsp;At book value without adjustment (minimal or no charge or adjustment) | 1672467 |  |  | 1672467 | 94.3 |
| Not subject to discretionary withdrawal | 99775 |  |  | 99775 | 5.7 |
| Total gross group annuities reserves | 1772663 |  |  | 1772663 | 100.0% |
| Less reinsurance ceded | 22674 |  |  | 22674 |  |
| Total net group annuities reserves | $1749989 | $— | $— | $1749989 |  |
| Amount at book value with surrender charge in the current year that will move to at book value without adjustment in the year after the statement date | $189 | $— | $— | $189 |  |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **General Account** | **Separate Account with Guarantees** | **Separate Account Non-Guaranteed** | **Total** | **Percent of Total** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |  |
| **Deposit-Type Contracts (no life contingencies):** |  |  |  |  |  |
| Subject to discretionary withdrawal: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;With market value adjustment | $— | $— | $— | $— | —% |
| &nbsp;&nbsp;&nbsp;At book value less current surrender charge of 5% or more |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;At fair value |  |  |  |  |  |
| Total with market value adjustment or at fair value |  |  |  |  | —% |
| &nbsp;&nbsp;&nbsp;At book value without adjustment (minimal or no charge or adjustment) | 331153 |  |  | 331153 | 30.5 |
| Not subject to discretionary withdrawal | 755408 |  |  | 755408 | 69.5 |
| Total gross deposit-type contract reserves | 1086561 |  |  | 1086561 | 100.0% |
| Less reinsurance ceded | 83447 |  |  | 83447 |  |
| Total net deposit-type contract reserves | $1003114 | $— | $— | $1003114 |  |
| Amount at book value with surrender charge in the current year that will move to at book value without adjustment in the year after the statement date | $— | $— | $— | $— |  |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

At December 31, 2025 and 2024, the Company's life insurance reserves, including those held in separate accounts that are subject to discretionary withdrawal and not subject to discretionary withdrawal provisions are summarized as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Account Value** | **Cash Value** | **Reserve** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **December 31, 2025** |  |  |  |
| General Account |  |  |  |
| Subject to discretionary withdrawal, surrender values, or policy loans: |  |  |  |
| &nbsp;&nbsp;&nbsp;Term Policies with Cash Value | $— | $226237 | $880033 |
| &nbsp;&nbsp;&nbsp;Universal Life | 892420 | 863655 | 1048756 |
| &nbsp;&nbsp;&nbsp;Universal Life with Secondary Guarantees | 841751 | 839239 | 2069970 |
| &nbsp;&nbsp;&nbsp;Other Permanent Cash Value Life Insurance | 217719 | 917069 | 1097763 |
| &nbsp;&nbsp;&nbsp;Variable Life | 2574 | 2574 | 2574 |
| &nbsp;&nbsp;&nbsp;Variable Universal Life | 160619 | 160560 | 152023 |
| &nbsp;&nbsp;&nbsp;Miscellaneous Reserves |  |  | 114822 |
| Not subject to discretionary withdrawal |  |  |  |
| &nbsp;&nbsp;&nbsp;Term Policies without Cash Value | XXX | XXX | 6618893 |
| &nbsp;&nbsp;&nbsp;Accidental Death Benefits | XXX | XXX | 397 |
| &nbsp;&nbsp;&nbsp;Disability- Active Lives | XXX | XXX | 26406 |
| &nbsp;&nbsp;&nbsp;Disability- Disabled Lives | XXX | XXX | 219871 |
| &nbsp;&nbsp;&nbsp;Miscellaneous Reserves | XXX | XXX | 422908 |
| Total gross life insurance reserves | 2115083 | 3009334 | 12654416 |
| Less reinsurance ceded | 1963847 | 2788858 | 11990001 |
| Total net general account life insurance reserves | $151236 | $220476 | $664415 |
| Separate Account with Guarantees |  |  |  |
| Total net separate account with guaranteed life insurance reserves | $— | $— | $— |
| Separate Account Non-guaranteed |  |  |  |
| Subject to discretionary withdrawal, surrender values, or policy loans: |  |  |  |
| &nbsp;&nbsp;&nbsp;Variable Life | $42517 | $42517 | $42517 |
| &nbsp;&nbsp;&nbsp;Variable Universal Life | 1715466 | 1715466 | 1715466 |
| &nbsp;&nbsp;&nbsp;Miscellaneous Reserves |  |  | 33335 |
| Not subject to discretionary withdrawal |  |  |  |
| &nbsp;&nbsp;&nbsp;Miscellaneous Reserves | XXX | XXX | 1432 |
| Total gross life insurance reserves | 1757983 | 1757983 | 1792750 |
| Less reinsurance ceded |  |  |  |
| Total net separate account with non-guaranteed life insurance reserves | $1757983 | $1757983 | $1792750 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

---

| | | | |
|:---|:---|:---|:---|
| | **Account Value** | **Cash Value** | **Reserve** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **December 31, 2024** |  |  |  |
| General Account |  |  |  |
| Subject to discretionary withdrawal, surrender values, or policy loans: |  |  |  |
| &nbsp;&nbsp;&nbsp;Term Policies with Cash Value | $— | $229548 | $835602 |
| &nbsp;&nbsp;&nbsp;Universal Life | 942048 | 910108 | 1098873 |
| &nbsp;&nbsp;&nbsp;Universal Life with Secondary Guarantees | 926469 | 923037 | 2170260 |
| &nbsp;&nbsp;&nbsp;Other Permanent Cash Value life Insurance | 223652 | 957180 | 1126510 |
| &nbsp;&nbsp;&nbsp;Variable Life | 2574 | 2574 | 2574 |
| &nbsp;&nbsp;&nbsp;Variable Universal life | 157178 | 157113 | 148567 |
| &nbsp;&nbsp;&nbsp;Miscellaneous Reserves |  |  | 36500 |
| Not subject to discretionary withdrawal |  |  |  |
| &nbsp;&nbsp;&nbsp;Term Policies without Cash Value | XXX | XXX | 7044113 |
| &nbsp;&nbsp;&nbsp;Accidental Death Benefits | XXX | XXX | 393 |
| &nbsp;&nbsp;&nbsp;Disability- Active Lives | XXX | XXX | 26529 |
| &nbsp;&nbsp;&nbsp;Disability- Disabled Lives | XXX | XXX | 229551 |
| &nbsp;&nbsp;&nbsp;Miscellaneous Reserves | XXX | XXX | 474170 |
| Total gross life insurance reserves | 2251921 | 3179560 | 13193642 |
| Less reinsurance ceded | 2100973 | 2958655 | 12635429 |
| Total net general account life insurance reserves | $150948 | $220905 | $558213 |
| Separate Account with Guarantees |  |  |  |
| Total net separate account with guaranteed life insurance reserves | $— | $— | $— |
| Separate Account Non-guaranteed |  |  |  |
| Subject to discretionary withdrawal, surrender values, or policy loans: |  |  |  |
| &nbsp;&nbsp;&nbsp;Variable Life | $38723 | $38723 | $38723 |
| &nbsp;&nbsp;&nbsp;Variable Universal life | 1586638 | 1585378 | 1585378 |
| &nbsp;&nbsp;&nbsp;Miscellaneous Reserves |  |  |  |
| Not subject to discretionary withdrawal |  |  |  |
| &nbsp;&nbsp;&nbsp;Miscellaneous Reserves | XXX | XXX | 1975 |
| Total gross life insurance reserves | 1625361 | 1624101 | 1626076 |
| Less reinsurance ceded |  |  |  |
| Total net separate account with non-guaranteed life insurance reserves | $1625361 | $1624101 | $1626076 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

Deferred and uncollected life insurance premiums and annuity considerations as of December 31, 2025 and 2024 are as follows:

---

| | | |
|:---|:---|:---|
| **Type** | **Gross** | **Net of Loading** |
|  | *(In Thousands)* | *(In Thousands)* |
| **December 31, 2025** |  |  |
| Ordinary new business | $2801 | $(139) |
| Ordinary renewal | (83911) | (87219) |
| Group Life | (72970) | (77207) |
| Totals | $(154080) | $(164565) |
| **December 31, 2024** |  |  |
| Ordinary new business | $3624 | $(158) |
| Ordinary renewal | (95272) | (98093) |
| Group Life | (91268) | (95877) |
| Totals | $(182916) | $(194128) |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**7. Employee Benefit Plans**

*Defined Benefit Plan*: Voya Services Company ("VSC") sponsors the Voya Retirement Plan (the "Qualified Plan"). The Qualified Plan is a tax qualified defined benefit plan, the benefits of which are guaranteed (within certain specified legal limits) by the Pension Benefit Guaranty Corporation ("PBGC"). The Qualified Plan operates under a cash balance pension formula where participants earn a credit equal to 4% of eligible pay. The accrued vested balance is portable. The costs allocated to the Company for its employees' participation in the Qualified Plan, which are based on salary cost incurred, were $4.4, $4.0 and $3.6 for 2025, 2024 and 2023, respectively. VSC is responsible for all Qualified Plan liabilities.

*Defined Contribution Plans*: VSC sponsors the Voya 401(k) Savings Plan (the "Savings Plan"). Substantially all employees of VSC and its subsidiaries and affiliates (excluding certain employees, including but not limited to Career Agents) are eligible to participate, including the Company's employees other than Company agents. The Savings Plan is a tax qualified defined contribution plan. Savings Plan benefits are not guaranteed by the Pension Benefit Guaranty Corporation ("PBGC"). The Savings Plan allows eligible participants to defer into the Savings Plan a specified percentage of eligible compensation on a pretax, Roth after-tax, and after-tax basis. VSC matches pretax and Roth after-tax contributions, up to a maximum of 6% of eligible compensation. All matching contributions are subject to a 4 year graded vesting schedule (although certain specified participants are subject to a 5 year graded vesting schedule). All contributions made to the Savings Plan are subject to certain limits imposed by applicable law. Amounts allocated to the Company for the Savings Plan were $8.4, $7.4 and $6.9 for 2025, 2024 and 2023, respectively.

*Omnibus Plan*: Certain employees of the Company participate in the Omnibus Employee Incentive Plans (the "Omnibus Plans") sponsored by Voya Financial. The Omnibus Plans each permit the granting of a wide range of equity-based awards, including restricted stock units ("RSUs"), performance share units ("PSUs"), and stock options. While the Company is not directly liable for the costs, an allocation is made based on the cost center of the participating employees. The costs allocated to the Company under these holding company arrangements for employee participation were $9.4, $12.6 and $14.2 for 2025, 2024 and 2023, respectively.

The Company also offers deferred compensation plans for eligible employees and certain other individuals who meet the eligibility criteria. The Company's deferred compensation commitment for employees is recorded on the balance sheet in other liabilities and totaled $0.1 and $0.1 for the years ended December 31, 2025 and 2024, respectively.

As of August 1, 2009, Voya's Postretirement Welfare Plans are no longer eligible for the Medicare Retiree Drug Subsidy ("RDS") that was being shared with retirees and beneficiaries.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

*Other Benefit Plans*: In addition to providing retirement plan benefits, the Company, in conjunction with VSC, provides certain supplemental retirement benefits to eligible employees and health care and life insurance benefits to retired employees and other eligible dependents. The supplemental retirement plan includes a nonqualified defined benefit pension plan and a nonqualified defined contribution plan, which means all benefits are payable from the general assets of the Company. The postretirement health care plan is contributory with retiree contribution levels adjusted annually. The life insurance plan provides a flat amount of noncontributory coverage and optional contributory coverage. Prior to April 1, 2017, coverage for Medicare eligible retirees was provided through a fully insured Medicare Advantage plan. Effective April 1, 2017, the fully insured Medicare Advantage Plan was replaced with access to individual coverage through a private exchange. The Company's premium subsidy ended and was replaced with a monthly health reimbursement arrangement ("HRA") contribution.

A summary of assets, obligations and assumptions of the non-qualified defined benefit and other postretirement benefit plans are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Overfunded** | **Overfunded** | **Underfunded** | **Underfunded** |
| | **2025** | **2024** | **2025** | **2024** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **Pension Benefits** |  |  |  |  |
| Benefit obligation at beginning of year | $— | $— | $15606 | $17497 |
| Service cost |  |  |  |  |
| Interest cost |  |  | 858 | 868 |
| Contribution by plan participants |  |  |  |  |
| Actuarial gain (loss) |  |  | 743 | (488) |
| Foreign currency exchange rate changes |  |  |  |  |
| Benefits paid |  |  | (2257) | (2272) |
| Plan amendments |  |  |  |  |
| Business combinations, divestitures, curtailments, settlements and special termination benefits |  |  |  |  |
| Benefit obligation at end of year | $— | $— | $14950 | $15606 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Overfunded** | **Overfunded** | **Underfunded** | **Underfunded** |
| | **2025** | **2024** | **2025** | **2024** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **Postretirement Benefits** |  |  |  |  |
| Benefit obligation at beginning of year | $— | $— | $1827 | $2070 |
| Service cost |  |  |  |  |
| Interest cost |  |  | 91 | 99 |
| Contribution by plan participants |  |  | 478 | 448 |
| Actuarial gain |  |  | 248 | 287 |
| Foreign currency exchange rate changes |  |  |  |  |
| Benefits paid |  |  | (1027) | (1077) |
| Plan amendments |  |  |  |  |
| Business combinations, divestitures, curtailments, settlements and special termination benefits |  |  |  |  |
| Benefit obligation at end of year | $— | $— | $1617 | $1827 |
| **Special or Contractual Benefits Per SSAP No. 11\*** | **Special or Contractual Benefits Per SSAP No. 11\*** | **Special or Contractual Benefits Per SSAP No. 11\*** | **Special or Contractual Benefits Per SSAP No. 11\*** | **Special or Contractual Benefits Per SSAP No. 11\*** |
| Benefit obligation at end of year | $— | $— | $— | $— |
| \* SSAP No. 11, *Postemployment Benefits and Compensated Absences* ("SSAP No. 11") | \* SSAP No. 11, *Postemployment Benefits and Compensated Absences* ("SSAP No. 11") | \* SSAP No. 11, *Postemployment Benefits and Compensated Absences* ("SSAP No. 11") | \* SSAP No. 11, *Postemployment Benefits and Compensated Absences* ("SSAP No. 11") | \* SSAP No. 11, *Postemployment Benefits and Compensated Absences* ("SSAP No. 11") |

---

A reconciliation of the beginning and ending balances of the fair value of plan assets is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Pension Benefits** | **Pension Benefits** | **Postretirement Benefits** | **Postretirement Benefits** |
| | **2025** | **2024** | **2025** | **2024** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Fair value of plan assets at beginning of year | $— | $— | $— | $— |
| Reporting entity contribution | 2257 | 2272 | 549 | 629 |
| Plan participants' contributions |  |  | 478 | 448 |
| Benefits paid | (2257) | (2272) | (1027) | (1077) |
| Fair value of plan assets at end of year | $— | $— | $— | $— |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The funded status of the plans are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Pension Benefits** | **Pension Benefits** | **Postretirement Benefits** | **Postretirement Benefits** |
| | **2025** | **2024** | **2025** | **2024** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Components: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued benefit costs | $12070 | $13325 | $3094 | $3850 |
| &nbsp;&nbsp;&nbsp;&nbsp;Liability for pension benefits | 2880 | 2281 | (1476) | (2023) |
| Assets and Liabilities recognized: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Liabilities recognized | $14950 | $15606 | $1618 | $1827 |
| Unrecognized liabilities | $— | $— | $— | $— |

---

The amount of the net periodic benefit cost recognized is shown below:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Pension Benefits** | **Pension Benefits** | **Pension Benefits** | **Postretirement Benefits** | **Postretirement Benefits** | **Postretirement Benefits** | **Special or Contractual Benefits Per SSAP No. 11** | **Special or Contractual Benefits Per SSAP No. 11** | **Special or Contractual Benefits Per SSAP No. 11** |
| | **2025** | **2024** | **2023** | **2025** | **2024** | **2023** | **2025** | **2024** | **2023** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Interest cost | $858 | $868 | $901 | $91 | $99 | $113 | $— | $— | $— |
| Transition asset or obligation |  |  |  |  |  |  |  |  |  |
| Gains and losses | 143 | 226 |  | (273) | (321) | (330) |  |  |  |
| Prior service cost or credit |  |  |  | (25) | (25) | (177) |  |  |  |
| Total net periodic benefit cost | $1001 | $1094 | $901 | $(207) | $(247) | $(394) | $— | $— | $— |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The amounts in unassigned funds (surplus) recognized as components of net periodic benefit cost are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Pension Benefits** | **Pension Benefits** | **Pension Benefits** | **Postretirement Benefits** | **Postretirement Benefits** | **Postretirement Benefits** |
| | **2025** | **2024** | **2023** | **2025** | **2024** | **2023** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Items not yet recognized - prior year | $2280 | $2994 | $1580 | $(2023) | $(2656) | $(3158) |
| Net prior service cost or credit recognized |  |  |  | 25 | 25 | 177 |
| Net gain and loss arising during period | 743 | (488) | 1414 | 248 | 287 | (5) |
| Net gain and loss recognized | (143) | (226) |  | 273 | 321 | 330 |
| Items not yet recognized - current year | $2880 | $2280 | $2994 | $(1477) | $(2023) | $(2656) |

---

The amounts in unassigned funds (surplus) that have not yet been recognized as components of net periodic benefit cost are as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Pension Benefits** | **Pension Benefits** | **Pension Benefits** | **Postretirement Benefits** | **Postretirement Benefits** | **Postretirement Benefits** |
| | **2025** | **2024** | **2023** | **2025** | **2024** | **2023** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Net transition asset or obligation | $— | $— | $— | $— | $— | $— |
| Net prior service cost or credit | $— | $— | $— | $(141) | $(166) | $(191) |
| Net recognized gains and losses | $2880 | $2280 | $2994 | $(1336) | $(1857) | $(2465) |

---

Assumptions used in determining year-end liabilities for the defined benefit plans as of December 31, 2025 and 2024 were as follows:

---

| | | |
|:---|:---|:---|
| | **2025** | **2024** |
| Weighted average discount rate | 5.63% | 5.88% |

---

The weighted-average discount rate used to determine year-end liabilities of other benefit plans was 5.02% and 5.56% as of December 31, 2025 and 2024, respectively.

Assumptions used in determining expense for the defined benefit plans as of December 31, 2025, 2024 and 2023 were as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **2025** | **2024** | **2023** |
| Weighted average discount rate | 5.88% | 5.28% | 5.47% |

---

The weighted-average discount rate used to determine expense of other benefit plans was 5.56%, 5.16% and 5.33% as of December 31, 2025, 2024, and 2023, respectively.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The amount of accumulated benefit obligation for defined benefit pension plans was $14.9 and $15.6 as of December 31, 2025 and 2024, respectively.

The Company expects to pay the following benefits in future years:

---

| | |
|:---|:---|
| **Year ending December 31,** | **Benefits** |
|  | *(In Thousands)* |
| 2026 | $2291 |
| 2027 | 2160 |
| 2028 | 2028 |
| 2029 | 1889 |
| 2030 | 1752 |
| 2030 through 2034 | 6698 |

---

The Company's expected future contributions are equal to its expected future benefit payments.

The Company has multiple postretirement welfare benefit plans. The medical plans are contributory, with plan premiums and participants' contributions adjusted annually. The life insurance plan for retirees is contributory based on retirement date.

The Company does not have any regulatory contribution requirements for 2025, and the Company currently intends to make voluntary contributions of $2.3 to the defined benefit pension plan for 2025.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**8. Separate Accounts** 

Separate account assets and liabilities represent funds segregated by the Company for the benefit of certain policy and contract holders who bear the investment risk. Revenues and expenses on the separate account assets and related liabilities equal the benefits paid to the separate account policy and contract holders.

The general nature and characteristics of the separate accounts business is as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Nonindexed Guarantee Less Than/Equal to 4%** | **Non-Guaranteed Separate Accounts** | **Total** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **December 31, 2025** |  |  |  |
| Premium, consideration or deposits | $— | $38542 | $38542 |
| Reserves for separate accounts with assets at: |  |  |  |
| &nbsp;&nbsp;Fair value | $9459 | $2784443 | $2793902 |
| Total reserves | $9459 | $2784443 | $2793902 |
| Reserves for separate accounts by withdrawal characteristics: |  |  |  |
| &nbsp;&nbsp;Subject to discretionary withdrawal: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;With market value adjustment | $9459 | $— | $9459 |
| &nbsp;&nbsp;&nbsp;&nbsp;At fair value |  | 2784438 | 2784438 |
| Subtotal | $9459 | $2784438 | $2793897 |
| Not subject to discretionary withdrawal |  | 5 | 5 |
| Total separate account aggregate reserves | $9459 | $2784443 | $2793902 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

---

| | | | |
|:---|:---|:---|:---|
| | **Nonindexed Guarantee Less Than/Equal to 4%** | **Non-Guaranteed Separate Accounts** | **Total** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **December 31, 2024** |  |  |  |
| Premium, consideration or deposits for the year | $— | $44129 | $44129 |
| Reserves for separate accounts with assets at: |  |  |  |
| &nbsp;&nbsp;Fair value | $10872 | $2636464 | $2647336 |
| Total reserves | $10872 | $2636464 | $2647336 |
| Reserves for separate accounts by withdrawal characteristics: |  |  |  |
| &nbsp;&nbsp;Subject to discretionary withdrawal: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;With market value adjustment | $10872 | $— | $10872 |
| &nbsp;&nbsp;&nbsp;&nbsp;At fair value |  | 2636458 | 2636458 |
| Subtotal | $10872 | $2636458 | $2647330 |
| Not subject to discretionary withdrawal |  | 6 | 6 |
| Total separate account aggregate reserves | $10872 | $2636464 | $2647336 |

---

The Company utilizes separate accounts to record and account for assets and liabilities for particular lines of business. For the years ended December 31, 2025 and 2024, the Company reported assets and liabilities from Individual Annuity, Individual Life and Market Value Adjustment ("MVA") product lines in separate accounts.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

Assets in the separate account are considered legally insulated from the general account, providing protection of such assets from being available to satisfy claims resulting in the general account. The assets legally and not legally insulated from the general account are summarized in the following table, by product or transaction type:

---

| | |
|:---|:---|
| **Product or Transaction** | **Legally Insulated Assets** |
|  | *(In Thousands)* |
| **December 31, 2025** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Individual Annuity | $1026474 |
| &nbsp;&nbsp;&nbsp;&nbsp;Individual Life | 1756476 |
| &nbsp;&nbsp;&nbsp;&nbsp;MVA | 9645 |
|  | $2792595 |
| **December 31, 2024** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Individual Annuity | $1012374 |
| &nbsp;&nbsp;&nbsp;&nbsp;Individual Life | 1622596 |
| &nbsp;&nbsp;&nbsp;&nbsp;MVA | 10830 |
|  | $2645800 |

---

As of December 31, 2025 and 2024 separate account assets for products registered with the SEC totaled $2.8 billion and $2.6 billion, respectively.

In accordance with the products/transactions recorded within the separate account, some separate account liabilities are guaranteed by the general account. To compensate the general account for the risk taken, the separate account paid the following amounts in risk charges:

---

| | |
|:---|:---|
| **Year ended** | **Risk Charges** |
|  | *(In Thousands)* |
| 2025 | $12814 |
| 2024 | 12753 |
| 2023 | 11532 |
| 2022 | 12131 |
| 2021 | 14694 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

Total separate account guarantees paid by the Company's general account are as follows:

---

| | |
|:---|:---|
| **Year ended** | **Guarantees Paid** |
|  | *(In Thousands)* |
| 2025 | $162 |
| 2024 | 311 |
| 2023 | 281 |
| 2022 | 286 |
| 2021 | 200 |

---

The Company does not engage in securities lending transactions within the separate account.

A reconciliation of the amounts transferred to and from the separate accounts is presented below:

---

| | | | |
|:---|:---|:---|:---|
| | **Year ended December 31** | **Year ended December 31** | **Year ended December 31** |
| | **2025** | **2024** | **2023** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Transfers as reported in the Summary of Operations |  |  |  |
| &nbsp;&nbsp;of the Separate Accounts Statement: |  |  |  |
| Transfers to separate accounts | $38163 | $44342 | $44945 |
| Transfers from separate accounts | (235556) | (234190) | (177024) |
| Transfers as reported in the Statements of Operations | $(197393) | $(189848) | $(132079) |

---

Assets supporting separate accounts with additional insurance benefits and minimum investment return guarantees are comprised of bonds, equity securities, including mutual funds, and other invested assets. The aggregate fair value of the invested assets as of December 31, 2025 and 2024 was $2.8 billion and $2.6 billion, respectively.

The Company has separate account accounts for which less than 100% of investment proceeds, net of contract fees and assessments, are attributable to a contract holder. The reinvestment of investment proceeds within the separate account did not result in the Company having a combined investment portfolio that exceeded the state investment limitations imposed on the general account as of December 31, 2025 and 2024.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**9. Federal Income Taxes** 

The Company has entered into a federal tax sharing agreement with members of an affiliated group as defined in Section 1504 of the Internal Revenue Code of 1986, as amended. The agreement provides for the manner of calculation and the amounts/timing of the payments between the parties as well as other related matters in connection with the filing of consolidated federal income tax returns. The federal tax sharing agreement generally provides for a separate entity approach and that Voya Financial, Inc. will pay its subsidiaries for the tax benefits of ordinary and capital losses only to the extent the consolidated tax group actually uses the tax benefit of losses generated.

The following is a list of all affiliated companies that participate in the filing of this consolidated federal income tax return:

---

| | |
|:---|:---|
| Voya Financial, Inc. | Pen-Cal Administrators, Inc. |
| Voya Holdings Inc. | Voya Special Investments, Inc. |
| Voya Retirement Insurance and Annuity Company | Voya Institutional Trust Company |
| ReliaStar Life Insurance Company | Voya Payroll Management, Inc. |
| ReliaStar Life Insurance Company of New York | Benfitfocus, Inc. |
| Voya Financial Advisors, Inc. | Benfitfocus.com, Inc. |
| Voya Services Company | Tango Health, Inc. |
| Security Life Assignment Corp. | |

---

Under the intercompany tax sharing agreement, the Company had a receivable of $6.2 at December 31, 2025 and $24.2 at December 31, 2024, from Voya Financial, Inc., an affiliate, for federal income taxes.

For the tax years 2023 through 2025, Voya Financial, Inc. participates in the Internal Revenue Service ("IRS") Compliance Assurance Process ("CAP"), which is a continuous audit program provided by the IRS. For the 2023 tax year, Voya Financial, Inc. is in the Compliance Maintenance Bridge ("Bridge") phase of CAP. In the Bridge phase, the IRS did not conduct any review or provide any letters of assurance for that tax year. For the 2024 and 2025 tax years, Voya Financial, Inc. is in the Compliance Maintenance Bridge Plus ("Bridge Plus") phase of CAP. In the Bridge Plus phase, the IRS will review the tax return and issue either a full or partial acceptance letter upon completion of review.

Voya Financial, Inc. received a partial acceptance letter for the 2024 tax year and does not anticipate any material adjustments to its tax return as filed.

Voya Financial, Inc. filed amended federal income tax returns for tax years 2012 through 2018 to claim a foreign tax credit instead of utilizing a foreign tax deduction. Voya Financial, Inc. does not anticipate an adjustment to its claim as filed. The audit of the claim is ongoing.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

In August 2022, the Inflation Reduction Act was signed into law creating the corporate alternative minimum tax ("CAMT"). In September 2024, the Department of Treasury issued proposed regulations providing additional guidance on the CAMT. The Company, as a member of a controlled group, is a nonapplicable taxpayer as it does not expect to be subject to CAMT for 2025. The Company's parent, Voya Financial, Inc., continues to review the proposed regulations, and its CAMT determination will need to be evaluated in light of future guidance.

In July 2025, the One Big Beautiful Bill Act ("OBBBA") was signed into law, which includes changes to the Internal Revenue Code. The OBBBA did not have a material impact on the Company's surplus.

Current income taxes incurred consisted of the following major components:

---

| | | | |
|:---|:---|:---|:---|
| | **Year ended December 31** | **Year ended December 31** | **Year ended December 31** |
| | **2025** | **2024** | **2023** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Federal tax (benefit) expense on operations | $(19321) | $(30316) | $18503 |
| Federal tax expense (benefit) on capital gains and losses | 4832 | 5000 | (4804) |
| Total current tax (benefit) expense incurred | $(14489) | $(25316) | $13699 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The components of deferred tax asset and deferred tax liability that make up a Net Deferred Tax Asset (DTA) at December 31, 2025 and 2024 are as follows:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **12/31/2025** | **12/31/2025** | **12/31/2025** | **12/31/2024** | **12/31/2024** | **12/31/2024** | **Change** | **Change** | **Change** |
| | Ordinary | Capital | Total | Ordinary | Capital | Total | Ordinary | Capital | Total |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Gross DTAs | $407903 | $11769 | $419672 | $471866 | $13878 | $485744 | $(63963) | $(2109) | $(66072) |
| Statutory Valuation Allowance Adjustments |  |  |  |  |  |  |  |  |  |
| Adjusted gross DTAs | 407903 | 11769 | 419672 | 471866 | 13878 | 485744 | (63963) | (2109) | (66072) |
| Deferred Tax Assets Nonadmitted | 187942 |  | 187942 | 269341 |  | 269341 | (81399) |  | (81399) |
| Admitted Adjusted Gross DTAs | 219961 | 11769 | 231730 | 202525 | 13878 | 216403 | 17436 | (2109) | 15327 |
| Gross Deferred tax liabilities | 44612 | 11769 | 56381 | 59269 | 13878 | 73147 | (14657) | (2109) | (16766) |
| Net Admitted Adjusted Gross DTAs | $175349 | $— | $175349 | $143256 | $— | $143256 | $32093 | $— | $32093 |

---

The Company has no unrecognized tax liability as of December 31, 2025 and December 31, 2024.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The admission calculation components by tax character of admitted adjusted gross deferred tax assets as the result of the application of SSAP No. 101 as of December 31, 2025 and 2024 are as follows:

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **12/31/2025** | **12/31/2025** | **12/31/2025** | **12/31/2024** | **12/31/2024** | **12/31/2024** | **Change** | **Change** | **Change** |
| | | Ordinary | Capital | Total | Ordinary | Capital | Total | Ordinary | Capital | Total |
|  |  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| a. | Federal income taxes paid in prior years recoverable through loss carrybacks | $— | $— | $— | $— | $— | $— | $— | $— | $— |
| b. | Adjusted gross DTAs expected to be realized (excluding the amount of DTAs from (a)) after application of the threshold limitation (the lesser of (b)1 and (b)2 below) | 175349 |  | 175349 | 143256 |  | 143256 | 32093 |  | 32093 |
|  | &nbsp;&nbsp;&nbsp;&nbsp;1. Adjusted gross DTAs expected to be realized following the balance sheet date | 175349 |  | 175349 | 143256 |  | 143256 | 32093 |  | 32093 |
|  | &nbsp;&nbsp;&nbsp;&nbsp;2. Adjusted gross DTAs allowed per limitation threshold | XXX | XXX | 175349 | XXX | XXX | 143256 | XXX | XXX | 32093 |
| c. | Adjusted gross DTAs (excluding the amount of DTAs from (a) and (b) above) offset by gross deferred tax liabilities | 44612 | 11769 | 56381 | 59269 | 13878 | 73147 | (14657) | (2109) | (16766) |
| d. | Deferred tax assets admitted as the result of application SSAP No. 101 Total | $219961 | $11769 | $231730 | $202525 | $13878 | $216403 | $17436 | $(2109) | $15327 |

---

The ratio percentage and the amount of adjusted capital and surplus used to determine the recovery period and threshold limitation are as follows:

---

| | | |
|:---|:---|:---|
| | **2025** | **2024** |
|  | *(Amounts in Thousands)* | *(Amounts in Thousands)* |
| Ratio percentage used to determine recovery period and threshold limitation amount | 910.42% | 716.81% |
| Amount of adjusted capital and surplus used to determine recovery period and threshold limitation | $1313345 | $1127179 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

Below shows the calculation to determine the impact of tax planning strategies on adjusted gross and net admitted DTAs:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **12/31/2025** | **12/31/2025** | **12/31/2024** | **12/31/2024** | **Change** | **Change** |
| | Ordinary | Capital | Ordinary | Capital | Ordinary | Capital |
|  | *(Amounts in Thousands)* | *(Amounts in Thousands)* | *(Amounts in Thousands)* | *(Amounts in Thousands)* | *(Amounts in Thousands)* | *(Amounts in Thousands)* |
| Adjusted gross DTAs | $407903 | $11769 | $471866 | $13878 | $(63963) | $(2109) |
| Percentage of adjusted gross DTAs by tax character attributable to the impact of tax planning strategies | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Admitted Adjusted Gross DTAs | $219961 | $11769 | $202525 | $13878 | $17436 | $(2109) |
| Percentage of net admitted adjusted gross DTAs by tax character admitted because of the impact of tax planning strategies | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |

---

The Company's tax planning strategies do not include the use of reinsurance.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The significant components of deferred tax assets and deferred tax liabilities are as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **12/31/2025** | **12/31/2024** | **Change** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Deferred Tax Assets |  |  |  |
| &nbsp;&nbsp;Ordinary: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Discounting of unpaid losses | $1955 | $1537 | $418 |
| &nbsp;&nbsp;&nbsp;&nbsp;Policyholder reserves | 20674 | 38817 | (18143) |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments | 42136 | 39760 | 2376 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred acquisition costs | 138026 | 97986 | 40040 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed assets | 565 |  | 565 |
| &nbsp;&nbsp;&nbsp;&nbsp;Compensation and benefits accrual | 11105 | 9502 | 1603 |
| &nbsp;&nbsp;&nbsp;&nbsp;Pension accrual | 5915 | 5153 | 762 |
| &nbsp;&nbsp;&nbsp;&nbsp;Receivables - nonadmitted | 3047 | 3624 | (576) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net operating loss carry-forward | 175510 | 263346 | (87836) |
| &nbsp;&nbsp;&nbsp;&nbsp;Tax credit carry-forward | 5199 | 5380 | (181) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other | 3769 | 6762 | (2992) |
| &nbsp;&nbsp;&nbsp;&nbsp;Subtotal | 407903 | 471867 | (63964) |
| &nbsp;&nbsp;&nbsp;&nbsp;Nonadmitted | 187942 | 269341 | (81399) |
| &nbsp;&nbsp;&nbsp;&nbsp;Admitted ordinary deferred tax assets | $219961 | $202526 | $17435 |
| &nbsp;&nbsp;Capital: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments | $11769 | $13878 | $(2109) |
| &nbsp;&nbsp;&nbsp;&nbsp;Subtotal | 11769 | 13878 | (2109) |
| &nbsp;&nbsp;&nbsp;&nbsp;Admitted capital deferred tax assets | $11769 | $13878 | $(2109) |
| &nbsp;&nbsp;Admitted deferred tax assets | $231730 | $216404 | $15326 |
| Deferred Tax Liabilities |  |  |  |
| &nbsp;&nbsp;Ordinary: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments | $26079 | $27197 | $(1118) |
| &nbsp;&nbsp;&nbsp;&nbsp;Fixed assets | 325 | 4179 | (3854) |
| &nbsp;&nbsp;&nbsp;&nbsp;Policyholder reserves | 1610 | 9279 | (7669) |
| &nbsp;&nbsp;&nbsp;&nbsp;Other (including items <5% of total ordinary tax liabilities) | 728 | 838 | (110) |
| &nbsp;&nbsp;&nbsp;&nbsp;Subtotal | $28743 | $41493 | $(12751) |
| &nbsp;&nbsp;Capital: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investments | $27638 | $31654 | $(4016) |
| &nbsp;&nbsp;&nbsp;&nbsp;Subtotal | $27638 | $31654 | $(4016) |
| &nbsp;&nbsp;Total deferred tax liabilities | $56381 | $73147 | $(16767) |
| Net deferred tax assets/(liabilities) | $175349 | $143257 | $32093 |

---

Valuation allowances are provided when it is considered more likely than not that some portion or all of the deferred tax assets will not be realized. As of December 31, 2025 and 2024, the Company had no valuation allowances.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The provision for federal income tax expense and change in deferred taxes differs from the amount which would be obtained by applying the statutory federal income tax rate to income (including capital items) before income taxes.

The significant items causing this difference are as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | | **Year Ended December 31** | **Year Ended December 31** | **Year Ended December 31** | **Year Ended December 31** | **Year Ended December 31** | **Year Ended December 31** |
| | | **2025** | **2025** | **2024** | **2024** | **2023** | **2023** |
| | | **Amount** | **Effective Tax Rate** | **Amount** | **Effective Tax Rate** | **Amount** | **Effective Tax Rate** |
|  |  | *(Amounts In Thousands)* | *(Amounts In Thousands)* | *(Amounts In Thousands)* | *(Amounts In Thousands)* | *(Amounts In Thousands)* | *(Amounts In Thousands)* |
| Ordinary income (loss) | Ordinary income (loss) | $248248 |  | $146496 |  | $421055 |  |
| Capital gains (losses) | Capital gains (losses) | (18267) |  | (9304) |  | (6764) |  |
| Total pretax income (loss) | Total pretax income (loss) | $229981 |  | $137192 |  | $414291 |  |
| Expected tax expense (benefit) at 21% statutory rate | Expected tax expense (benefit) at 21% statutory rate | 48296 | 21.0% | 28810 | 21.0% | 87001 | 21.0% |
| Increase (decrease) in actual tax reported resulting from: | Increase (decrease) in actual tax reported resulting from: |  |  |  |  |  |  |
| a. | Dividends received deduction | (12936) | (5.6)% | (10893) | (7.9)% | (9352) | (2.3)% |
| b. | Interest maintenance reserve | 1787 | 0.8% | 2685 | 2.0% | (4404) | (1.1)% |
| c. | Reinsurance | (4743) | (2.1)% | (4881) | (3.6)% | (4933) | (1.2)% |
| d. | Tax credits \*\* | (69) | —% | (403) | (0.3)% | (347) | (0.1)% |
| e. | Prior year tax (including net operating loss adjs.) \*\* | (1002) | (0.4)% | (13642) | (9.9)% | (35670) | (8.6)% |
| f. | Other | 8931 | 3.9% | 175 | 0.0% | 161 | 0.2% |
| Total income tax reported | Total income tax reported | $40265 | 17.5% | $1851 | 1.3% | $32456 | 7.8% |
| Current income taxes incurred | Current income taxes incurred | $(14489) | (6.3)% | $(25316) | (18.5)% | $13698 | 3.3% |
| Change in deferred income tax\* | Change in deferred income tax\* | 54754 | 23.8% | 27167 | 19.8% | 18758 | 4.5% |
| Total income tax reported | Total income tax reported | $40265 | 17.5% | $1851 | 1.3% | $32456 | 7.8% |

---

\* Excluding tax on unrealized gains (losses) and other surplus items.

\*\* On January 4, 2021, Voya Financial, Inc. completed a series of transactions pursuant to a Master Transaction Agreement with Resolution Life U.S. Holdings Inc. ("Resolution Life US"). As a part of these transactions, Resolution Life US acquired Voya Financial, Inc.'s wholly owned subsidiary, Security Life of Denver Company ("SLD"). SLD generated capital losses in the 2023 and 2022 tax years, which are included in the tax return for Voya Financial, Inc. The Company recorded a $14.2 and $36.6 tax benefit in 2024 and 2023, respectively, resulting in a decrease to the effective tax rate. The decrease to the effective tax rate consists of a $14.1 net operating loss and $0.1 foreign tax credit adjustment, included in the Prior year tax (including net operating loss adjs.) and Tax credit lines, respectively, as of December 31, 2024. The decrease to the effective tax rate consists of a $36.2 net operating loss and $0.4 foreign tax credit adjustment, included in the Prior year tax (including net operating loss adjs.) and Tax credit lines, respectively, as of December 31, 2023.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

As of December 31, 2025, the Company's tax credit and net operating loss carryforwards, along with origination and expiration dates, are as follows:

---

| | | | |
|:---|:---|:---|:---|
| | **Year of Origination** | **Year of Expiration** | **Amount** |
|  |  |  | *(In Thousands)* |
| Low Income Housing Tax Credit | 2013 | 2033 | $3904 |
| Low Income Housing Tax Credit | 2014 | 2034 | 2 |
| Low Income Housing Tax Credit | 2015 | 2035 | 2 |
| Total Low Income Housing Credit |  |  | $3908 |
| Foreign Tax Credit | 2015 | 2025 | $11 |
| Foreign Tax Credit | 2016 | 2026 | 204 |
| Foreign Tax Credit | 2017 | 2027 | 227 |
| Foreign Tax Credit | 2018 | 2028 | 341 |
| Foreign Tax Credit | 2019 | 2029 | 147 |
| Foreign Tax Credit | 2020 | 2030 | 152 |
| Foreign Tax Credit | 2022 | 2032 | 137 |
| Foreign Tax Credit | 2024 | 2034 | 71 |
| Total Foreign Tax Credit |  |  | $1290 |
| Net Operating Loss | 2018 | 2033 | $826479 |
| Net Operating Loss | 2019 | 2034 | 9284 |
| Total Net Operating Loss |  |  | $835763 |

---

There are no amounts of federal income tax incurred that will be available for recoupment in the event of future net losses from 2025 and 2024.

There were no deposits admitted under Section 6603 of the Internal Revenue Service Code as of December 31, 2025 and 2024.

The Company has no tax loss contingencies for which it is reasonably possible that the total liability will significantly increase within twelve months of the reporting date.

The Company has no transferable or non-transferable state tax credit assets as of December 31, 2025 and 2024.

The Company recognizes accrued interest and penalties related to tax contingencies in Federal income taxes and Federal income tax expense on the balance sheet and statements of operation, respectively. The Company had no accrued interest or penalties as of December 31, 2025 and 2024.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**10. Investment in and Advances to Subsidiaries**

The Company has one wholly owned insurance subsidiary, ReliaStar Life Insurance Company of New York ("RNY"). The company also has a minority ownership of Voya Special Investments, Inc. ("VSI"), a non-insurance subsidiary.

On June 24, 2025, the NAIC accepted the SUB-2 filing for VSI. The valuation at the time of filing was $54.8.

Amounts invested in SCA investments within the scope of SSAP 97 (except paragraph 8.b.i entities) are summarized as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **December 31** | **December 31** | **December 31** | **December 31** |
| | **2025** | **2025** | **2024** | **2024** |
| | **Admitted Amount** | **Nonadmitted Amount** | **Admitted Amount** | **Nonadmitted Amount** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| SCA Entity |  |  |  |  |
| &nbsp;&nbsp;Voya Special Investments, Inc. | $9027 | $— | $54798 | $— |
| Total amounts invested in SCA entities | $9027 | $— | $54798 | $— |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**11. Reinsurance**

The Company is involved in both ceded and assumed reinsurance with other companies for the purpose of diversifying risk and limiting exposure on larger risks. To the extent that the assuming companies become unable to meet their obligations under these treaties, the Company remains contingently liable to its policyholders for the portion reinsured. To minimize its exposure to significant losses from the reinsurer insolvencies, the Company evaluates the financial condition of the reinsurer and monitors concentrations of credit risk.

The company is not relieved of its primary obligation to the policyholder in a reinsurance transaction.

Assumed premiums amounted to $208.2, $74.9 and $79.5 for 2025, 2024 and 2023, respectively.

The Company's ceded reinsurance arrangements reduced certain items in the accompanying financial statements by the following amounts:

---

| | | | |
|:---|:---|:---|:---|
| | **2025** | **2024** | **2023** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Premiums for the year ended | $2716569 | $2938614 | $2586945 |
| Benefits paid or provided for the year ended | 3234355 | 3189820 | 2891336 |
| Policy and contract liabilities at year end | 13097863 | 13830404 | 14481060 |

---

The Company has no reinsurance agreements in effect under which the reinsurer may unilaterally cancel the agreement.

The amount of reinsurance credits taken for new agreements executed since January 1, 2025 which include policies or contracts that were in force or which had existing reserves established by the Company were $0.2.

The Company estimates that an aggregate reduction in surplus of $6.3 billion would occur in the event that all reinsurance agreements were terminated, by either party, as of December 31, 2025. The amount estimated as of December 31, 2024 and 2023 was $6.6 billion and $6.8 billion, respectively. This excludes any agreements under which the reinsurer may unilaterally cancel for reasons other than nonpayment of premium or other similar credits.

The Company has written off uncollectible reinsurance claims incurred balances due from Scottish Re of $0.4 in 2023.

The Company has reported claims incurred as a result of commutation of reinsurance with Texas Workers Compensation Insurance Fund of $6.4 and with All State Insurance Company of Canada of $0.3 in 2023.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**12. Capital and Surplus** 

Under Minnesota insurance regulations, the Company is required to maintain a minimum total capital and surplus of $2.0. Under Minnesota insurance law, an extraordinary dividend or distribution is defined as a dividend or distribution that, together with other dividends and distributions made within the preceding twelve months, exceeds the greater of (1) 10% of the insurer's policyholder surplus as of the preceding December 31 or (2) the insurer's net gain from operations for the twelve-month period ended the preceding December 31, in each case determined in accordance with statutory accounting principles. In addition, under Minnesota insurance law, no dividend or other distribution exceeding an amount equal to an insurance company's earned surplus may be paid without the domiciliary insurance regulator's prior approval. An extraordinary dividend or distribution cannot be paid without the prior approval of the Minnesota Department of Commerce-Insurance Division.

On March 8, 2024, the Company declared an ordinary dividend in the amount of $57.0, which was paid to its sole shareholder, Voya Holdings, on March 25, 2024.

On July 15, 2024, the Company declared an ordinary dividend in the amount of $345.0, which was paid to its sole shareholder, Voya Holdings, on July 26, 2024.

Life and health insurance companies are subject to certain Risk Based Capital ("RBC") requirements as specified by the NAIC. Under those requirements, the amount of capital and surplus maintained by a life and health insurance company is to be determined based on the various risk factors related to it. The Company exceeded the minimum RBC requirements that would require any regulatory or corrective action for all periods presented herein.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**13. Fair Values of Financial Instruments**

The fair value of an asset is the amount at which that asset could be bought or sold in a current transaction between willing parties, that is, other than in a forced or liquidation sale. The fair value of a liability is the amount at which that liability could be incurred or settled in a current transaction between willing parties, that is, other than in a forced or liquidation sale.

Fair values are based on quoted market prices when available. When market prices are not available, fair value is generally estimated using discounted cash flow analyses, incorporating current market inputs for similar financial instruments with comparable terms and credit quality (matrix pricing). In instances where there is little or no market activity for the same or similar instruments, the Company estimates fair value using methods, models and assumptions that management believes market participants would use to determine a current transaction price. These valuation techniques involve some level of management estimation and judgment which becomes more significant with increasingly complex instruments or pricing models. Where appropriate, adjustments are included to reflect the risk inherent in a particular methodology, model or input used.

In cases where quoted market prices are not available, fair values are based on estimates using present value or other valuation techniques. Those techniques are significantly affected by the assumptions used, including the discount rate and estimates of future cash flows. In that regard, the derived fair value estimates cannot be substantiated by comparison to independent markets and, in many cases, could not be realized in immediate settlement of the financial instrument. Accordingly, the aggregate fair value amounts presented herein do not represent the underlying value of the Company.

Life insurance liabilities that contain mortality risk and all nonfinancial instruments have been excluded from the disclosure requirements. However, the fair values of liabilities under all insurance contracts are taken into consideration in the Company's overall management of interest rate risk, such that the Company's exposure to changing interest rates is minimized through the matching of investment maturities with amounts due under insurance contracts.

The Company's financial assets and liabilities have been classified, for disclosure purposes, based on a hierarchy defined by SSAP No. 100, *Fair Value.*

The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure fair value fall within different levels of the hierarchy, the category level is based on the lowest priority level input that is significant to the fair value measurement of the instrument. Financial assets and liabilities recorded at fair value on the balance sheets are categorized as follows:

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;▪ Level 1 - Unadjusted quoted prices for identical assets or liabilities in an active market.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;▪ Level 2 - Quoted prices in markets that are not active or inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)Quoted prices for similar assets or liabilities in active markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Quoted prices for identical or similar assets or liabilities in non-active markets;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)Inputs other than quoted market prices that are observable; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d)Inputs that are derived principally from or corroborated by observable market data through correlation or other means.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;▪ Level 3 - Prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These valuations, whether derived internally or obtained from a third party, use critical assumptions that are not widely available to estimate market participant expectations in valuing the asset or liability.

The following valuation methods and assumptions were used by the Company in estimating the reported values for the investments and derivatives described below, though the Company's composition of asset mix can change from period to period and all assets described below may not be held at December 31, 2025.

*Bonds and other invested assets:* Fair values for corporate bonds, asset-backed securities, U.S. agency bonds, and foreign securities are obtained through observable pricing method such as matrix pricing, market corroborated pricing, or inputs such as yield curves and indices. Several commercial pricing services are used, which incorporate a variety of market observable information in their valuation techniques, including benchmark yields, broker-dealer quotes, credit quality, issuer spreads, bids, offers and other reference data to provide estimated fair values.

Privately placed are determined using a matrix-based pricing model. The model considers the current level of risk-free interest rates, current corporate spreads, the credit quality of the issuer, and cash flow characteristics of the security. Also considered are factors such as the net worth of the borrower, the value of collateral, the capital structure of the borrower, the presence of guarantees, and the Company's evaluation of the borrower's ability to compete in its relevant market. Using this data, the model generates estimated market values which the Company considers reflective of the fair value of each privately placed bond.

When a price cannot be obtained from a commercial pricing service, independent broker quotes are solicited. The valuations obtained from brokers and third-party commercial pricing services are non-binding. The valuations are reviewed and validated monthly through

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

the internal valuation committee price variance review, comparisons to internal pricing models, back testing to recent trades, or monitoring of trading volumes.

*Preferred and Common Stock:* Fair values of publicly traded equity securities are generally based upon quoted market price, while some preferred and common stock prices are obtained through commercial pricing services. Other equity securities, typically private equities or equity securities not traded on an exchange are valued by other sources such as analytics or brokers.

*Mortgage loans:* Fair values for commercial real estate loans were generated using a discounted cash flow analyses which utilizes rates currently being offered in the marketplace for similar loans to borrowers with similar credit ratings. Loans with similar characteristics are aggregated for purposes of the calculations. Loans in good standing are discounted using interest rates determined by U.S. Treasury yields on December 31st and spreads applied on new loans with similar characteristics. The amortizing features of all loans are incorporated in the valuation. Where data on option features is available, option values are determined using a binomial valuation method, and are incorporated into the mortgage valuation. Restructured loans are valued in the same manner; however, these loans were discounted at a greater spread to reflect increased risk.

*Contract loans:* Fair values approximate the carrying value of the loans. Contract loans are collateralized by the cash surrender value of the associated insurance contracts.

*Cash equivalents and short-term investments:* Fair values are generally determined based on most quoted market prices.

*Derivatives:* Fair values are generally calculated based on broker/dealer valuations or on internal discounted cash flow pricing models. These models take into account current cash flow assumptions, the counterparties' credit standing, and observable key financial data, such as yield curves, exchange rates, Standard and Poor's ("S&P") 500 Index prices, Secured Overnight Financing Rate ("SOFR"), and Overnight Index Swap Rates ("OIS"), which are obtained from third party sources and uploaded into the derivative accounting system. For those derivatives that are unable to be valued by the accounting system, the Company typically utilizes values established by third party brokers. Valuations for the Company's futures contracts are based on unadjusted quoted prices from an active exchange. Derivatives which qualify for hedge accounting treatment are reported in a manner that is consistent with the accounting for the hedged asset or liability.

*Assets held in separate accounts:* Fair values are calculated based on the underlying investments in the separate accounts. The underlying investments include mutual funds, short-term investments and cash, the valuations of which are based upon a quoted market price. The underlying instruments in bonds have valuations that are obtained from third-party

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

commercial pricing services and brokers and are classified in the fair value hierarchy consistent with the policies described above for bonds.

*Supplementary contracts and immediate annuities:* Fair value are estimated as the present value of expected cash flows associated with the contract liabilities discounted using risk-free rates plus an adjustment for nonperformance risk. The valuation is consistent with current market parameters. Margins for non-financial risks associated with the contract liabilities are also included.

*Deposit type contracts:* Fair values are estimated as the present value of expected cash flows associated with the contract liabilities discounted using risk-free rates plus an adjustment for nonperformance risk. The valuation is consistent with current market parameters. Margins for non-financial risks associated with the contract liabilities are also included. For certain deposit type contracts, fair value is estimated by discounting cash flows at rates that are risk-free rates plus an adjustment for nonperformance risk.

*Long-term debt:* Fair values are based upon discounted future cash flows using a discount rate approximating the current market rate, incorporating nonperformance risk.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The following table shows the Company's financial instruments and the Level within the fair value hierarchy in which the fair value measurements fall as of December 31, 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Type of Financial Instrument** | **Aggregate Fair Value** | **Carrying Value** | **Level 1** | **Level 2** | **Level 3** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **Assets:** |  |  |  |  |  |
| Issuer Credit Obligations | $3308866 | $3527673 | $98480 | $2825764 | $384622 |
| Assets-Backed Securities | 2451389 | 2661690 |  | 2259262 | 192127 |
| Preferred stock | 109839 | 109039 | 2719 | 36172 | 70948 |
| Common stock | 39607 | 39607 | 1628 | 31368 | 6612 |
| Mortgage loans | 900286 | 915530 |  |  | 900286 |
| Policy loans |  |  |  |  |  |
| Contract loans | 147746 | 147746 |  | 147746 |  |
| Other invested assets | 185978 | 186123 |  | 171608 | 14370 |
| Cash equivalents and short-term investments | 106205 | 106205 | 106205 |  |  |
| Derivatives |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Credit contracts | 4 |  |  | 4 |  |
| &nbsp;&nbsp;&nbsp;Equity contracts | 2388 | 2388 |  | 2388 |  |
| &nbsp;&nbsp;&nbsp;Foreign exchange contracts | 1225 | 883 |  | 1225 |  |
| &nbsp;&nbsp;&nbsp;Interest rate contracts | 37608 | 38486 | 334 | 37273 |  |
| Separate account assets | 2792595 | 2792595 | 2791860 | 736 |  |
| Total Assets | $10083737 | $10527967 | $3001226 | $5513546 | $1568965 |
| **Liabilities:** |  |  |  |  |  |
| Supplementary contracts and immediate annuities | $68526 | $69432 | $— | $— | $68526 |
| Deposit type contracts | 776346 | 774362 |  | 776346 |  |
| Derivatives |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Credit contracts | 27 |  |  | 27 |  |
| &nbsp;&nbsp;&nbsp;Equity contracts | 1670 | 1670 |  | 1670 |  |
| &nbsp;&nbsp;&nbsp;Foreign exchange contracts | 3215 | 5091 |  | 3215 |  |
| &nbsp;&nbsp;&nbsp;Interest rate contracts | 54684 | 37496 |  | 54684 |  |
| Total Liabilities | $904468 | $888051 | $— | $835942 | $68526 |

---

The Company did not have any financial instruments for which it was not practicable to estimate fair value or measured and reported at net asset value (NAV) as of December 31, 2025.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The following table shows the Company's financial instruments and the Level within the fair value hierarchy in which the fair value measurements fall as of December 31, 2024:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Type of Financial Instrument** | **Aggregate Fair Value** | **Carrying Value** | **Level 1** | **Level 2** | **Level 3** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **Assets:** |  |  |  |  |  |
| Bonds, including securities pledged | $5942816 | $6553820 | $55686 | $5477158 | $409973 |
| Preferred stock | 67470 | 69232 | 2817 |  | 64654 |
| Common stock | 37635 | 37635 | 2197 | 31659 | 3779 |
| Mortgage loans | 920735 | 963460 |  |  | 920735 |
| Contract loans | 161973 | 161973 |  | 161973 |  |
| Other invested assets | 133537 | 140061 |  | 133412 | 125 |
| Cash equivalents and short-term investments | 87226 | 87225 | 82672 | 748 | 3807 |
| Derivatives |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Equity contracts | 2198 | 2198 |  | 2198 |  |
| &nbsp;&nbsp;&nbsp;Foreign exchange contracts | 7576 | 6350 |  | 7576 |  |
| &nbsp;&nbsp;&nbsp;Interest rate contracts | 45994 | 44788 | 5 | 45989 |  |
| Separate account assets | 2645800 | 2645800 | 2635872 | 9928 |  |
| Total Assets | $10052960 | $10712543 | $2779249 | $5870641 | $1403073 |
| **Liabilities:** |  |  |  |  |  |
| Supplementary contracts and immediate annuities | $78109 | $79197 | $— | $— | $78109 |
| Deposit type contracts | 925944 | 923916 |  | 925944 |  |
| Derivatives |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Credit contracts | 113 | 58 |  | 113 |  |
| &nbsp;&nbsp;&nbsp;Equity contracts | 1485 | 1485 |  | 1485 |  |
| &nbsp;&nbsp;&nbsp;Foreign exchange contracts | (32) | 341 |  | (32) |  |
| &nbsp;&nbsp;&nbsp;Interest rate contracts | 51111 | 45112 | 782 | 50329 |  |
| Short-term debt | 68000 | 68000 |  | 68000 |  |
| Total Liabilities | $1124730 | $1118109 | $782 | $1045839 | $78109 |

---

The Company did not have any financial instruments for which it was not practicable to estimate fair value or measured and reported at net asset value (NAV) as of December 31, 2024.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The table below shows assets and liabilities measured and reported at fair value as of December 31, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Level 1** | **Level 2** | **Level 3** | **Total** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **Assets:** |  |  |  |  |
| Asset-Backed Securities | $— | $1257 | $— | $1257 |
| Preferred stock | 2719 | 1036 | 32932 | 36687 |
| Common stock | 1628 | 31368 | 6612 | 39608 |
| Other invested assets |  | 303 | 1059 | 1362 |
| Derivatives |  |  |  |  |
| &nbsp;&nbsp; Equity contracts |  | 2388 |  | 2388 |
| &nbsp;&nbsp; Foreign exchange contracts |  | 4 |  | 4 |
| &nbsp;&nbsp; Interest rate contracts | 334 | 38150 |  | 38484 |
| Separate account assets | 2791860 | 736 |  | 2792595 |
| Total assets | $2796541 | $75242 | $40603 | $2912385 |
| **Liabilities:** |  |  |  |  |
| Supplementary contracts and immediate annuities | $— | $— | $33199 | $33199 |
| Deposit type contracts |  | 246922 |  | 246922 |
| Derivatives |  |  |  |  |
| &nbsp;&nbsp; Equity contracts |  | 1670 |  | 1670 |
| &nbsp;&nbsp; Foreign exchange contracts |  | 388 |  | 388 |
| &nbsp;&nbsp; Interest rate contracts |  | 37495 |  | 37495 |
| Total liabilities | $— | $286475 | $33199 | $319674 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The table below shows assets and liabilities measured and reported at fair value as of December 31, 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Level 1** | **Level 2** | **Level 3** | **Total** |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| **Assets:** |  |  |  |  |
| Preferred stock | $2817 | $— | $32235 | $35052 |
| Common stock | 2197 | 31659 | 3779 | 37635 |
| Other invested assets |  | 484 | 125 | 609 |
| Derivatives |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Equity contracts |  | 2198 |  | 2198 |
| &nbsp;&nbsp;&nbsp;Foreign exchange contracts |  | 379 |  | 379 |
| &nbsp;&nbsp;&nbsp;Interest rate contracts |  | 44788 |  | 44788 |
| Separate account assets | 2635872 | 9928 |  | 2645800 |
| Total assets | $2640886 | $89436 | $36139 | $2766461 |
| **Liabilities:** |  |  |  |  |
| Supplementary contracts and immediate annuities | $— | $— | $38847 | $38847 |
| Deposit type contracts |  | 395571 |  | 395571 |
| Derivatives |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Equity contracts |  | 1485 |  | 1485 |
| &nbsp;&nbsp;&nbsp;Interest rate contracts | 780 | 44327 |  | 45107 |
| Total liabilities | $780 | $441383 | $38847 | $481010 |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

The following table summarizes the change in fair value of the Company's Level 3 assets and liabilities for the year ended December 31, 2025:

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| Description | Beginning of the Year | Transfers into Level 3 | Transfers Out of Level 3 | Total Gains and (Losses) Included in Net Income | Total Gains and (Losses) Included in Surplus | Purchases | Issuances | Sales | Settlements | End of the Year |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Assets |  |  |  |  |  |  |  |  |  |  |
| Preferred Stock | $32235 | $— | $— | $— | $697 | $— | $— | $— | $— | $32932 |
| Common Stock | 3779 |  |  | (1008) | 2269 | 2743 |  | (1171) |  | 6612 |
| Other Invested Assets | 125 |  |  |  | (80) | 1372 |  | (125) | (234) | 1059 |
| Total | $36139 | $— | $— | $(1008) | $2886 | $4115 | $— | $(1296) | $(234) | $40603 |
| Liabilities |  |  |  |  |  |  |  |  |  |  |
| Supplementary contracts and immediate annuities | $38847 | $— | $— | $— | $— | $— | $— | $— | $(5648) | $33199 |
| Total | $38847 | $— | $— | $— | $— | $— | $— | $— | $(5648) | $33199 |

---

There were no transfers into and out of Level 3 during the year ended December 31, 2025.

The following table summarizes the change in fair value of the Company's Level 3 assets and liabilities for the year ended December 31, 2024:

---

| | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| Description | Beginning of the Year | Transfers into Level 3 | Transfers Out of Level 3 | Total Gains and (Losses) Included in Net Income | Total Gains and (Losses) Included in Surplus | Purchases | Issuances | Sales | Settlements | End of the Year |
|  | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* | *(In Thousands)* |
| Preferred Stock | $33317 | $— | $— | $— | $(1082) | $— | $— | $— | $— | $32235 |
| Common Stock | 3254 |  |  |  | 525 |  |  |  |  | 3779 |
| Other Invested Assets |  | 125 |  |  |  |  |  |  |  | 125 |
| Separate account assets | 623 |  | (576) |  | (46) |  |  |  |  |  |
| Total | $37194 | $125 | $(576) | $— | $(603) | $— | $— | $— | $— | $36139 |
| Liabilities |  |  |  |  |  |  |  |  |  |  |
| Supplementary contracts and immediate annuities | $44548 | $— | $— | $— | $— | $— | $— | $— | $(5701) | $38847 |
| Total | $44548 | $— | $— | $— | $— | $— | $— | $— | $(5701) | $38847 |

---

Transfers into and out of Level 3 during the year ended December 31, 2024 are due to the variation in inputs relied upon for valuation each quarter. Securities that are primarily valued using independent broker quotes, when prices are not available from one of the commercial pricing services, are reflected as transfers into Level 3. These securities are generally less liquid with very limited trading activity or where less transparency exists corroborating the inputs to the valuation methodologies. When securities are valued using more widely available information, the securities are transferred out of Level 3 and into Level 1 or 2, as appropriate.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**14. Commitments and Contingencies**

*Operating Leases*: The Company is party to certain cost sharing agreements with other affiliated Voya Financial, Inc. companies. Included in these cost sharing arrangements is rent expense, which is allocated to the Company in accordance with systematic cost allocation arrangements. During the years ended December 31, 2025, 2024 and 2023, rent expense totaled $0.9, $1.0 and $1.2, respectively.

*Legal Proceedings:* The Company is involved in threatened or pending lawsuits or arbitrations arising from the normal conduct of business. Due to the climate in insurance and business litigation and arbitrations, suits against the Company sometimes include claims for substantial compensatory, consequential or punitive damages and other types of relief. Certain claims are asserted as class actions, purporting to represent a group of similarly situated individuals.

*Regulatory Matters:* As with many financial services companies, the Company periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations in connection with examinations, inquiries, investigations and audits of the products and practices of the Company or the financial services industry. Some of the investigations, examinations, audits and inquiries could result in regulatory action against the Company. The potential outcome of such regulatory action is difficult to predict, but could subject the Company to adverse consequences, including, but not limited to, additional payments to beneficiaries, settlement payments, penalties, fines and other financial liability, and changes to the Company's policies and procedures. The potential economic consequences cannot be predicted, but management does not believe that the outcome of any such action will have a material adverse effect on the Company's financial position.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

*Investment Purchase Commitments*: As part of its overall investment strategy, the Company has entered into agreements to purchase private placements and commercial mortgage loans of $269.4 and $140.7 at December 31, 2025 and 2024, respectively. The Company is also committed to provide additional capital contributions of $274.4 and $315.6 at December 31, 2025 and 2024, respectively, in partnerships.

*Liquidity*: The Company's principal sources of liquidity are product charges, investment income, premiums, proceeds from the maturity and sale of investments, and capital contributions. Primary uses of these funds are payments of commissions and operating expenses, interest credits, investment purchases, and contract maturities, death benefits, withdrawals, surrenders and dividends to its parent.

The Company's liquidity position is managed by maintaining adequate levels of liquid assets, such as cash, cash equivalents, and short-term investments. In addition, the investment portfolio is primarily composed of high quality fixed income investments, which include holdings of U.S. Government securities, high quality corporate bonds and agency backed residential mortgage backed securities. Asset/liability management is integrated into many aspects of the Company's operations, including investment decisions, product development, and determination of crediting rates. As part of the risk management process, different economic scenarios are modeled, including cash flow testing required for insurance regulatory purposes, to determine that existing assets are adequate to meet projected liability cash flows.

The fixed account liabilities are supported by a general account portfolio principally composed of fixed rate investments with matching duration characteristics that can generate predictable, steady rates of return. The portfolio management strategy for the general account considers the assets available-for-sale. This strategy enables the Company to respond to changes in market interest rates, prepayment risk, relative values of asset sectors and individual securities and loans, credit quality outlook, and other relevant factors. The Company's asset/liability management discipline includes strategies to minimize exposure to loss as interest rates and economic and market conditions change. In executing this strategy, the Company uses derivative instruments to manage these risks. The Company's derivative counterparties are of high credit quality.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**15. Financing Agreements** 

The Company has entered into a reciprocal loan agreement with Voya Financial, Inc. to promote efficient management of cash and liquidity and to provide for unanticipated short-term cash requirements. Under this agreement, which expires December 31, 2030, the Company and Voya Financial, Inc. can borrow up to 3% of the Company's admitted assets excluding separate accounts as of December 31 of the preceding year from one another. Interest on any borrowing by a subsidiary under a reciprocal loan agreement is charged at a rate based on the prevailing market rate for similar third-party borrowing or securities. Under this agreement, the Company received $4.2 interest income for the year ended December 31, 2025, and $4.8 and $4.9 for the years ended December 31, 2024 and 2023, respectively.

There was $0.4 interest expense incurred on borrowed money for the years ended December 31, 2025, and minimal interest expense incurred on borrowed money 2024 and 2023.

As of December 31, 2025, the Company had no outstanding receivable including principal and interest and no outstanding payable under the reciprocal loan agreement with Voya Financial, Inc. As of December 31, 2024, the Company had a $68.0 outstanding payable to Voya Financial, Inc.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**16. Related Party Transactions**

The Company has entered into various management and services contracts with other affiliated Voya Financial, Inc. companies. The costs associated with these agreements are allocated among those companies in accordance with systematic cost allocation methods. Balances due to/from affiliates are settled monthly. The Company's material related party agreements are detailed below:

*Investment Management*: The Company has entered into an investment advisory agreement with Voya Investment Management LLC ("VIM") under which VIM provides the Company with investment management services. For the years ended December 31, 2025, 2024 and 2023, expenses were incurred in the amounts of $18.4, $21.5, and $19.0, respectively.

The Company has entered into a services agreement with VSC whereby VSC provides certain administrative, management, professional, advisory, consulting and other services to the Company. For the years ended December 31, 2025, 2024 and 2023, expenses were incurred in the amounts of $544.0, $449.9 and $448.3 respectively.

*Tax Sharing Agreements*: See Note 9 for disclosure related to the federal tax sharing agreement.

The Company has also entered into a state tax sharing agreement with Voya Financial, Inc. and each of the specific subsidiaries that are parties to the agreement. The state tax agreement applies to situations in which Voya Financial, Inc. and all or some of the subsidiaries join in the filing of a state or local franchise, income tax, or other tax return on a consolidated, combined or unitary basis.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**17. Accident and Health Contracts**

The change in the liability for unpaid accident and health claims and claim adjustment expenses is summarized as follows:

---

| | | |
|:---|:---|:---|
| | **2025** | **2024** |
|  | *(In Thousands)* | *(In Thousands)* |
| Balance at January 1 | $783615 | $538349 |
| Less reinsurance recoverables | 101931 | 105780 |
| Net balance at January 1 | 681684 | 432569 |
| Incurred related to: |  |  |
| Current year | 958177 | 1162752 |
| Prior years | (485824) | (276453) |
| Total incurred | 472353 | 886299 |
| Paid related to: |  |  |
| Current year | 433019 | 501229 |
| Prior years | 162397 | 135954 |
| Total paid | 595416 | 637183 |
| Net balance at December 31 | 558623 | 681684 |
| Plus reinsurance recoverables | 100797 | 101931 |
| Balance at December 31 | $659420 | $783615 |

---

The change in incurred losses and loss adjustment expenses attributable to insured events of prior years is generally the result of ongoing analysis of recent loss development trends, but could include a reduction due to retrospectively rated contracts. Incurred and paid claims are presented net of reinsurance. Original estimates are increased or decreased as additional information becomes known regarding individual claims.

The liability for unpaid accident and health claims and claim adjustment expenses is included in accident and health reserves and policy and contract claims on the balance sheets.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**18. Retrospectively Rated Contracts**

The Company estimates accrued retrospective premium adjustments for its group life and health insurance business through a mathematical approach using an algorithm of the Company's underwriting rules and experience rating practices. The Company records accrued retrospective premium as an adjustment to earned premium. The amount of group life premiums written, net of reinsurance, by the Company that was subject to retrospective rating features was $0.0, $15.8, and $16.7 for December 31, 2025, 2024, and 2023, respectively. This represented 0.0%, 8.4%, and 9.6% of the total group life premiums written, for December 31, 2025, 2024 and 2023, respectively. The amount of group health premiums written, net of reinsurance, which are subject to retrospective rating features by the Company was $138.8, $153.7, and $132.6 for December 31, 2025, 2024 and 2023, respectively. This represented 13.7%, 15.1%, and 14.9% of net group health premiums written at December 31, 2025, 2024 and 2023, respectively.

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**19. Direct Premiums Written/Produced by Managing General Agents/Third Party**

**Administrators** 

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name of Managing General Agent or Third Party Administrator** | **FEIN Number** | **Exclusive Contract** | **Type of Business Written** | **Type of Authority Granted \*** | **Total Direct Premiums Written** |
|  |  |  |  |  | *(In Thousands)* |
| **2025** |  |  |  |  |  |
| Disability Reinsurance Management Services<br>One Riverfront Plaza<br>Westbrook, ME 04092-9700 | 01-0483086 | No | Disability Income | C,CA,B,U | $283348 |
| Total |  |  |  |  | $283348 |
| **2024** |  |  |  |  |  |
| Disability Reinsurance Management Services<br>One Riverfront Plaza<br>Westbrook, ME 04092-9700 | 01-0483086 | No | Disability Income | C,CA,B,U | $279625 |
| Total |  |  |  |  | $279625 |
| **2023** |  |  |  |  |  |
| Disability Reinsurance Management Services<br>One Riverfront Plaza<br>Westbrook, ME 04092-9700 | 01-0483086 | No | Disability Income | C,CA,B,U | $252475 |
| Total |  |  |  |  | $252475 |
| \* C = Claims payment, CA = Claims adjustment, B = Binding authority, U = Underwriting | \* C = Claims payment, CA = Claims adjustment, B = Binding authority, U = Underwriting | \* C = Claims payment, CA = Claims adjustment, B = Binding authority, U = Underwriting | \* C = Claims payment, CA = Claims adjustment, B = Binding authority, U = Underwriting | \* C = Claims payment, CA = Claims adjustment, B = Binding authority, U = Underwriting | \* C = Claims payment, CA = Claims adjustment, B = Binding authority, U = Underwriting |

---

------

**RELIASTAR LIFE INSURANCE COMPANY**

**Notes to Financial Statements – Statutory Basis**

**December 31, 2025&nbsp;&nbsp;&nbsp;&nbsp;**

____________________________________________________________________________________________________________________________________________________________

(Dollar amounts in millions, unless otherwise stated)

**20. Subsequent Events**

During the first quarter of 2026, the Company sold the Atlanta building. The sale resulted in an impairment loss of $7.3, which reflects the excess of the building's carrying value over the final sale proceeds, net of closing costs. Because the conditions leading to the sale and the related loss existed as of December 31, 2025, the transaction represents a Type I recognized subsequent event.

On March 3, 2026, the Company declared an ordinary dividend in the amount of $267.0, which was paid to its sole shareholder, Voya Holdings, on March 16, 2026.

The Company is not aware of any other events occurring subsequent to December 31, 2025 that may have a material effect on the Company's financial statements. The Company evaluated events subsequent to December 31, 2025 through April 1, 2026, the date the financial statements were available to be issued.

<br>